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About this toolkit
This toolkit on HIV in prisons aims to provide information and guidance primarily to 
individuals and institutions with responsibilities for prisons and prisoners, and to 
people who work in and with prisons. In addition, it will assist everyone who has 
 anything to do with prisons.
It is written primarily for use in low- and middle-income countries, but will also be a 
useful resource for individuals and institutions in high-income countries.
Its focus is on HIV, but it recognizes that other diseases—in particular hepatitis and 
tuberculosis—are linked to HIV and also represent serious problems in prisons.
It is based on the requirements of international law and standards, scientific evidence 
and best practice experience.
It complements a series of other documents produced by United Nations agencies, and 
refers to them, and to other documents, for additional information on HIV in prisons.
How does the toolkit relate to other United Nations documents 
on HIV in prisons?
This toolkit is part of a set of documents produced by United Nations agencies aimed at providing 
up-to-date evidence-informed guidance on HIV in prisons. These include:
HIV/AIDS Prevention, Care, Treatment and Support in Prison Settings: A Framework for an  "
Effective National Response. This document provides a framework for mounting an effective 
national response to HIV in prisons, based on the evidence reviewed in the Evidence for Action 
Technical Papers and on accepted international standards and guidelines, and reflecting 
principles of good prison management. It sets out 11 principles and 100 actions. Available at 
www.unodc.org/pdf/HIV-AIDS_prisons_July06.pdf 
Policy Brief: Reduction of HIV Transmission in Prisons.  " This document provides a two-page 
 summary of the evidence related to HIV prevention programmes in prisons. Available in English 
and Russian via www.who.int/hiv/pub/idu/idupolicybriefs/en/index.html.
Evidence for Action Technical Papers on Effectiveness of Interventions to Address HIV in  "
 Prisons. These papers provide a comprehensive review of the effectiveness of interventions to 
address HIV in prison settings. They contain the most detailed and rigorous analysis of the 
 evidence related to HIV in prisons undertaken to date, with hundreds of references. They are 
essential background documents for everyone interested in HIV in prisons, and serve as companion 
pieces to the toolkit and framework document. They are available in English and Russian via 
www.unodc.org/unodc/en/hiv-aids/publications.html or www.who.int/hiv/idu/prison/en/index.html.
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As it complements these papers, the toolkit does not contain references. Detailed  references 
for all statements made in the toolkit are provided in the “Evidence for Action Technical 
Papers—Interventions to address HIV in prisons” 
(WHO/UNODC/UNAIDS, 2007) available at www.unodc.org/unodc/en/hiv-aids/publications.html 
or www.who.int/hiv/idu/prison/en/index.html.
!
Another document (HIV/AIDS and HCV in Prisons: A Select Annotated Bibliography) was prepared for the 
Third International Policy Dialogue on HIV/AIDS in Prisons, hosted by the Government of Canada and 
UNAIDS. It contains the references and short summaries of hundreds of documents dealing with issues 
related to HIV in prisons. It aims to increase knowledge of and access to the literature on issues 
related to HIV and HCV in prisons; and to increase the capacity of governments, prison systems, 
non- governmental organizations, and researchers to respond effectively to the challenges posed 
by HIV and HCV in prisons. It was updated in 2007 and is available in English and French via 
www.hc-sc.gc.ca/ahc-asc/pubs/int-aids-sida/hiv-vih-aids-sida-prison-carceral_e.html.
The toolkit is divided into five modules
Module 1 is for anyone who has anything to do with prisons and should be read in 
conjunction with the other modules. It provides essential background information about 
HIV and explains why and how addressing HIV in prisons is linked to the wider 
 questions of prison reform and to human rights. 
Module 2 is intended primarily for policymakers, politicians and legislators who are 
responsible for developing policies and laws on prisons, criminal justice, and health. 
We hope it will be useful to:
Ministries of justice and ministries of interior or other ministries that have  "
oversight of prison issues, but also ministries of health (since prison health 
is public health);
Parliamentarians with interest in justice, corrections, and health;  "
Senior government officials in departments of justice, interior, corrections,  "
and health;
Judges, magistrates, prosecutors and other state actors in the criminal justice  "
system;
Civil society organizations with an interest in prisons, HIV, and human rights  "
of prisoners;
Donors who provide funding to the programmes aimed at strengthening  "
 governance, the rule of law and adherence to human rights, as well as 
 activities aimed at promoting and protecting health.
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Module 3 is intended primarily for those who have responsibilities for the  management 
of prison systems and individual prisons. We hope it will be useful to:
Heads of national and provincial or regional prison administrations; "
Prison directors and managers; "
Judges and inspectors with responsibilities for external scrutiny of prison  "
conditions.
Module 4 is intended primarily for people who work in prisons and provide security 
or programmes for prisoners on a day-to-day basis. We hope it will be useful to:
Prison officers; "
Teachers and instructors working in prisons; "
Civil society organizations, including volunteers and staff of non-governmental  "
organizations, including faith-based organizations, who visit prisons and 
undertake activities in prisons.
Module 5 is intended primarily for health staff who work in prisons. We hope it will 
be useful to:
Medical doctors; "
Nursing staff; "
Paramedical and ancillary workers; "
Counsellors and psychiatrists. "
Each module takes a similar approach and discusses the same issues, but identifies 
the issues that are of particular relevance for the different target audiences and what 
those audiences can and must do to address HIV in prisons.
Although much can be done by individuals committed to particular parts of the overall 
task of addressing HIV in prisons, an appropriate response can best be achieved if all 
partners are active and involved.
Why a toolkit on HIV in prisons?
HIV is a serious health threat for prison populations, and poses significant challenges for 
prison and public health authorities and national governments. 
Worldwide, the levels of HIV infection among prison populations tend to be higher than 
in the populations outside prisons. This situation is often accompanied and exacerbated 
by high rates of other infections such as hepatitis B and C and tuberculosis.
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In many countries, the groups most vulnerable to HIV are also groups at increased risk 
for criminalization and incarceration, as many of the same social and economic condi-
tions that increase vulnerability to HIV also increase vulnerability to imprisonment. As a 
result, in some countries the populations with the highest rates of HIV infection are also 
disproportionately represented within the prisons. In countries where the injection of 
drugs is present, the prevalence of injecting drug users in prison will be high.
In prison, there is a high risk of transmission of HIV and other infections. Prisons are 
frequently overcrowded and characterized by an atmosphere of violence and fear. Even 
though sexual activity is forbidden, it nevertheless occurs in prisons. As within the gene-
ral community, despite the control measures implemented, illicit drugs are circulating. 
Tensions abound. Release from these tensions, and difficulties of prison life, is often found 
in the consumption of drugs or in sex. Often condoms are not available. When drugs are 
injected, needles and syringes—being scarce, illegal and difficult to hide—are almost 
 always shared, carrying with them a high risk of transmission of infectious  diseases. 
 Tattooing is also common in prison, part of the subculture, but in the absence of clean 
equipment can also be a factor of transmission. Health, dental and gynaecological 
services are often poorer and not always safe as it relates to the risk of transmission of 
infections.
Prisoners are most at risk, but prison staff shares this high-risk environment with the 
prisoners. Because HIV is transmitted only through contact with blood or other body 
 fluids, prison staff can adopt simple and routine practices to greatly reduce the likelihood 
that they will become infected with HIV as a result of an occupational exposure, practices 
that are called “universal precautions”.1 However, other infections that can spread more 
easily than HIV—in particular tuberculosis—pose a real threat to prison staff.
In addition, prison health is public health. Prisoners and prison staff are in continuous 
contact with the community. Prisoners come from the community and most go back to the 
community, often after serving short sentences. Prison staff, visitors, and suppliers also 
go in and out of prisons. This means that whatever is done—or not done—to promote 
health in prisons and protect prisoners and staff from contracting infections will 
ultimately have an impact on the health of the public outside prisons. Prison health issues 
necessarily are community health issues (see figure 1).
1Universal precautions are simple infection control measures that reduce the risk of transmission of 
blood borne diseases through exposure to blood or body fluids among patients, health care workers and 
other staff. Under the “universal precaution” principle, blood and body fluids from all persons should be 
considered as infected with HIV, regardless of the known or supposed status of the person. Improving the 
safety of injections is an important component of universal precautions.
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Figure 1. Prisons and the general community—how HIV spreads
HIV
HIV
Prison Community
Implementing effective HIV prevention, treatment, care and support programmes in 
 prisons is therefore good public health practice.
There is strong evidence about what can be done in prisons to reduce the risk of HIV 
transmission and to provide adequate treatment, care and support for prisoners living 
with HIV, and there is growing awareness and widespread concern about HIV and AIDS 
in prisons. For example, in April 2005, at the 11th United Nations Crime Congress, 
 attended by most countries, governments noted that “the physical and social conditions 
associated with imprisonment may facilitate the spread of HIV in pre trial and correc-
tional facilities and thus in society, thereby presenting a critical prison management 
 problem.” The Bangkok Declaration issued at the Congress called upon States to develop 
and adopt measures and guidelines to ensure that the particular problems of HIV are 
adequately addressed in such facilities. International law requires countries to promote 
health in prisons and therefore to invest their maximum efforts to reduce the risk of 
transmission of infections.
Despite this, many countries have yet to implement comprehensive HIV prevention pro-
grammes in prisons, or to achieve a standard of prison health care equivalent to the 
standard outside of prison, thereby jeopardizing the health of prisoners, prison staff, and 
the wider community. 
Some policymakers and prison administrations may find it difficult to accept that inject-
ing drug use and/or sexual activity take place in their prisons. But evidence indicates that 
drug use and/or sex occurs in virtually all prisons around the world. Others may fear that 
HIV prevention measures (such as making condoms and sterile needles and syringes 
available to prisoners) will undermine security and control, or further encourage such 
behaviours. Again, there is evidence that this is not the case.
This toolkit is designed to assist countries in their efforts to mount an effective 
national response to HIV in prisons and to improve and, if necessary, reform their 
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prison systems. It offers, based on evidence from scientific research and evaluation 
and experience around the world:
P " ractical guidance on what measures countries need to take in the short term to 
prevent the spread of HIV (and other infections) among prisoners and to provide 
them with treatment, care and support; and
G " uidance on the reforms necessary in the medium and longer term to facilitate 
such measures.
This toolkit does not respond to all health and security related issues in prison. The 
health of prisoners and their access to services is a wide and complex issue. Very 
often people arrive in prison with many health problems such as drug addiction, infec-
tious diseases, mental or psychiatric diseases, infectious diseases, malnutrition, dental 
problems, and skin diseases. Not all of these issues could be addressed in this 
toolkit. 
A note about terminology and scope
In some jurisdictions different terms are used to denote whether places of detention hold people who 
are awaiting trial, who have been convicted or who are subject to different conditions of security. 
Similarly, different words are being used for various groups of people who are detained.
In this toolkit, the term “prison” has been used for all places of detention and the term “prisoner” has 
been used to describe all who are held in such places, including adult and juvenile males and females 
detained in criminal justice and correctional facilities during the investigation of a crime; while awaiting 
trial; after conviction and before sentencing; and after sentencing. Although the term does not formally 
cover persons detained for reasons relating to immigration or refugee status, those detained without 
charge, and those sentenced to compulsory treatment and rehabilitation centres as they exist in some 
countries, nonetheless most of the considerations in this paper apply to them as well.
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Module
Introduction: HIV and AIDS—what is the problem?
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This module:
P " rovides basic information about HIV and AIDS (“Basic information about HIV and 
AIDS”);
S " hows that HIV is a major problem in countries around the world (“Living in a 
world with HIV”);
S " hows that worldwide, the levels of HIV infection among prison populations tend 
to be much higher than in the population outside prisons; and explains why this 
is the case (“HIV in prisons: A serious problem”); and discusses the links between 
HIV, human rights and prison reform (“HIV, human rights, and prison reform”).
Basic information about HIV and AIDS
What is HIV?
HIV stands for “human immunodeficiency virus”. HIV is a virus that infects cells of the 
human immune system and destroys or impairs their function. Infection with HIV results 
in the progressive destruction of the immune system, leading to “immune deficiency”. 
People with immune deficiency are much more vulnerable to a wide range of infections 
than other people because the body is unable to fight these infections. 
What is AIDS?
AIDS stands for “acquired immunodeficiency syndrome” and describes the collection of 
symptoms and infections associated with deficiency of the immune system resulting from 
HIV infection. The level of CD4 cells in the body and the appearance of certain infections 
or cancers are used as indicators that HIV infection has progressed to AIDS.
Diseases associated with severe immunodeficiency are known as “opportunistic 
infections” because they take advantage of a weakened immune system. In the prison 
context the most significant of these is tuberculosis, which can spread very quickly in 
overcrowded conditions.
CD4 refers to a kind of cell in the blood that contributes to the defence system of the 
 human body. HIV attacks and kills CD4 cells. When there are not enough CD4 cells, it is 
easier for germs that attack the body to make people sick. 
What are the symptoms of HIV infection?
Most people infected with HIV do not know that they have become infected, because no 
symptoms develop immediately after the initial infection. Some people have a fever-like 
illness (with fever, rash, joint pains and enlarged lymph nodes) that can occur at the time 
when antibodies to HIV develop—usually between six weeks and three months after an 
infection has occurred.
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Despite the fact that HIV infection does not cause any initial symptoms, an HIV-infected 
person can transmit the virus to another person. The only way to determine whether HIV 
is present in a person’s body is by taking a test for HIV.
How is HIV transmitted?
HIV is transmitted when infected blood, semen, vaginal fluids, or breast milk enter 
another person’s body. This most often occurs during unprotected sex or during injection 
drug use (when needles are shared). Anyone who is infected with HIV can transmit it, 
whether or not they appear sick, have an AIDS diagnosis, or are taking effective treat-
ment for their infection. Infected women who become pregnant can transmit HIV to their 
newborns during pregnancy or delivery, as well as through breast-feeding.
Unprotected sexual contact 
Worldwide, unprotected sex, primarily through unprotected vaginal or anal intercourse 
with an infected partner, is the leading mode of HIV transmission. Oral sex is much less 
likely than vaginal or anal intercourse to result in the transmission of HIV. 
Exposure to infected blood
The most efficient means of HIV transmission is the introduction of HIV-infected blood 
into the bloodstream, particularly through transfusion of infected blood. Most blood-to-
blood transmission now occurs as a result of the use of contaminated injecting equipment 
during injecting drug use. Use of improperly sterilized syringes and other medical equip-
ment in health-care settings can also result in HIV transmission. Direct exposure to 
another person’s blood should always be avoided in order to prevent not only HIV trans-
mission but also the transmission of hepatitis B or C and other blood-borne infections.
Overwhelming evidence indicates that people cannot become infected with HIV in any 
of the following ways:
S " haking hands
C " oughing or sneezing
V " isiting a hospital or medical wing 
O " pening a door
S " haring food or eating or drinking utensils
U " sing drinking fountains
U " sing toilets or showers
B " eing bitten by a mosquito or other insect
W " orking, socializing, or living side by side with HIV-positive prisoners or staff. 
When does a person have AIDS?
The term AIDS applies to the most advanced stages of HIV infection. The majority of 
 people infected with HIV, if not treated, develop signs of AIDS within 8 to 10 years. 
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Antiretroviral therapy (see below) can slow down the progression of the disease by 
decreasing the amount of HIV in an infected body.
How can I tell if someone has HIV or AIDS?
You cannot. A fraction of people infected with HIV develop symptoms early in the course 
of infection, while others remain without symptoms for 15 or more years after they 
become infected. Because most people with HIV do not appear sick, it is impossible to tell 
if a person is living with HIV just by looking at, or talking to, him or her. Prisoners or 
 fellow staff with HIV look just like people without HIV infection.
What is an HIV test, and how should it be done?
HIV testing is a procedure by which a person’s blood or body fluids is analysed in order 
to determine the presence of antibodies that are produced as a response to an HIV infec-
tion. There is a “window-period” inherent in the testing technology, which means that it 
may take up to 14 weeks—and perhaps longer—for a person infected with HIV to develop 
HIV antibodies in sufficient concentration to trigger a positive test result.
An HIV test should be:
A " ccompanied by pre- and post-test counselling;
C " onducted with the informed consent of the person being tested (meaning that 
people should be informed about the benefits and risks of testing, and voluntarily 
consent to testing); and
C " onfidential (meaning that the test result is only communicated to the patient and 
otherwise kept secret).
In prisons, HIV testing usually involves a number of different steps. A prisoner is offered 
HIV testing or asks for an HIV test. A doctor, nurse, or trained counsellor will provide 
information about the test and discuss HIV-related issues with the prisoner, and the pris-
oner can ask questions (pre-test counselling). If the prisoner consents to have the test, a 
nurse or an aide will draw blood from the arm using a needle. The blood sample is then 
tested for signs of HIV. If the first test is positive, the blood will be tested again to confirm 
the result.
When test results are available, a nurse or counsellor will share the results only with the 
prisoner, and provide post-test counselling. If the test shows that the prisoner has HIV 
infection (is HIV-positive), referral to care, treatment, and support should follow.
Pre- and post-test counselling are important components of HIV testing. The counselling 
process should address issues such as the risk of HIV transmission, facilitation of preven-
tive behaviours, the evaluation of coping mechanism should one be confronted with a 
positive result, and referral to care, treatment and support. Counselling should take place 
before and after the HIV test and should be done regardless of whether the result is 
positive or negative.
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In some countries, rapid HIV tests are also available. Rapid HIV testing can be 
 performed more quickly than the standard HIV test, and can provide a result within 
10 to 30 minutes. Many rapid tests are relatively easy to use and can be conducted 
and read by non-laboratory personnel such as clinical doctors and nurses. All rapid 
tests, however, are subject to error if the testing protocol is not strictly followed. In 
addition, as with standard tests, a confirmatory HIV test is recommended for all people 
who test positive on the rapid test. Confirmatory tests are not necessary if the test 
result is negative or if there are signs of immune deficiency.
Is HIV infection always fatal?
Not necessarily. Today, there are treatments that slow the progression of HIV infection 
and allow people infected with the virus to live healthily and productively for many 
years.
What treatments exist for HIV?
Anti-HIV medications are medications that slow down the growth of the HIV virus. 
Because HIV is a special type of virus called “retrovirus,” the medications are usually 
called “antiretrovirals.” 
There are different types (or classes) of anti-HIV medications. Each type of anti-HIV medi-
cation works by blocking a different protein that the HIV virus needs in its reproduction. 
Currently two major classes of anti-HIV medications are available: 
M " edications that block the protein “reverse transcriptase,” known as reverse 
 transcriptase inhibitors or RT inhibitors;
M " edications that block the protein “protease,” known as protease inhibitors.
Several different types of drugs exist to treat HIV infection. These drugs attack various 
aspects of the process used by the virus to replicate itself. Because HIV quickly mutates to 
become resistant to any single drug, patients must take a combination of drugs to achieve 
maximum suppression of HIV. 
Combination anti-HIV therapy is known as antiretroviral therapy, or ART. ART changes 
the natural course of HIV infection, significantly extending the period between initial 
infection and the development of symptoms. To achieve these results, it is important 
to initiate therapy before AIDS symptoms develop, although even patients who start 
on therapy after being diagnosed with AIDS often receive major and long-lasting health 
benefits. Although effective in slowing the progression of HIV-related disease, ART is 
not a cure. In addition to treatments for HIV infection itself, therapies exist to prevent 
and/or treat many HIV-related opportunistic infections. In both developing and indus-
trialized countries, ART generally leads to significant improvement in the health and 
well-being of people living with HIV.
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Box 1. Treatment works!
In Brazil, approximately 125,000 people received ART between 1997 and 2002. Officials estimate that 
access to treatment averted 90,000 deaths that would have occurred during this period had treatment 
not been available.
In the United States of America, where ART has been widely available since the mid-1990s, AIDS 
mortality declined by 66 per cent between 1995 and 2002.
Box 2. Basic information about tuberculosis
Tuberculosis is a contagious disease, transmitted by the inhalation of droplet nuclei. These are produced 
when a person with the active form of the disease coughs. Exposure on the order of days to weeks 
is necessary to acquire a tuberculous infection. Only about 10 per cent of those who acquire this 
infection will go on to develop the active disease, tuberculosis, although some groups such as those 
with later stages of HIV infection, are at greater risk. Overcrowding, poor ventilation and certain 
 characteristics of the contagious individual increase the likelihood of becoming infected with TB. 
Preventative treatment of infected individuals (as defined by a positive tuberculin skin test) with  isoniazid 
can be 70 to 90 per cent effective in preventing these individuals from developing active disease. 
Early detection and isolation of contagious persons with active TB is the key to disease control. A 
constant state of alertness is necessary to find such individuals sooner rather than later. 
With appropriate treatment, active tuberculosis is 98 per cent curable, except in the case of multiply-
drug resistant (MDR) TB, where the cure rate is lower.
For more information about the basics of HIV/AIDS, see www.thebody.com/basics.html or 
www.cdc.gov/hiv/topics/basic/index.htm!
What does HIV have to do with tuberculosis?
The emergence of the HIV pandemic has seriously threatened tuberculosis (TB) control 
efforts globally. HIV weakens the immune response and dramatically increases the risk of 
developing active TB. When an individual is infected with HIV, and is infected with TB 
that is dormant, the risk that the person develops active tuberculosis is estimated to be 
5 to 15 per cent per year, as opposed to a 10 per cent lifetime risk in those people who 
have the TB infection but who are not infected with HIV. This means that in a prison 
 setting where both TB and HIV infection are more common, people living with HIV will 
have a higher risk of contracting and developing TB. 
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Living in a world with HIV
HIV is one of the most serious public health problems in the world. About 33 million peo-
ple are estimated to be living with HIV, with 2.5 million new infections in 2007. During 
that year, 2.1 million people died of AIDS. Almost two thirds of people with HIV live in 
sub-Saharan Africa, but every region of the world is affected by the epidemic. The fastest 
growing epidemics are currently observed in Eastern Europe and Central Asia. HIV is a 
global problem, affecting people in every country.
Do you know how many people with HIV live in your country?
Box 3. Adults and children estimated to be living with HIV, end of 2007
Western & 
Central Europe
8000
[4800 – 17 000]
Middle East & North Africa
27 000
[20 000 – 35 000]
Sub-Saharan Africa
1.5 million
[1.3 – 1.7 million]
Eastern Europe 
& Central Asia
58 000 
[41 000 – 88 000]
South & South-East Asia
340 000
[230 000 – 450 000]
Oceania
1000
[<1000 – 1400]
North America
23 000
[9100 – 55 000]
Latin America
63 000
[49 000 – 98 000]
East Asia
40 000
[24 000 – 63 000]Caribbean
230000
[11 000 – 16 000]
North America
1.3 million
[480,000-1.9 million] 
Western and
Central Europe
760,000
[600,000-1.1 million]
Eastern Europe
and Central Asia
1.6 million
[1.2-2.1 million] East Asia
80 ,0 0
[620, 00-96 , 00]Middle East and North frica
380, 0
[27 , -500,000] South and South-Ea t Asia
4.0 million
[3.3-5.1 million]
Oceania
75,0 0
[53,000-120,000]
22.5 million
[20.9-24.3 million]
ti  i
1.6 million
[1.4-1.9 million]
Total: 33.2 (30.6-36.1 million)
Caribbean
230,000
[210,000-270,000]
For information about HIV prevalence in countries around the world, see: UNAIDS. Report 
on the global AIDS epidemic, 2007. Available at www.unaids.org/en/HIV_data/2007EpiUpdate/
default.asp.
!
HIV in prisons: a serious problem
HIV is a serious health threat for the 10 million people in prison across the world. In most 
countries, levels of HIV infection among prison populations are much higher than in the 
population outside prisons, but the prevalence of HIV infection in different prisons within 
and across countries varies considerably. In some cases, the prevalence of HIV infection 
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in prisons is up to a hundred times higher than in the community. Even in  countries with 
large heterosexual HIV epidemics, such as in Africa, studies have shown that rates of HIV 
infection in prisons are higher than outside prisons.
The following are some examples of what we know about the HIV epidemic in prisons:
I " n the Russian Federation, by late 2002, the registered number of people living 
with HIV or AIDS in the penal system exceeded 36,000 (4 per cent of the prison 
population), and accounted for about 20 per cent of known cases of HIV in the 
country.
I " n Latvia, it has been estimated that prisoners comprise a third of the country’s 
HIV-positive population. In a 2003 study, HIV prevalence was found to be 
6.2 per cent.
E " stonia reported four studies of HIV prevalence with rates of 8.8 to 23.9 per cent.
I " n Indonesia, nine studies found HIV prevalence rates of 4 per cent to 22 per cent 
in 2001.
I " n Viet Nam, data reported in 2000 indicated a total of 22,161 prisoners had tested 
positive for HIV, for a prevalence of 28.4 per cent.
I " n Brazil, in several studies, prevalence rates ranged from 3.2 per cent to over 
20 per cent.
H " onduras reported a prevalence of 6.8 per cent among 2,028 prisoners in 
1998/1999.
I " n Zambia, four studies revealed HIV prevalence rates ranging from 16.1 to 
27.2 per cent.
I " n South Africa, according to one estimate, HIV prevalence in prisons was 
41.4 per cent in 2002.
I " n Western Europe, particularly high rates have been reported from countries in 
southern Europe—for example, 14 per cent in Spain.
I " n the United States, 1.9 per cent of prisoners are known to be HIV-positive. In a 
few jurisdictions, however, rates are much higher, particularly among women. In 
New York, for example, 7.3 per cent of male and 14.6 per cent of female prisoners 
were known to be HIV-positive; and in Florida, 3.7 per cent of male and 7.3 per cent 
of female prisoners.
I " n Canada, in a large number of studies published between 1989 and 2005, rates 
between one and 11.94 per cent have been reported.
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Box 4. Data about HIV prevalence in prisons in selected countries 
Western & 
Central Europe
8000
[4800 – 17 000]
Middle East & North Africa
27 000
[20 000 – 35 000]
Sub-Saharan Africa
1.5 million
[1.3 – 1.7 million]
Eastern Europe 
& Central Asia
58 000 
[41 000 – 88 000]
South & South-East Asia
340 000
[230 000 – 450 000]
Oceania
1000
[<1000 – 1400]
North America
23 000
[9100 – 55 000]
Latin America
63 000
[49 000 – 98 000]
East Asia
40 000
[24 000 – 63 000]Caribbean
14 000
[11 000 – 16 000]
 
Brazil
up to 15 per cent
South Africa
up to 44 per ce t
Spain
up to 14 per cent
Egypt
up to 1.6 per cent
Indonesia
up to 15 per cent
Viet Nam
up to 28 per cent
Russian Feder tion
up to 4 per cent
United States
up to 2 per cent
Canada
between 2-8 per cent
Cuba
up to 26 per centHondurasup to 7 per cent
Hepatitis C seroprevalence rates in prisons are even higher than HIV rates. The World 
Health Organization estimates that about 3 per cent of the world’s population has been 
infected with hepatitis C virus (HCV), but the prevalence of HCV in prisons has been 
reported to range from 4.8 per cent in an Indian jail to 92 per cent in two prisons in 
northern Spain. 
Box 5. Basic information about hepatitis C
Hepatitis C is a liver disease that is caused by the hepatitis C virus (HCV). The virus enters the liver 
cells, uses the cell's inner genetic machinery to make copies of itself, which then infect more cells. In 
about 15 per cent of cases, hepatitis C infection is acute, meaning it is cleared spontaneously by the 
body and there are no long-term consequences. Unfortunately, in the majority of cases (85 per cent), 
the infection becomes chronic and slowly damages the liver over many years. Over time, this liver 
damage can lead to cirrhosis (or scarring) of the liver, end-stage liver disease, and liver cancer. 
Like HIV and hepatitis B, HCV is spread through contact with the blood (or body fluids containing 
blood) of infected people. This can happen if a person:
Ever, even once, shares needles, straws used for snorting drugs, pipes, spoons and other  "
drug-related equipment;
Gets a tattoo or has body piercing or acupuncture where the operator uses unsterile or homemade  "
equipment or unsterile techniques;
Is pricked by a needle that has infected blood on it; "
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Within prison populations, certain groups have higher levels of infection. In particular, 
rates of HIV and HCV infection among women tend to be higher than among men. 
It is believed that this is due to a higher concentration of females in prison for 
drug-related offences.
High rates of HIV and HCV in prisons are often accompanied by high rates of tuberculosis 
(which may include resistant and multi drug resistant cases), sexually transmitted 
 infections, drug dependence, and mental health problems.
Is born to a mother who has hepatitis C; "
Shares personal household articles such as a shaver or toothbrush with an infected person. "
HCV has been shown to live much longer outside the body and in a dormant state, even on dried 
surfaces, than HIV. Activities that would be negligible risks for HIV transmission, such as sharing 
toothbrushes or shavers or straws to snort cocaine, are much higher risks for HCV transmission. This 
is because they often involve exchanging small amounts of blood and the external exposure (to air, 
temperature and light) that kills HIV may not kill HCV. 
The risk of contracting HCV through sexual contact is not as well-established. Recent studies show 
that there is little to no HCV present in vaginal fluids and semen. However, this area is still being 
researched and no final conclusions have been made on the assessment of risk for transmission through 
sexual activities that do not involve the presence of blood.
HCV is not spread by casual contact, such as hugging, kissing or shaking hands, or by being around 
someone who is sneezing or coughing.
For more information about HIV rates in countries around the world, see the chapter on 
“evidence of the prevalence of HIV in prisons” in:
WHO, UNODC, UNAIDS (2007). [Comprehensive review.] Effectiveness of Interventions 
to Address HIV in Prisons. Evidence for Action Technical Papers. Available via www.who.int/
hiv/idu/prison/en/index.html.
!
Why are rates of HIV so high in prisons?
First, many people come to prison already infected with HIV.
In many countries, HIV rates are high in prison because HIV infection rates are high 
among injecting drug users in the community, and injecting drug use is treated principally 
as a criminal rather than a health issue—meaning that many injecting drug users spend 
years of their lives going in and out of prison.
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In other countries, rates are high because of high rates of HIV in the general population.
The groups most-at-risk to HIV are also groups at increased risk for criminalization and 
incarceration, as many of the same social and economic conditions (such as poverty, 
lower level of education, and living in medically underserved and minority communities) 
that increase vulnerability to HIV also increase vulnerability to imprisonment.
Second, people become HIV infected in prison. This is because high-risk behaviours 
are prevalent (particularly sexual relations, both consensual and non-consensual, and 
injecting drug use), but many prisons still do not provide HIV prevention measures, 
such as condoms and sterile needles and syringes, that could decrease the risk of HIV 
transmission. In addition, the risk of transmission may be increased by environmental 
factors such as overcrowding and violence.
What about staff in prisons?
Adequately trained and equipped prison staff are not at high risk of contracting infections 
like HIV that are spread only through contact with blood or other body fluids. Just like 
health care workers, prison staff can adopt simple and routine practices to greatly reduce 
the likelihood that they will become infected with HIV as a result of an occupational expo-
sure, practices that are called “universal precautions”. Prison staff need to be trained 
concerning the use of universal precautions and given the means to observe them.
In contrast to HIV, other diseases that are prevalent in prisons and that are much more 
easily spread than HIV—particularly tuberculosis—pose a real threat not only to the staff 
directly, but also to their families and to the wider community.
Where prison staff are not adequately trained, they more likely react with fear to people 
with HIV. This can lead to stigma and discrimination against people living with HIV and 
those perceived to be at risk of HIV. Lack of correct information on HIV, as well as fear 
and stigma, greatly hamper HIV prevention efforts. It is therefore essential that prison 
staff are provided with correct and consistent information and training on matters per-
taining to HIV.
Prison staff also play a crucial role in HIV prevention, treatment, care and support pro-
grammes in prisons. Their cooperation is vital for HIV programmes to achieve their goal 
of reducing the spread of HIV among prisoners. In addition, prison staff also benefit from 
such programmes. Lowering the prevalence of infections in prisons means that their risk 
of exposure to these infections will also be lowered, and will ultimately result in a less 
stressful workplace.
What does HIV in prisons have to do with the community outside prison?
There is a constant flow of people between the community and prisons. With 30 mil-
lion prisoners released back into the community each year, increased rates of illness 
in prison have serious consequences for society as a whole. Reducing the extent to 
which prisons contribute to the HIV (as well as hepatitis C and tuberculosis) epidemics 
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is a  central concern of public health policy. Unless urgent action is taken, prisons will 
continue to fuel and refuel epidemics causing enormous social and financial costs. 
Prison health is public health.
For a good explanation of why prison health is public health, and suggestions about what 
should be done to protect both: Irish Penal Reform Trust (2004). Dublin Declaration on 
HIV/AIDS in Prisons in Europe and Central Asia: Prison Health is Public Health. Available in many 
languages via www.iprt.ie.
See also the “Moscow Declaration” that recognizes the need for a close link between public 
health and the provision of health care to those in prison: World Health Organization 
(Europe) (2003). Moscow Declaration: Prison Health as part of Public Health. Available in English, 
French, Russian, and German via www.euro.who.int/prisons/publications/20050610_1. 
!
HIV, AIDS, human rights and prison reform
Addressing HIV in prisons effectively cannot be separated from wider questions of 
human rights and prison reform. People in prison are vulnerable to human rights 
violations and they are vulnerable to HIV. Prison conditions, the way in which prisons 
are managed, and national policy all impact on the issue of HIV in prisons.
Overcrowding, violence, inadequate natural lighting and ventilation, and lack of protec-
tion from extreme climatic conditions are common in many prisons of the world. When 
these conditions are combined with inadequate means for personal hygiene, inadequate 
nutrition, lack of access to clean drinking water, and inadequate health services, the vul-
nerability of prisoners to HIV infection and other infectious diseases is increased, as is 
HIV-related morbidity and mortality. Substandard conditions can also complicate or 
undermine the implementation of effective responses to HIV by prison staff. Therefore, 
action to prevent the spread of HIV infection in prisons and to provide health services to 
prisoners living with HIV is integral to—and enhanced by—broader efforts to improve 
prison conditions. This is why efforts to stop the transmission of HIV in prisons must start 
with making HIV prevention measures available, but should include reforms aimed at 
addressing these underlying conditions. 
Every country’s response to HIV in prisons is influenced by economic and social condi-
tions, as well as by cultural, social, and religious traditions. However, these national and 
local conditions do not reduce or negate government obligation to meet recognized inter-
national prison, health, and human rights standards. International law is clear that a lack 
of resources does not excuse a state from its obligations to provide proper and humane 
prison conditions.
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There are a number of international instruments and covenants, both legally binding and 
normative, that are particularly relevant to HIV in prisons. According to them:
A " ll persons deprived of their liberty have the right to be treated with respect and 
dignity and not to be subjected to cruel, inhumane or degrading treatment or 
torture;
P " risoners must not be discriminated against, but must be separated according to 
their sex, age and whether or not they have been convicted;
A " ccommodation in which prisoners live must be conducive to maintaining good 
health, provide access to bathing and sanitary facilities and have adequate lighting, 
ventilation, heating and floor space;
P " risoners must have a diet sufficient for health and be provided with drinking 
water.
More generally, the international community has generally accepted that prisoners retain 
all rights that are not taken away as a fact of incarceration. Loss of liberty alone is the 
punishment, not the deprivation of fundamental human rights. Like all persons, there-
fore, prisoners have a right to enjoy the highest attainable standard of health. In the 
context of HIV/AIDS, this includes a right to HIV/AIDS prevention tools. 
For a list of relevant human rights instruments, see: A Coyle. A Human Rights Approach to 
Prison Management. Handbook for prison staff. London: International Centre for Prison Studies, 
2002. Available in many languages via www.kcl.ac.uk/depsta/rel/icps/publications.html.
For an article on the right to health of prisoners in international human rights law, see: 
R Lines. The right to health of prisoners in international human rights law. International 
Journal of Prisoner Health 2008; 4(1): 3-53.
!
Two additional international instruments are relevant to the situation of prisoners in the 
context of HIV: the World Health Organization Guidelines on HIV infection and AIDS in 
prisons, which provide standards that prison authorities should strive to achieve in their 
efforts to prevent HIV transmission in prisons and to provide care to those living with 
HIV; and the International Guidelines on HIV/AIDS and Human Rights.
The Guidelines on HIV infection and AIDS in prisons were issued in 1993. They confirm 
that “[a]ll prisoners have the right to receive health care, including preventive measures, 
equivalent to that available in the community without discrimination” and that “the gen-
eral principles adopted by national AIDS programmes should apply equally to prisoners 
and to the community”.
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The International Guidelines on HIV/AIDS and Human Rights, released in 1998 by the 
Joint United Nations Programme on HIV/AIDS and the Office of the United Nations 
High Commissioner for Human Rights, identify the following specific action in relation 
to prisons:
Prison authorities should take all necessary measures, including adequate staffing, 
effective surveillance and appropriate disciplinary measures, to protect prisoners 
from rape, sexual violence and coercion. Prison authorities should also provide 
prisoners (and prison staff, as appropriate), with access to HIV-related prevention 
information, education, voluntary testing and counselling, means of prevention 
(condoms, bleach and clean injection equipment), treatment and care and volun-
tary participation in HIV-related clinical trials, as well as ensure confidentiality, and 
should prohibit mandatory testing, segregation and denial of access to prison facil-
ities, privileges and release programmes for HIV-positive prisoners. Compassionate 
early release of prisoners living with AIDS should be considered.
For various reasons, only relatively few prison systems have implemented all measures 
necessary to curb the spread of HIV infection in prison and to provide prisoners living 
with HIV or AIDS with the treatment, care and support they need. This may be due to lack 
of knowledge or awareness, negative attitudes against people with HIV or vulnerable to 
infection, or other barriers such as inadequate financial resources for prisons generally 
and prison health care specifically.
This toolkit has been developed with the aim to assist prison systems worldwide to intro-
duce comprehensive HIV prevention, treatment, care and support programmes, and to 
scale them up rapidly, acting for the benefit of public health and human rights.
For further information on HIV/AIDS, human rights, and prison reform, see:
Office of the United Nations High Commissioner for Human Rights and UNAIDS (re-issued, 
2006). HIV/AIDS and Human Rights: International Guidelines. New York and Geneva: 
United Nations. Available via www.ohchr.org/english/issues/hiv/guidelines.htm. See, in 
particular, recommendation 29(e).
World Health Organization (1993). WHO Guidelines on HIV Infection and AIDS in Prisons. 
Geneva: WHO (WHO/GPA/DIR/93.3). Available via www.who.int/hiv/idu/prison/en/index.
html. These 10-page guidelines, written from a public health perspective, propose standards 
for prison authorities in efforts to prevent HIV transmission and provide care to those with 
HIV/AIDS in prisons, and emphasise that prisoners have a right to HIV care, including HIV 
prevention, equivalent to that available in the community outside prison.
!
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This module is intended primarily for policymakers, politicians and legislators who are 
responsible for creating policies and laws on prisons, criminal justice, and health. We 
hope it will be useful to:
M " inistries of justice, ministries of interior, or other ministries that have oversight 
of prison issues, but also ministries of health;
P " arliamentarians with interest in justice, corrections, and health;
S " enior government officials in departments of justice, interior, corrections, and 
health;
J " udges, magistrates, prosecutors and other state actors in the criminal justice 
system;
C " ivil society organizations with an interest in prisons, HIV, and human rights;
D " onors who fund activities aimed at strengthening governance, the rule of law and 
adherence to human rights, as well as activities aimed at promoting and protecting 
health.
Ultimately, we hope it will equip policymakers, politicians and parliamentarians with 
knowledge about how best to address HIV in prisons; increase commitment to address 
this important issue; and lead to action. 
The module first provides some background information on HIV in prisons. It then 
highlights four ways in which policymakers, politicians and legislators can make a 
difference: 
A " ddressing the specific risk factors for HIV transmission in prison by introducing 
comprehensive HIV prevention measures;
P " roviding health services in prisons equivalent to those in the community;
I " mproving prison conditions through reforms to the prison system; and
R " educing prison populations.
It then lists three priority actions that policymakers, politicians and legislators should 
take:
Providing leadership;1. 
Reforming laws and policies;2. 
Advocating for increased funding.3. 
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Module 2
Issues for policymakers, politicians and parliamentarians
Background
HIV has had a significant impact on the health sector, the economy, the education system, 
social welfare, armed forces and uniformed services in many countries. Places of deten-
tion are no exception: HIV rates are usually higher in prisons than in the general com-
munity. In addition, prisoners are at increased risk for acquiring HIV as well as HCV and 
TB in prisons and, once released, may transmit the infections to others outside prison.
Therefore, it is essential that each country develop and implement policies and action 
plans on HIV in prisons, based on the requirements of international law and standards, 
scientific evidence and best practice experience. To do this, the first requirement is that 
governments acknowledge the realities of how prisons contribute to the problem of HIV 
(and HCV and TB) and agree to take the necessary steps to address the problem. Reluc-
tance to do this would represent a failure to accept that prisons have an important role to 
play in HIV prevention and provision of treatment and care. 
What are the realities in prisons related to HIV?
In general, those groups of people who are more at risk of contracting HIV while in the 
community are over-represented in prison. As a result, the percentage of people with HIV 
in prisons is often much higher than in the community.
Inside prison, prisoners may use drugs and have sex, with limited access to HIV preven-
tion measures (such as condoms and sterile injecting equipment) and health education 
that are available to people outside prison. 
Unsafe sexual behaviours are widespread, with prisoners having sex (forced or consen-
sual) with each other and, at times, with prison staff. 
Drug use is also widespread in prisons in most countries, including injecting drug use and 
the sharing of contaminated injecting equipment.
Even high-income countries have not been able to eradicate drug use in prisons. Indeed, 
some of the measures introduced to deter drug use can increase rather than reduce the 
risk of HIV infection.
Additional risk factors include the sharing or reuse of tattooing and body piercing equip-
ments, sharing of razors for shaving, blood sharing/“brotherhood” rituals and the 
improper sterilization or reuse of medical or dental instruments.
Factors related to the prison infrastructure and prison management contribute indirectly 
to HIV vulnerability. They include overcrowding, violence, gang activities, lack of protec-
tion for vulnerable or young prisoners, prison staff that lack training or may be corrupt, 
and poor medical and social services.
As a result of all these factors, the risk of HIV infection in prisons can be high. Serious 
outbreaks of HIV infection have occurred in prisons in a number of countries. 
HIV and AIDS in places of detention
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You can make a difference!
Four elements are key to preventing and responding to HIV/AIDS and other infections 
such as hepatitis B and C and tuberculosis in prisons: 
I " ntroducing comprehensive HIV prevention measures;
P " roviding equivalent health services in prisons to those in the community, including 
provision of antiretrovirals;
I " mproving prison conditions and undertaking other prison reforms;
R " educing prison populations.
Introducing comprehensive HIV prevention measures
National governments should urgently adopt or expand programmes for preventing HIV 
transmission in prisons. Such programmes should include all the measures against HIV 
transmission that are carried out in the community outside prisons, including:
E " ducation on HIV and AIDS;
V " oluntary HIV testing and counselling;
C " ondom provision and prevention of rape, sexual violence and coercion;
D " rug-dependence treatment, particularly substitution treatment;
M " easures that reduce the demand for, and supply of, drugs in prisons;
P " rovision of needles and syringes and, as a second-line strategy if provision of 
needles and syringes is not yet possible, provision of bleach or other disinfectants; 
and
P " rogrammes for the detection and treatment of sexually transmitted diseases;
P " rovision of preventive measures for mother-to-child transmission for the women 
prisoners.
All these interventions contribute to reducing the risk of HIV transmission in prisons, 
and some of them also reduce the risk of hepatitis C transmission. They have been 
shown to have no unintended negative consequences. The available scientific evidence 
suggests that they can be reliably expanded from pilot projects to nationwide pro-
grammes. Ultimately, since most prisoners leave prison at some point to return to their 
community, implementing them will benefit not only prisoners and prison staff, but also 
society in general.
In addition to programmes on HIV and hepatitis C, programmes to prevent the spread of 
hepatitis B and tuberculosis are also important.
Information and education
Education is an essential precondition to the implementation of HIV prevention measures 
in prisons. The World Health Organization Guidelines on HIV infection and AIDS in prisons 
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recommend that both prisoners and prison staff be informed about ways to prevent HIV 
transmission. Written materials should be appropriate for the educational level in the 
prison population. Furthermore, prisoners and staff should participate in the develop-
ment of educational materials. Finally, peer educators can play a vital role in educating 
other prisoners. 
However, information and education alone are not sufficient responses to HIV in prisons. 
A few evaluations have indicated improvements in levels of knowledge and self-reported 
behavioural change as a result of prison-based educational initiatives. But education and 
counselling are not of much use to prisoners if they do not have the means (such as con-
doms and clean injecting equipment) to act on the information provided.
For more details (and full references) on information and education programmes, and on 
all other interventions in this module, see:
WHO, UNODC, UNAIDS (2007). [Comprehensive review.] Effectiveness of Interventions to Address 
HIV in Prisons. Evidence for Action Technical Papers. Available via www.who.int/hiv/idu/prison/
en/index.html.
!
HIV counselling and testing
Counselling and testing are important for two reasons:
A " s part of an HIV prevention programme (it gives those who may be engaging in 
risky behaviours information and support for behaviour change); and
A " s a way to diagnose those living with HIV and offer them appropriate treatment, 
care and support.
In practice, HIV testing in prisons is often available only on demand of prisoners, but in 
some systems voluntary testing and counselling is easily available. In some other systems, 
HIV testing is undertaken routinely or is even compulsory (or mandatory). The World 
Health Organization Guidelines on HIV infection and AIDS in prisons state:
10. Compulsory testing of prisoners for HIV is unethical and ineffective, and should 
be prohibited.  
11. Voluntary testing for HIV infection should be available in prisons when availa-
ble in the community, together with adequate pre- and post-test counselling. Volun-
tary testing should only be carried out with the informed consent of the prisoner. 
Support should be available when prisoners are notified of test results and in the 
period following.  
12. Test results should be communicated to prisoners by health personnel who 
should ensure medical confidentiality.
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There is evidence suggesting that mandatory HIV testing and segregation of HIV-positive 
prisoners is costly, inefficient, and can have negative health consequences for segregated 
prisoners. Therefore, HIV testing in prison should always be voluntary and everyone 
being tested should give informed consent and receive pre-and post-test counselling.
Box 6. The negative effects of mandatory testing and segregation
Mandatory testing and segregation can have negative health consequences for segregated prisoners. 
In a prison in South Carolina, United States, segregating HIV-positive prisoners contributed to a 
tuberculosis outbreak in which 71 per cent of prisoners residing in the same housing area either 
had new tuberculosis skin-test conversion or developed tuberculosis disease. Thirty-one prisoners, 
and one medical student in the community’s hospital, subsequently developed active tuberculosis.
Prison systems should offer voluntary HIV counselling and testing to all prisoners upon 
entry. In addition, because entry is a stressful time and many prisoners may not want to 
have an HIV test at that time, HIV testing should be available to prisoners at any time 
during imprisonment, so that prisoners can learn their HIV status, and prisoners with 
HIV can benefit from access to treatment (including antiretroviral treatment), care and 
support.
HIV testing and counselling should be closely linked to access to treatment, care and sup-
port for those testing positive, and be part of a comprehensive HIV prevention programme 
that includes access to HIV prevention measures. As mentioned above, many prisoners, 
including prisoners who are aware of their HIV status, engage in activities that carry a 
risk of HIV transmission. Knowledge of HIV status alone is not sufficient to prevent HIV 
transmission when the means that would enable a person to take steps to reduce that risk 
are not accessible in prison. 
For more details and further references, see WHO, UNODC, UNAIDS (2007). Interventions 
to Address HIV in Prisons: HIV Care, Treatment and Support. Evidence for Action Technical Papers. 
Available at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/ 
hiv-aids/publications.html.
!
Provision of condoms and prevention of rape, sexual violence and coercion
Recognizing the fact that sex occurs in prisons and given the risk of disease transmission 
that it carries, providing condoms has been widely recommended. As early as 1993, the 
World Health Organization, in its Guidelines on HIV infection and AIDS in prisons, 
recommended that condoms be made available to prisoners “throughout their period of 
detention” and “prior to any form of leave or release”. 
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As early as 1991, 23 of 52 prison systems surveyed by the World Health Organization 
provided condoms to prisoners. Today, many more prison systems make condoms avail-
able, including most systems in Western Europe, Canada, and Australia, some prisons in 
the United States, parts of the Eastern Europe and Central Asia, and countries like Brazil, 
South Africa, Iran (Islamic Republic of) and Indonesia.
There is evidence that condoms can be provided in a wide range of prison settings—
including in countries in which same-sex activity is criminalized—and that prisoners use 
condoms to prevent HIV infection during sexual activity when condoms are accessible in 
prison. No prison system allowing condoms has reversed its policy, and none has reported 
security problems or any other relevant major negative consequences. In particular, it has 
been found that condom access represents no threat to security or operations, does not 
lead to an increase in sexual activity, and is accepted by most prisoners and correctional 
officers once it is introduced.
However, in some countries where legal sanctions against sodomy exist in the community 
outside prison, and where there are deeply held beliefs and prejudices against homo-
sexuality, introduction of condoms into prisons as an HIV prevention measure may have 
to be particularly well prepared. This can be done through education and information 
about the purpose of the introduction of condoms, as well as initiatives to counter the 
stigma that people engaging in same-sex activity face. 
Box 7. Potential liability of prison systems for not providing condoms
The potential liability of correctional authorities that do not make condoms available to civil action 
was illustrated by an out-of-court financial settlement achieved by a South African former prisoner. 
The former prisoner claimed he contracted HIV through sex while in prison between 1993 and 1994. 
Condoms were introduced in South African prisons in 1996. He contended that the authorities did not 
warn prisoners about the risks of unprotected sex or supply condoms. The South African Department 
of Correctional Services denied any liability under the settlement.
Legal action was also taken by 52 prisoners in New South Wales (Australia) in 1994, challenging the 
Departmental policy which at the time prohibited condom provision. Before the court action reached 
conclusion, a pilot distribution of condoms was introduced. Following the successful distribution of 
condoms in three New South Wales prisons, a state-wide distribution began and was evaluated, 
showing positive results.
Finally, while providing condoms in prisons is important, it is not enough to address the 
risk of sexual transmission of HIV. There is evidence that violence, including sexual abuse, 
is common in many prison systems. In many prisons, it would be counter-productive not 
to realize that HIV prevention depends as much or more on prison and penal reform, 
than on condoms. Prison and penal reform need to greatly reduce the prison populations, 
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so that the few and often underpaid guards are able to protect the vulnerable prisoners 
from violence—and sexual coercion.
The Guidelines on HIV Infection and AIDS in Prisons and the International Guidelines 
on HIV/AIDS and Human Rights highlight that prison authorities are responsible for 
combating aggressive sexual behaviour such as rape, exploitation of vulnerable pris-
oners and all forms of prisoner victimization by providing adequate staffing, effective 
surveillance, disciplinary sanctions, and education and work and leisure programmes. 
Structural interventions such as better lighting, better shower and sleeping arrange-
ments are also needed. 
For more details and references, see: WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Prevention of Sexual Transmission. Evidence for Action Technical Papers. 
Available at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-
aids/publications.html.
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Substitution treatment and other drug dependence treatment
As shown above, many prisoners in countries around the world use drugs while in prison, 
including by injecting. At least in part this is due to the fact that a substantial proportion 
of prisoners are drug dependent.
In the absence of effective drug dependence treatment, it is likely that a high proportion 
of these prisoners will continue using drugs and persist in crime—and many will be at 
risk of contracting HIV, during or after imprisonment.
All forms of drug dependence treatment have some impacts on risks of HIV transmission, but 
substitution treatment programmes have the greatest potential to reduce injecting drug use 
and the risk of spread of infection resulting from injecting drug use. Such programmes, which 
entail prescribing a drug with a similar action to the illegal drug used, but with a lower degree 
of risk, have been established in prisons in a growing number of countries around the world, 
including in a number of prison systems in Eastern Europe or in countries like Indonesia or 
Iran (Islamic Republic of). Studies have shown that, if dosage is adequate and treatment is 
provided for the duration of imprisonment, they reduce drug injecting and needle sharing 
and the spread of HIV and other blood borne infections. In addition, they have additional and 
worthwhile benefits, both for the health of prisoners participating in the programmes, and for 
prison systems and the community. For example:
S " ubstitution treatment has a positive effect on institutional behaviour by reducing 
drug-seeking behaviour and thus improving prison safety and security;
R " e-incarceration is significantly less likely among those prisoners who receive 
substitution treatment.
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Various other drug-dependence treatment modalities are being implemented in prison 
settings, including therapeutic community methods and group counselling. Although 
there is much less evidence about their effectiveness in preventing HIV, some such 
programmes have also yielded promising results, particularly if there was good release 
planning and follow-up after imprisonment. However, while imprisonment provides an 
opportunity to deliver other drug-dependence treatment, treatment in prison will never 
be a viable alternative to treatment in the community, because of the high cost of imprison-
ment. Studies suggest that alternatives to incarceration, such as treatment of addiction in 
the community, may be more cost-effective at reducing health, social, and economic 
implications of illegal drug use. 
Ultimately, reducing the number of people who are in prison because of problems 
related to their drug use must be a priority (see below, the section on reducing prison 
populations).
“Substitution maintenance therapy is one of the most effective treatment options for opioid dependence. It can 
decrease the high cost of opioid dependence to individuals, their families and society at large by reducing heroin 
use, associated deaths, HIV risk behaviours and criminal activity. Substitution maintenance therapy is a critical 
component of community-based approaches in the management of opioid dependence and the prevention of 
HIV infection among injecting drug users.”
UNAIDS, WHO, UNODC, 2004
For more details and references, see WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Drug Dependence Treatments. Evidence for Action Technical Papers. 
Available at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-
aids/publications.html.
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Drug demand and drug supply reduction strategies 
In addition to drug dependence treatment, adopting other strategies to reduce the demand 
for, and the supply of, drugs in prisons can also assist efforts to prevent HIV transmission 
in prisons. However, it is important to note from the outset that such efforts are unlikely 
to eliminate drug use in prisons. In fact, even prison systems that have devoted large 
financial resources to such efforts have not been able to eliminate drug use. Therefore, 
such efforts cannot replace the other measures described above, but rather should be 
undertaken to complement them.
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Drug demand reduction strategies
Research shows that one of the reasons why a relatively large number of prisoners in 
many prison systems take drugs when they are in prison is to combat boredom, aliena-
tion, and stress, and to promote relaxation. This suggests that, in addition to drug treat-
ment, one of the most effective ways to reduce the demand for drugs is to improve 
prison conditions (for more details, see the section below entitled “improving prison 
conditions—the need for prison reform”) and to offer more purposeful activities in pris-
ons. Providing prisoners with opportunities to work and/or study while in prison, or 
activities such as sports, theatre and spiritual and cultural enhancement aimed at provid-
ing people with challenging and healthy ways to employ their time, can have a positive 
effect on risky behaviours, particularly when complemented by appropriate drug use 
prevention education.
Another strategy to reduce the demand for drugs used by an increasing number of prison 
systems, mainly in resource-rich countries, is to establish so-called “drug-free” units. 
Typically, “drug-free” units or wings are separate living units within a prison that focus 
on limiting the availability of drugs and are populated with prisoners who have voluntar-
ily signed a contract promising to remain drug free. In some instances, they focus solely 
on drug interdiction through increased searching, while some systems provide a multi-
faceted approach combining drug interdiction measures with treatment services. “Drug-
free” units could assist efforts to combat the spread of HIV in prison if they resulted in 
decreased drug use, particularly injecting drug use. There is some evidence from a small 
number of studies that so-called “drug-free” units do indeed significantly reduce levels of 
drug use among residents in these units. Such units appeal to a large number of prison-
ers, including prisoners who do not have any drug problems and want to live in a “drug-
free” environment. However, the studies do not say anything about whether “drug-free” 
units appeal to, and are successful in retaining, the most problematic users, in particular 
prisoners who inject drugs. Currently, there is therefore no data on the effectiveness of 
drug-free units as an HIV prevention strategy.
Drug supply reduction strategies
A broad range of search and seizure techniques and procedures can be used in an attempt 
to reduce the availability of drugs in prisons. These supply reduction measures include: 
random searches by security personnel; staff and visitor entry/exit screening and searches; 
drug detection dogs; closed-circuit monitoring; perimeter security measures (netting over 
exercise yards, higher internal fences to prevent projectiles, rapid response vehicles 
patrolling the prison perimeter); purchasing of goods from approved suppliers only; intel-
ligence analysts at every institution; drug detection technologies (such as ion scanners, 
x-ray machines, etc); modifications to the design and layout of visiting areas (use of fixed 
and low-level furniture); and drug testing (also called urinalysis).
Many prison systems, particularly in resource-rich countries, have placed considerable 
emphasis on these measures to reduce the supply of drugs. While such measures are not 
aimed at addressing HIV in prisons, they may result in unintended consequences for HIV 
(and HCV) prevention efforts. Drug interdiction measures may assist HIV prevention 
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efforts by reducing the supply of drugs and injecting in prisons. At the same time, they 
could make such efforts more difficult.
For example, many resource-rich prison systems regularly or randomly test prisoners’ 
urine for illegal drug use. Prisoners who are found to have consumed illegal drugs can 
face penalties. From a public health perspective, concerns have been raised that these 
programmes may increase, rather than decrease, prisoners’ risk of HIV infection. There 
is evidence that implementing such programmes may contribute to reducing the demand 
for and use of cannabis in prisons. However, such programmes seem to have little effect 
on the use of opiates. In fact, there is evidence that a small number of people may switch 
to injectable drugs to avoid detection of cannabis use through drug testing. Cannabis is 
traceable in urine for much longer (up to one month) than drugs administered by inject-
ing, such as heroin and other opiates. Some prisoners choose to inject drugs rather than 
risk the penalties associated with smoking cannabis simply to minimize the risk of detec-
tion and punishment. Given the scarcity of sterile needles and syringes and the frequency 
of needle sharing in prisons, the switch to injecting drugs may have serious health conse-
quences for prisoners.
Box 8. Impact of drug testing on drug use: the example of Canada
A 2001 study by the Correctional Service of Canada found that between 1996—when the drug testing 
programme was implemented nationally—and 2000 the percentage of samples testing positive for drug 
use remained largely unchanged (11 per cent to 12 per cent). At the same time, the percentage of prison-
ers refusing to submit a sample for random drug testing increased significantly, from 9 per cent to 
14 per cent. In particular, in maximum-security institutions, the refusal rate increased from 16 per cent 
in 1996 to 29 per cent in 2000, although regulations stipulate that the sanctions for refusing to provide 
a sample are identical to those incurred when a sample tests positive for drug use.
Generally, despite the fact that many prison systems make substantial investments in 
drug supply reduction measures, there is little solid and consistent empirical evidence 
available to confirm their efficacy in reducing levels of drug use. In particular, there is no 
evidence that these measures may lead to reduced HIV risk. 
Prison systems facing resource constraints should therefore not implement costly meas-
ures such as drug detection technologies and drug testing that may use up a substantial 
amount of financial and human resources that could otherwise be used for addressing 
HIV in prisons. Instead, they should focus on the proven and cost-effective HIV preven-
tion measures described above and on efforts to improve prison conditions and working 
conditions and pay for prison staff, without whom other drug supply reduction strategies 
are unlikely to be successful.
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Box 9.  Implementation, cost, and evaluation of drug supply  
reduction strategies
An Australian study examined the implementation, cost, and evaluation of drug supply reduction, drug 
demand reduction, and harm reduction strategies in Australian prisons (Black, Dola and Wodak, 2004). 
It concluded that “supply reduction strategies [drug detection dogs and urinalysis] were relatively 
expensive, had not been evaluated and possibly had unintended negative consequences.” In contrast, 
it found that demand reduction strategies and harm reduction strategies “were relatively inexpensive 
and evaluation had been favourable.”
For more details and references, see WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Drug Dependence Treatments. Evidence for Action Technical Papers. 
Available at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-
aids/publications.html.
!
Bleach and decontamination strategies
One strategy to reduce the risk of HIV transmission through the sharing of injecting equip-
ment is to provide bleach or other disinfectants for sterilizing needles and syringes. Bleach 
programmes have received support particularly in situations where opposition to needle 
and syringe programmes has been strongest, including in prisons.
Bleach is available in many prison systems, including in Western Europe, Canada, Aus-
tralia, Indonesia, Iran (Islamic Republic of), and some systems in Eastern Europe and 
Central Asia.
Evaluations of bleach programmes in prisons have shown that distribution of bleach is 
feasible in prisons and does not compromise security. However, studies in the community 
have raised doubts about the effectiveness of bleach in decontamination of injecting 
equipment, and conditions in prisons further reduce the probability that injecting equip-
ment may be effectively decontaminated. This is because the type of syringes available in 
prisons are more difficult to effectively disinfect with bleach and because cleaning is a 
time consuming procedure and prisoners are reticent to engage in any activity that 
increases the risk that prison staff will be alerted to their drug use. 
“Prisoners are highly unlikely to spend 45 minutes shaking the syringes to clean them while waiting to inject in 
some hidden corner of the prison. Bleach can therefore create a false sense of security between prisoners sharing 
paraphernalia. The effectiveness of disinfection procedures … depends greatly on the method used. Effectiveness 
varies and disinfection is now regarded as a second-line strategy to needle- and syringe-exchange programmes.”
WHO Europe, 2005
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Therefore, bleach programmes should be available in prisons, but only as a second-line 
strategy to needle and syringe programmes, until opposition to such programmes can be 
overcome or in addition to them.
For more details and references, see WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons. Needle and Syringe Programmes and Decontamination Strategies. Evi-
dence for Action Technical Papers. Available at www.who.int/hiv/idu/prison/en/index.html 
or www.unodc.org/unodc/en/hiv-aids/publications.html.
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Needle and syringe programmes
Introducing needle and syringe programmes in prisons has been controversial. However, 
studies have demonstrated conclusively that needle and syringe programmes in the com-
munity are one of the most important, if not the most important, components of efforts to 
reduce the spread of HIV among people who inject drugs. More recently, good results 
have also been shown in prisons.
Needle and syringe programmes have been successfully introduced in a wide range of 
prison settings, including in men’s and women’s prisons, prisons of all security levels, 
small and large prisons, and prisons in which prisoners live in units of individual cells 
and in barrack-style facilities. They have been implemented in countries in which prison 
systems are relatively well resourced, as well as in countries in which prisons operate 
with significantly less funding and infrastructural support, such as in Eastern Europe and 
Central Asia.
There is strong evidence that providing sterile needles and syringes is readily accepted by 
injecting drug users in prisons and contributes to a significant reduction of syringe shar-
ing and resulting HIV infections. At the same time, it has not had any serious, unintended 
negative consequences. In particular, drug use and injecting did not increase, and needles 
have never been used as weapons. Evaluations have found that providing needles and 
syringes in prisons actually facilitates referral of drug users to drug dependence treat-
ment programmes. In order to be successful, prisoners should have easy, confidential 
access to needle and syringe programmes, and prisoners and staff should receive 
information and education about the programmes and be involved in their design and 
implementation.
Needle and syringe programmes should therefore be urgently introduced in prisons in 
countries that are experiencing or are threatened by an epidemic of HIV infections among 
injecting drug users. Experience has shown that, in order to overcome objections against 
them, such programmes may best be introduced as experimental pilot projects that are 
carefully evaluated. However, this should not delay the rapid expansion of the programmes 
to other prisons.
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Detection and treatment of sexually transmitted infections
Early detection and treatment of sexually transmitted infections is important because 
these infections increase the chances of an individual transmitting and acquiring HIV. 
Sexually transmitted infections that disrupt the integrity of the skin or mucous mem-
branes can bleed easily, increasing the infectiousness and susceptibility to HIV. For this 
reason it is recommended that prison systems, in conjunction with health ministries 
and public health authorities, develop a comprehensive programme for early identifica-
tion and treatment for sexually transmitted infections to reduce their incidence and 
prevalence in prisons.
Controlling the spread of tuberculosis
In some countries, it has been estimated that tuberculosis is 100 times more common in 
prisons than in the community. Wherever tuberculosis is evident in prisons it is a significant 
health problem. Sub-standard prison living conditions, including overcrowding, poor ven-
tilation and inadequate nutrition, make the attempts to control the spread of tuberculosis in 
prisons more difficult. Moreover, prisons in geographically disparate places (from Thailand 
to New York State to Russia) have reported high levels of drug-resistant tuberculosis. Tuber-
culosis poses a substantial danger to the health of all prisoners, staff, and the community 
outside prisons. Prisoners living with HIV are at particular risk. HIV infection is the most 
For more details and references, see WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Needle and Syringe Programmes and Decontamination Strategies. Evi-
dence for Action Technical Papers. Available at www.who.int/hiv/idu/prison/en/index.html 
or www.unodc.org/unodc/en/hiv-aids/publications.html.
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For comprehensive information about tuberculosis control in prisons, see:
World Health Organization and International Committee of the Red Cross (2001). Tubercu-
losis Control in Prisons: A Manual for Programme Managers. Available in English, Spanish, and 
Russian via www.who.int/docstore/gtb/publications/prisonsNTP/.
J. Veen. Tuberculosis control in prisons. In: World Health Organization, Regional Office for 
Europe (2007). Health in Prisons—A WHO Guide to the Essentials in Prison Health. Available in 
English and Russian via www.euro.who.int/prisons.
WHO (2007). The Status Paper on Prisons and Tuberculosis. Available at www.euro.who.int/
Document/E89906.pdf.
For information about a programme to treat multiple drug resistant TB in prisons in Siberia, 
see: www.phri.org/programs/programme_russiantb.asp
!
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important risk factor for the development of tuberculosis, and tuberculosis is the main 
cause of death among people living with HIV.
For all these reasons, in addition to improving conditions in prisons that fuel the spread 
of tuberculosis (see the section below), prisons must develop and implement comprehen-
sive tuberculosis control programmes, which should be coordinated with or integrated in 
national tuberculosis control programmes.
Hepatitis B vaccination
Hepatitis B is easily spread in prisons. In contrast to HIV, the risk of infection can be 
reduced through the administration of a vaccine. Some prison systems already offer hep-
atitis B vaccination to all staff and prisoners. Other prison systems should follow suit. In 
addition, consideration should be given to providing hepatitis A vaccination to prisoners 
at risk.
Box 10. Hepatitis B immunization in Canadian prisons
In 1989, the Correctional Service of Canada (CSC) instituted a programme for hepatitis B immunization 
of prisoners. The hepatitis B vaccine is a safe and effective means of preventing hepatitis B virus infec-
tion. Vaccination is encouraged for all incoming offenders and is available on request throughout a 
prisoner’s sentence.
Hepatitis C prevention
In addition to contributing to reduced risk of HIV transmission in prisons, most of the 
measures described above also contribute to reducing the risk of hepatitis C virus (HCV) 
transmission. However, as explained above, in box 3, HCV is much more easily spread 
than HIV, including through sharing of shavers and toothbrushes, as well as through 
tattooing and body piercing. It is therefore important that prison systems make informa-
tion available to all prisoners and to staff about the risks of HCV transmission in prison 
and educate them about the ways to reduce that risk. In addition, shavers and tooth-
brushes should be made available to prisoners so that they do not have to share them 
with fellow prisoners; and prison systems should consider implementing measures to 
reduce the spread of HCV through tattooing and body piercing, such as making sterile 
tattooing equipment available to prisoners.
Providing health services in prisons equivalent to those in the community
In addition to providing comprehensive HIV prevention programmes, national govern-
ments have a responsibility to provide prisoners with treatment, care and support equiv-
alent to that available to other members of the community.
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Prisoners shall have access to the health services available in the country without discrimination on the grounds 
of their legal situation.
United Nations Basic Principles for the Treatment of Prisoners (principle 9)
The right to health and the equivalence principle 
Health in prison is a right guaranteed in international law, as well as in international 
rules, guidelines and covenants. The right to health includes the right to medical treat-
ment and to preventive measures and to standards of health care equivalent to those 
available in the community. As it was stated in April 1996 by the Joint United Nations 
Programme on HIV/AIDS (UNAIDS) to the United Nations Commission on Human Rights 
at its fifty-second session:
HIV/AIDS in prisons remains a difficult and controversial subject... Often there are 
not enough resources to provide basic health care in prisons, much less HIV/AIDS 
programmes. Yet the situation is an urgent one. It involves the rights to health, secu-
rity of the person, equality before the law and freedom from inhuman and degrading 
treatment... With regard to effective HIV/AIDS prevention and care programmes, 
prisoners have a right to be provided the basic standard of medical care available in 
the community.
The 1993 World Health Organization Guidelines on HIV infection and AIDS in prisons 
also highlight that as a general principle prisoners have the right to receive health care 
“equivalent to that available in the community without discrimination”. 
Effective HIV treatment in prison settings
The right to medical care in prisons includes the provision of antiretroviral therapy (ART) 
in the context of comprehensive HIV treatment, care and support. The advent of combi-
nation ART has significantly decreased mortality due to HIV infection and AIDS in coun-
tries around the world where ART has become accessible. There has been a parallel 
decrease in the mortality rate among incarcerated individuals in prison systems in those 
countries.
Providing access to ART for those in need in prisons is a challenge, but it is necessary and 
feasible. Studies have documented that, when provided with care and access to medica-
tions, prisoners respond well to antiretroviral treatment. The right to enjoyment of the 
highest attainable standard of physical and mental health, in concert with the principle of 
equivalence, dictates that prisoners should have access to the same standard of care 
available to people outside prisons.
In September 2003, the WHO, UNAIDS, and the Global Fund to Fight AIDS, TB and 
Malaria launched the Treat 3 Million by 2005 (3 by 5) Initiative, partly out of the recogni-
tion that HIV was exacerbating inequities between rich and poor countries, and the 
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conviction that the right to health and life should not be dependent on ability to pay for 
medicines. Although the ambitious target of 3 by 5 was not reached, at the 2005 World 
Summit and the 2006 High Level Meeting on AIDS, world leaders committed to pursue all 
necessary efforts towards the goal of universal access to comprehensive HIV prevention, 
treatment, care and support by 2010. In support of this, additional resources to fund an 
expanded response have become available, including through the Global Fund to Fight 
AIDS, Tuberculosis and Malaria.
As ART is increasingly becoming available in developing countries and countries in tran-
sition, and as countries are moving towards the goal of universal access to HIV preven-
tion, treatment, care and support by 2010, it will be critical to ensure that treatment also 
becomes available to all prisoners who need it. Ensuring continuity of care from the 
community to the prison and back to the community, as well as continuity of care within 
the prison system, is a fundamental component of successful treatment scale-up efforts.
The following actions will facilitate this:
P " rison departments must have a place within the national AIDS coordinating com-
mittees, and prison issues need to be part of the agreed AIDS action framework 
and country-level monitoring and evaluation system;
P " rison departments need to be involved in all aspects of treatment scale-up, from 
applications for funding (to ensure that funds are specifically earmarked for pris-
ons), to development, implementation, and monitoring and evaluation of treatment 
roll-out plans;
T " he ministry responsible for health and the ministry responsible for the prison 
system should collaborate closely, recognizing that prison health is public health;
P " olicies or guidelines should be developed specifying that people with HIV or AIDS 
are allowed to keep their HIV medication upon them, or are to be provided with 
their medication, upon arrest and incarceration and at any time they are trans-
ferred within the system or to court hearings. Police and prison staff need to be 
educated about the importance of continuity of treatment.
For more details and references, see WHO, UNODC, UNAIDS (2007). Interventions to Address 
HIV in Prisons: HIV Care, Treatment and Support. Evidence for Action Technical Papers. Available 
at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-aids/publi-
cations.html.
!
Prison health care: the need for increased funding and a new model
HIV, HCV, and TB have exacerbated existing problems in health care provision in prisons. 
Correctional health care budgets must reflect the growing needs of the prison population. 
Correctional health care should be recognized as an integral part of the public health 
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sector, and evolve from its present reactive “sick call” model into a proactive system that 
emphasizes early disease detection and treatment, health promotion, and disease pre-
vention. There is a need for a public health infrastructure to fulfil the core functions of 
public health services within prisons—i.e., to assess the health status of prisoners; have 
an effective surveillance system for infectious and chronic diseases; undertake health 
promotion efforts; have coordinated actions to prevent diseases and injuries; protect 
the health of prisoners; and evaluate the effectiveness, accessibility, and quality of 
health services. Addressing prisoners’ health needs will contribute to the prisoner’s 
rehabilitation and successful reintegration into the community.
Transferring control of prison health
In the longer term, transferring control of prison health to public health authorities could 
have a positive impact on HIV care in prison, at least in countries with a well functioning 
public health service.
In the vast majority of prison systems in the world, health care is provided by the same 
ministry or department responsible for prison administration, not by the ministry or 
department responsible for health. Prisons are not designed and are generally not 
equipped to deal with prisoners infected with chronic, potentially fatal diseases such as 
HIV, hepatitis, and tuberculosis. They do not have adequate staffing levels, staff training 
or equipment to meet the health needs of prisoners suffering from these diseases.
Experience in a range of prison systems has shown that health care in prisons can be 
delivered more effectively by public health authorities than by the prison system. This 
has the advantage of strengthening the link between health in the community and health 
in prisons. Some countries have already introduced such a change in prison health 
administration. 
Moving responsibility for prison health is not a straightforward handover of responsi-
bility and requires detailed and careful assessment of the feasibility on a case-by-case 
basis. However, closer integration between community health services and prison health 
services has the potential to: 
P " rotect the independence of the clinical judgement of the prison health staff;
I " mprove the continuity of treatment and care between prison and the community, 
which is in the interests of prisoners and of society as a whole;
P " rovide support and training from other health professionals to their colleagues 
working in prisons;
P " rovide strong support for public health measures such as provision of condoms, 
bleach, and needles and syringes, even when these may be perceived to cause 
problems in the prison environment;
I " ncrease the trust between prisoners and health staff, and thus facilitate the 
introduction of health prevention and promotion activities.
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Attention to the needs of women prisoners 
As prison systems develop and implement HIV prevention, treatment and care pro-
grammes, special attention should be given to women prisoners, who require information 
and services specifically designed for their needs.
Women prisoners are fewer than males, and the health services provided for women are 
sometimes minimal or second-rate. With the advent of HIV, a new problem has arisen for 
women prisoners. Women prisoners need the same preventive measures and the same 
level of treatment, care and support as male prisoners. In addition, however, there is a 
need for initiatives that acknowledge that the problems encountered by women in the 
correctional environment often reflect, and are augmented by, their vulnerability and the 
abuse many of them have suffered outside prison. The task of protecting women prison-
ers from HIV transmission and of providing those living with HIV or AIDS with care, 
treatment, and support, therefore presents different—and sometimes greater—challenges 
than that of dealing with HIV infection in male prisoners.
Improving prison conditions—the need for prison reform 
Much can be done to address the problems linked to HIV in prisons by taking action in 
the areas outlined above. In the medium and longer-term, however, it will be essential to 
take action to improve prison conditions. Prison conditions are integrally linked to prison 
health, and have the potential to affect the health of prisoners in positive or negative 
ways. Minimum standards for the housing and treatment of prisoners are defined by 
international agreement.
In the context of HIV, substandard living conditions can increase the risk of HIV trans-
mission among prisoners by promoting and encouraging drug use in response to bore-
dom or stress (most often involving unsafe injecting practices) and by enabling prison 
violence, fighting, bullying, sexual coercion, and rape. Substandard prison conditions 
can also have a negative impact on the health of prisoners living with HIV by increasing 
their exposure to infectious diseases such as tuberculosis and hepatitis; housing them 
in unhygienic and unsanitary environments; confining them in spaces that do not meet 
the minimum requirements for size, natural lighting, and ventilation; limiting access to 
open air and to educational, social or work activities, and by failing to provide them 
with access to proper healthcare, diet, nutrition, and/or clean drinking water, and basic 
hygiene.
A comprehensive programme of prison reform based on the international human rights 
standards would do much to improve these conditions and, ultimately, to reduce the 
spread of HIV. Issues that need to be addressed include:
A "  proper system of classification needs to be in place which keeps children or 
youth separately from adults, women separate from men, and pre-trial prisoners 
separate from sentenced prisoners—such a system will decrease the likelihood of 
sexual abuse and violence in prisons.
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I " mproved prison conditions, with reasonable space, decent sanitation and daylight 
and regular access to the open air will improve general health of prisoners, reduce 
the spread of tuberculosis, and likely decrease use of drugs.
R " estricted access to adequate nutrition has an impact on the health of all prison-
ers, but is particularly problematic for the health of prisoners living with HIV or 
AIDS. Providing a more balanced and varied diet and clean drinking water will 
reduce prevalence and incidence of infections.
R " educing violence, including sexual violence, through a variety of activities, includ-
ing hiring additional staff, will also decrease the risk of HIV infection. 
P " roviding prisoners with work and other purposeful activities has many benefits, 
but it will also reduce high-risk behaviours that are often the result of boredom. 
R " egular contact with family and friends through visits, telephone and post is also 
important, for the same reasons.
S " everal aspects of corruption are relevant to HIV, including staff’s active involve-
ment or complicity in the smuggling of drugs. Improving the pay and working 
conditions of staff, and developing and strictly enforcing a code of conduct for staff 
are important elements of efforts to fight corruption.
For more information on how to improve prison conditions and make them conform to 
relevant international standards, see: A Coyle. A Human Rights Approach to Prison Manage-
ment. Handbook for prison staff. London: International Centre for Prison Studies, 2002. 
Available in many languages via www.kcl.ac.uk/depsta/rel/icps/publications.html.
!
Reducing prison populations
Overcrowding or congestion is an endemic problem in most prison systems. In Africa, 
there is an average of 150 prisoners for every 100 berths and in some countries the prob-
lem is greater still with insufficient space in dormitories for all the prisoners to sleep. In 
such conditions, violence and sexual activity, consensual or coerced, can be common. 
Overcrowded living conditions also increase the likelihood that the health of prisoners 
living with HIV will suffer through exposure to other infectious diseases and to unhygienic 
conditions, and create additional impediments to the ability of prison medical staff to 
provide adequate health services.
In the short term, overcrowding can be reduced by amnesties, reviewing the legality of 
detention status so that those held unlawfully can be released and removing groups inap-
propriately held, such as those prisoners with mental disorders.
In the medium and long term, there are two potential solutions to overcrowding: increas-
ing the capacity of the prison system or reducing the number of prisoners. The first solu-
tion is very costly, and many countries do not have the additional financial resources 
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required to expand their prison systems, or could put those resources to better use. 
Reducing imprisonment and pre-trial detention is a better solution. Prison should only 
be used as a place of last resort. In all other cases alternatives to custody should be 
used. A range of community-based pre-trial and sentencing options and programmes of 
supervised early release can help to ensure that prison is used as a last resort and for 
the shortest time. A good strategy is to adopt official government targets for reducing 
prison overcrowding.
The overuse of incarceration of people who use drugs is of particular concern. In many 
countries, a significant percentage of the prison population is comprised of individuals 
who are convicted of offences directly related to their own drug use (i.e. those incarcer-
ated for the possession of small amounts of drugs for personal use, those convicted of 
petty crimes specifically to support drug habits). The incarceration of significant numbers 
of people who use drugs increases the likelihood of drug use inside prisons, as well as 
unsafe injecting practices and the risk of HIV transmission. Many of the problems cre-
ated by HIV infection and by drug use in prisons could be reduced if alternatives to 
imprisonment are implemented, particularly in the context of drug-related crimes. As 
early as 1987, the World Health Organization, in a statement from the first Consultation 
on Prevention and Control of AIDS in Prisons, said that “[g]overnments may … wish to 
review their penal admission policies, particularly where drug abusers are concerned, 
in the light of the AIDS epidemic and its impact on prisons.” Options for non-custodial 
sentencing include:
A "  discharge (where the person is deemed not to have been convicted of the offence, 
despite being found guilty, and the person does not acquire a criminal record);
A "  suspension (where the sentence is suspended and often replaced by a probation 
order, with the additional condition that the sentence will be reinstated if the 
probation order is broken);
A "  fine;
A "  community service order; or
A "  supervised attendance order (which might order the person to attend a place of 
supervision).
Various combinations and variations of these sentencing options already exist in laws 
governing sentencing in many countries.
One alternative sentencing option is to order a person convicted of a drug-related offence 
to consult with, and be assessed by, professional staff of drug dependency treatment pro-
grammes. However, legislation should not enable a court to force people, upon pain of 
imprisonment, to undergo drug dependency treatment. The fact that people enter treat-
ment under the threat of incarceration, or abstain from drugs to avoid sanctions, has 
serious implications for the right to bodily integrity, the right to privacy and the right to 
equality. The extent to which people can give their free and informed consent to such 
treatment is doubtful. Thus, legislation should take advantage of the person’s contact 
with the criminal justice system to facilitate mostly voluntary access to drug dependence 
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treatment and other health services, consistent with the notion that treatment for drug 
dependence should be non-coercive. 
For more information on alternatives to imprisonment, see:
UNODC (2007). Handbook of Basic Principles and Promising Practices on Alternatives to Imprison-
ment. Criminal Justice Handbook Series at www.unodc.org/pdf/criminal_justice/07-80478_
ebook.pdf
Stern V (ed). Alternatives to Prison in Developing Countries. London: International Centre for 
Prison Studies, King’s College, University of London. See www.kcl.ac.uk/depsta/rel/icps/
publications.html for order information. In many developing countries there are few alterna-
tives to imprisonment. Case studies and detailed appendices in this book provide legislative 
and administrative guidance that will be a valuable tool for practitioners in developing 
countries and countries in transition.
!
Priorities for action
Policymakers, legislators, and parliamentarians have a crucial role to play when it comes 
to facilitating effective action on HIV in prisons, as outlined in the previous section. 
Simply stated, many of the necessary steps will not be possible without action by policy-
makers, legislators, and parliamentarians, or at least their explicit or tacit consent. 
Priorities for action include: 
P " roviding leadership by raising awareness of the issues, engaging with stake-
holders, and informing and educating the public;
U " ndertaking legislative and policy reform;
A " dvocating for increased funding to address HIV in prisons.
The prison service is a public service, meeting some fundamental needs in society, such 
as the need to feel safe, and to feel that crime is sufficiently punished and reparations 
made. As with all public services, the extent and the quality of provision is a political deci-
sion. Political support for effective action on HIV in prisons should be based on the accept-
ance that:
G " ood prison health is essential to good public health; 
G " ood public health will make good use of the opportunities presented by prison; 
and
P " risons can contribute to the health of communities, by helping to improve the 
health of some of the most marginalized in any society. 
37
Module 2
Issues for policymakers, politicians and parliamentarians
Action 1. Providing political leadership
According to the Declaration of Commitment on HIV/AIDS adopted by all member coun-
tries during the 2001 United Nations General Assembly Special Session on HIV/AIDS, 
“strong leadership at all levels of society is essential for an effective response to the [HIV] 
epidemic.” This is particularly true in the area of prisons.
In most countries, prison health standards and prison conditions suffer because of a lack of 
political and public interest in the well-being of prisoners. Taking action to address the 
broad concerns raised by HIV in prisons, and enabling prison authorities to implement 
effective policies and strategies, requires the political commitment to publicly identify prison 
health, improved prison conditions, and HIV as issues demanding government action. 
Policymakers, legislators, and parliamentarians can demonstrate leadership by raising 
awareness about these issues among their peers.
The prevention of HIV transmission in prisons is often hampered by the denial of govern-
ments of the existence of injecting drug use and unsafe sexual practices in prisons. There-
fore, official acknowledgement of the reality of high risk behaviours and HIV transmission 
in prisons is an essential first step in raising public awareness and implementing effective 
responses.
Informing and educating the public about the measures being undertaken is the next 
step. It is important to have a clear strategy about how to communicate to the public what 
is being done to address HIV in prisons and the rationale for it. Communication should 
emphasize that prison HIV policies are part of the national AIDS response with an aim to 
contain the HIV epidemic, as well as part of a broader national approach to public health 
issues in general which includes other major illnesses affecting the community as well as 
prisoners (in particular tuberculosis and hepatitis B and C).
Elements of the strategy might include:
E " mphasizing that action on HIV in prisons is necessary for the benefit of prison-
ers, but also of staff and the general public;
E " ngaging the medical community and public health practitioners as spokespersons;
W " orking closely with media that have demonstrated that they are able to cover 
HIV issues well and encouraging them to write in-depth articles, rather than 
issuing press releases and encouraging sensational media reporting.
For more information on the role of parliamentarians in responding to HIV/AIDS in 
prisons, see:
Inter-Parliamentary Union, UNAIDS, UNDP (2007). Taking Action Against HIV. Handbook for 
Parliamentarians. Available via www.ipu.org/english/handbks.htm#aids07.
!
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Checklist 1.  How you can raise awareness and engage other  
stakeholders: practical steps
Awareness raising and engagement of stakeholders is usually not very difficult because the subject 
matter is quite straightforward. However, if your country is still in a state of denial about the existence 
of HIV in prisons, it requires some courage to raise the issue. It is not recommended to go public at 
an early stage and involve the media, because this can create an emotional and uninformed public 
debate. Here are some practical suggestions on how to proceed:
To raise awareness and engage with stakeholders, you need to have some credible information  "
on HIV in prisons. Such information includes the number of prisoners in your country, the 
extent of overcrowding, the extent of high-risk behaviour, and data on HIV, HCV, and TB. In 
most countries this kind of information is already available. If this is not the case, you could 
commission a rapid assessment in one or two prisons of your country to collect this informa-
tion. A rapid assessment in the penitentiary system does not take more than two weeks. 
Intervention and response development—rather than the simple collection of data—is the ulti-
mate goal of a rapid assessment. To date, rapid assessments on drug use have been conducted 
in 70 countries by international agencies such as the World Health Organization.
For a technical guide on rapid assessments, see: G. V. Stimson, M. C. Donoghoe, C. Fitch 
and T. J. Rhodes, with A. Ball and G. Weiler (2003) Rapid Assessment and Response Techni-
cal Guide, World Health Organization (Department of Child and Adolescent Health and 
Development, and Department of HIV/AIDS) Geneva. Available at www.who.int/doc-
store/hiv/Core/Contents.html. For more information, contact the World Health Organi-
zation, Department of HIV/AIDS, 20, avenue Appia CH-1211 Geneva 27 Switzerland, 
E-mail: hiv-aids@who.int. 
Most countries have a multi-sectoral AIDS coordinating institution at the national level, usually  "
called the National AIDS Programme or the National AIDS Commission. In such programmes or 
commissions, all ministries addressing HIV should be represented, including the ministry respon-
sible for the penal system of your country. If your country is a recipient of grants from the Global 
Fund to Fight AIDS, Tuberculosis and Malaria, there will also be a so-called Country Coordination 
Mechanism (CCM). Participate in the next meetings of these fora and make sure that HIV in 
prisons is on the agenda. Make a presentation on the HIV situation in prisons in your country by 
presenting the available data. Explain the mechanisms of HIV transmission in prisons, and how 
prisons contribute to the spread of HIV in general society. 
If you make such a presentation, it usually triggers a lot of debate. Some of your colleagues will  "
react very emotionally. You should provide them with as much evidence-based information as 
possible. Have a two-page note on HIV in prisons in your country ready for distribution. Schedule 
bilateral meetings with some of your colleagues.
Depending on the form of government in your country, you could either use a bottom-up or a  "
top-down approach for awareness raising and engagement of stakeholders. To be successful in 
policy and programme development, it is usually necessary to have the support of the highest 
level of the government. It might be necessary to brief the minister or the head of government.
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Action 2. Undertaking legislative and policy reform
The next priority is to ensure that legislation, prison policy, and prison rules promote the 
effective responses to HIV in prisons outlined above, rather than impeding progress on 
reducing transmission of HIV and caring for prisoners living with HIV or AIDS. The extent 
to which new legislation or policy is needed will vary from jurisdiction to jurisdiction. In 
some countries, for example, legislation to explicitly authorize HIV prevention measures 
in prisons will be necessary, while in others a simple guideline issued by the head of the 
prison system will be enough. In all countries, however, a comprehensive review of all 
laws, policies, and rules that impact on the ability of prison systems to deal effectively 
with HIV (as well as sexually transmitted diseases, hepatitis, and tuberculosis) should be 
undertaken. 
In particular, such a review should:
E " nsure legal status of comprehensive HIV prevention, treatment, care and support 
services in prisons, including condom distribution, needle and syringe programmes 
and substitution therapy;
E " nsure there is no involuntary HIV testing or segregation of prisoners living with 
HIV or AIDS;
E " nsure that health decisions in prisons are made by health professionals;
It has been the experience in some countries that progress in implementing HIV strategies in  "
prisons has been significantly helped by the work of one or a small number of individuals within 
the prison system who have committed themselves to advocating internally for change. Therefore, 
you should identify and support “champions” within the system. These individuals should be 
tasked with—and supported in—promoting the strategy nationally (internally within the prison 
system and externally with the public). These champions should be supported in developing 
expertise on the issue of HIV in prisons, and to act as key centres of knowledge and information 
for the system as a whole.
Consult with other potential allies and explore with them how they could support you. Such allies  "
include representatives from the United Nations system in your country. Of particular help could 
be the representatives of the World Health Organization and United Nations Office on Drugs and 
Crime, the UNAIDS Country Coordinator, the United Nations Resident Coordinator and the Chair 
of the United Nations Theme Group on HIV. If the heads of these agencies come for a visit to 
your country, ensure that they are briefed about HIV in the penal system in your country, and 
that they raise the issue in their consultations with the highest government authorities.
Other potential allies you should consult with include associations of health professionals, health  "
researchers, human rights and other civil society organizations, people living with HIV, and 
prisoners and former prisoners.
Most importantly, base decisions affecting prison health on evidence, recognized best practice,  "
and on legal and ethical obligations, rather than on public opinion or political expediency.
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E " nsure there is effective protection against sexual violence and prosecution of 
offenders;
S " upport criminal law policies consistent with an effective HIV response—these laws and 
their interpretation and enforcement should be complementary to HIV strategies, so that 
they do not hinder HIV prevention and treatment, care, and support programmes;
A " llow for provisions to reduce imprisonment and pre-trial detention;
A " llow for early release of terminally ill prisoners.
Checklist 2. Review of legislation and prison rules
This list contains crucial elements of legislation and prison rules concerning HIV in prisons. Check here 
whether legislation in your country conforms to international good practice. 
Does the legislation provide for access to the following HIV-related prevention and treatment,  "
care and support services in prisons:
Information, education and communication? −
Voluntary and confidential counselling and testing? −
Condoms and lubricants so that prisoners can practice safer sex? −
Bleach or other disinfectants so that prisoners can clean injecting, tattooing and skin piercing  −
equipment?
Sterile injecting equipment (needles, syringes and cotton swaps) for drug injecting prisoners? −
Drug dependence treatment programmes, including substitution treatment? −
Early diagnosis and treatment of sexually transmitted infection? −
Antiretroviral treatment for prisoners with HIV/AIDS? −
Does the legislation provide for clear standards for effective detection, prevention and reduction  "
of prison rape and for effective prosecution of offenders?
Does the legislation provide for access to post-exposure prophylaxis for staff potentially exposed  "
to HIV during the course of their work and for prisoners who are sexually assaulted or otherwise 
exposed to HIV?
Does the legislation provide for hepatitis vaccination for staff and prisoners? "
Does the legislation provide for effective tuberculosis control? "
Does the legislation provide for confidentiality of prisoners’ medical and/or personal information,  "
including HIV status?
Does the legislation prohibit HIV discrimination in prisons, including isolating, segregating or  "
excluding from programmes prisoners living with HIV simply on the basis of their HIV status?
Does the legislation include provisions to reduce imprisonment and pre-trial detention? "
Does the legislation allow for early release of terminally ill prisoners and provide for an accessible  "
and quick mechanism to apply for such a release?
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Such a review is best undertaken by a joint working group or commission including rep-
resentatives of the ministry responsible for prisons, the ministry of justice, and the min-
istry of health, and should consult with representatives of the prison system, including 
staff and prisoners, civil society, medical associations, and international agencies. 
What should legislation look like?
Model legislation addressing the HIV epidemic among people who use drugs has been 
developed. This legislation contains a section on prisons. The model legislation—a 
detailed framework of model legal provisions—is a resource for the reform of prison 
laws and regulations related to HIV. It is “options-based”—that is, designed to be adopted 
or adapted to local contexts as part of an effective response to the epidemic. It is anno-
tated in order to highlight critical issues, areas of potential conflict and possible solu-
tions. It is “model” in the sense that it has not been developed with any particular 
jurisdiction in mind. Rather, it provides guidelines and principles with a hope that it can 
be useful in a variety of countries, particularly in those regions of the world where the 
HIV epidemic is driven by injecting drug use. It is also “model” in that it is based on 
human rights principles and “best practice” national legislation.
For more information and the text of the model legislation, see www.aidslaw.ca/publications/
publicationsdocEN.php?ref=587!
Box 11. Examples of legislation regarding pre-trial detention
Art. 109 of the Russian Federation Code of Criminal Procedure of 18 December 2001, No. 174-F3, last 
amended 29 May 2002 sets the time limits on pre-trial detention, which may not exceed two months.
Italy’s Law No. 89 of 24 March 2001, the so-called “Pinto” Act (from the name of the Senator who 
was its first signatory), introduced into Italian law a mechanism under which a private citizen is entitled 
to "fair reparation" if suffering damage due to the "unreasonable" length of proceedings.
What about prison policy?
It must be recognized from the outset that reform of legal frameworks represents only 
one element of a comprehensive response to HIV in prisons. If unaccompanied by vigor-
ous efforts to align actual practice in prisons with the law, legal reform will be nothing 
more than a cosmetic change. Legal reform is necessary for HIV/AIDS policies in prisons 
to be effective and respectful of human rights, but on its own it is insufficient to bring 
about meaningful change.
Therefore, the review of laws should be carried out in parallel with the formulation of an 
HIV prison policy. In fact, policy development often informs the legal review and vice 
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versa. Prison systems should develop or revise, implement, and make publicly accessible 
written policies and prison rules related to prison health, prison conditions, and prison 
HIV programmes and services. Written policies and rules, and their proper implementa-
tion, are essential in the effective management of prisons, the training and support of 
prison staff, the ethical and humane treatment of prisoners, and the development of 
consistent and equitable standards within prisons and between prisons. 
Box 12. National HIV/AIDS policy in Malawi
Prisoners are particularly vulnerable to exploitative and abusive sexual relations because of the envi-
ronment in which they are living. They, therefore, need to be empowered to make informed decisions 
in the same way as other vulnerable groups.
The government, through the National AIDS Commission undertakes to do the following:
Ensure that prisoners are not subjected to mandatory testing, nor quarantined, segregated, or  "
isolated on the basis of HIV status.
Ensure that all prisoners (and prison staff, as appropriate) have access to HIV-related prevention,  "
information, education, voluntary counselling and testing, the means of prevention (including con-
doms), treatment (including antiretroviral treatment), care and support.
Ensure that prison authorities take all necessary measures, including adequate staffing, effective  "
surveillance, and appropriate disciplinary measures, to protect prisoners from rape, sexual violence 
and coercion by fellow prisoners and by warders. Juveniles shall be segregated from adult prison-
ers to protect them from abuse.
Ensure that prisoners who have been victims of rape, sexual violence or coercion have timely  "
access to post-exposure prophylaxis, as well as effective complaint mechanisms and procedures 
and the option to request separation from other prisoners for their own protection.
Box 13. Indonesian national strategy for HIV control in prisons
In late 2002, the Ministry of Justice (MOJ) of Indonesia decided to promote HIV prevention and care 
activities for prisoners to prevent spread of HIV within prisons and from there to the community as a 
whole. In 2005, it launched the Indonesian National Strategy for HIV Prevention, Care and Support for 
Prisoners, the first national strategy of its kind in Asia. It has enabled education as well as provision 
of condoms, bleach, methadone and ARVs for prisoners.
For more information, see: National Strategy for Prevention and Control of HIV/AIDS and Drug Abuse 
in Indonesian Correction and Detention Centres, for the period 2005-2009, Ministry of Justice and 
Human Rights of Indonesia, Jakarta, 2005.
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Box 14.  Canadian Policy on Management of Infectious Diseases  
in Prisons
Correctional Service Canada (2004). Commissioner’s Directive 821: Management of Infectious Diseases. 
Ottawa: CSC. 
Available (in English and French) at www.csc-scc.gc.ca/text/plcy/cdshtm/821-cde-eng.shtml. This docu-
ment provides policy direction on the management of infectious diseases in Canadian federal prisons, 
but is useful as a model for other prison systems. It “reflects public health principles, and incorporates 
a full range of infectious disease programme elements.” Its objective is to “contribute to public health 
and a safe and healthy environment through a comprehensive infectious diseases programme.” Among 
other things, the Directive states that:
“A full range of infectious diseases programme elements, including but not limited to screening/testing,  "
immunization, education and training, harm reduction measures, care and treatment, surveillance activi-
ties, and partnerships, shall be implemented based on best evidence and public health expertise”;
“Approved harm reduction items shall be readily and discreetly accessible to inmates in CSC opera- "
tional units so that no inmate is required to make a request to a staff member for any item”;
“Inmates living with infectious diseases shall be provided with humane treatment and support, in  "
an environment free of discrimination”;
“The Institutional Head shall ensure that non-lubricated, non-spermicidal condoms, water-based  "
lubricants, dental dams and bleach are discreetly available to inmates at a minimum of three loca-
tions, as well as in all private family visiting units”;
“CSC’s Health Services shall ensure that partnerships are established nationally, regionally and locally  "
with other federal departments, provincial and municipal governments, service agencies and stake-
holder groups, in order to ensure the sharing of information, best practices, and expertise”.
From policy to implementation
Implementing effective policies on HIV prevention, treatment, care and support in pris-
ons requires a further set of actions, namely the development of an implementation 
strategy, and the training of those who will implement the policy.
Capacity building of prison administrators and staff is critical to the effective implementation 
of HIV policies in prisons. Prison administrators could be sent abroad to countries where 
effective HIV prison policies are being implemented and observe and learn how this is being 
done. Also, the government could bring in external experts who could advise on how to 
implement policies. In addition, prison staff training must include various modules on HIV. 
For further information on important elements of prison policies, see: HIV/AIDS Prevention, 
Care, Treatment, and Support in Prison Settings: A Framework for an Effective National 
Response, section 2, pages 17-19 (“Reform of prison policy and rules”). Available at www.
unodc.org/pdf/HIV-AIDS_prisons_July06.pdf 
!
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Action 3. Advocating for increased funding
Prison systems in many countries do not have the financial resources they need in order 
to be able to improve prison conditions and provide comprehensive HIV prevention, 
treatment, care and support. That is why prisons are often overcrowded, buildings dilap-
idated, nutrition insufficient, and prison staff underpaid and poorly motivated. Govern-
ments do not usually accord prisons a high priority, due to other urgent needs. In a world 
with HIV, more than ever, prison systems need additional financial resources. Conditions 
in under-funded prison systems not only violate human rights, but also create a danger 
for the health of prisoners and for public health.
Many governments have begun to allocate more resources to prison systems. Most of the 
HIV prevention measures outlined above, such as provision of condoms, bleach, and nee-
dles and syringes, are relatively inexpensive and have been successfully implemented in 
low and middle-income countries. Other measures, like decreasing the use of prisons as 
a response to illegal drug use, would free up resources by reducing the number of people 
in prison. Nevertheless, in order to effectively address the range of challenges that HIV 
poses to the effective and ethical management of prisons, and to meet recognized inter-
national standards on prison health and prison conditions, it is imperative that both 
national governments and the international community provide the resources necessary 
to develop and implement comprehensive, evidence-informed interventions. 
Funding from domestic sources
As much as possible, programmes and strategies to promote prison health, improve 
prison conditions, and address HIV (as well as hepatitis and tuberculosis) should be 
resourced from national budgets. Some actions that will facilitate this include:
I " dentifying prisoners as a key vulnerable population when allocating national 
resources to combat HIV.
E " xpanding the parameters of existing national funding earmarked for vulnerable 
populations to encompass prisoners, recognizing that in many countries the popula-
tions most vulnerable to HIV are also disproportionately represented in prisons.
M " aximizing support and encouragement of peer-based HIV prevention, education, 
counselling, and care initiatives. Increasing the role of prisoners in developing and 
providing health programmes and services increases the capacity of prisons to 
respond to HIV.
E " nsuring that prisoners have access to antiretroviral therapies under national 
treatment plans.
D " edicating specific funding and resources for HIV programmes and services within 
national prison budgets, and dedicating specific funding for prison initiatives within 
national HIV, health, and drugs budgets.
R " eviewing the impact of drug control and enforcement programmes in combating 
the transmission of HIV in prisons, and examining the re-allocation of funding from 
ineffective or counter-productive programmes into new health-based initiatives.
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E " nsuring that civil society organizations are provided with sufficient funding to 
play an integrated and effective role in prison HIV programmes and services, and 
that sufficient and sustainable resources and other supports are provided to outside 
medical, drug dependence treatment, mental health, and social services to enable 
them to provide post-release care for ex-prisoners.
Funding from international sources
International sources of funding to combat HIV include the Global Fund to Fight AIDS, 
Tuberculosis and Malaria, the United States President’s Emergency Fund for AIDS Relief, 
the World Bank, various international foundations such as the Bill and Melinda Gates 
Foundation and the Clinton Foundation, and various bilateral donors. In order to be able 
to access such resources, it is essential for the ministry responsible for the prison system 
to be represented in national AIDS coordination mechanisms such as the national AIDS 
coordinating authority and the Global Fund Country Coordination Mechanism. 
Whenever the government prepares proposals for HIV funding from international 
sources, the prison system should ensure that a component on prison is included within 
the proposal.
Box 15. The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Fund was created in 2002 to increase resources to fight three of the world's most devastating 
diseases, and to direct those resources to areas of greatest need. As a partnership between govern-
ments, civil society, the private sector and affected communities, the Global Fund represents an innova-
tive approach to international health financing. The purpose of the Fund is to attract, manage and 
disburse additional resources through a new public-private partnership that will make a sustainable 
and significant contribution to the reduction of infections, illness and death, thereby mitigating the 
impact caused by HIV, tuberculosis and malaria in countries in need, and contributing to poverty reduc-
tion as part of the Millennium Development Goals. More information about the Global Fund can be 
found at www.theglobalfund.org.
Many countries are implementing HIV prevention and treatment programmes in prisons with Global 
Fund grants.
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This module is intended primarily for those who have responsibilities for the management 
of prison systems and individual prisons. We hope it will be useful to heads of national and 
provincial or regional prison administrators; prison directors and managers; and judges 
and inspectors with responsibilities for external scrutiny of prison conditions.
The module is designed to provide them with knowledge about key issues in HIV preven-
tion and care. The key objectives are to:
E " xplain how HIV is transmitted in prisons;
E " xplain what factors contribute to making prisons high-risk environments for HIV, 
and how they can be addressed;
S " uggest what HIV prevention measures should be adopted in prisons;
S " uggest how prisons can best provide treatment, care and support to prisoners 
with HIV or AIDS.
The module concludes with answers to frequently asked questions.
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Introduction and key issues for prison management
Prison authorities and prison managers have a central role in implementing effective HIV 
prevention as well as treatment, care and support measures. 
Prisons in modern societies are complex places to manage. Overcrowding, the epidemics 
of serious life-threatening diseases, and the use of prisons for housing the mentally ill and 
people with problematic drug use have all contributed to increase the challenges of man-
aging prisons at all levels. The majority of prisoners have multiple problems. This all 
produces a very challenging environment for those required to guarantee security, safety, 
decency and health. We hope that this toolkit will be of value in showing how the 
problems related to HIV in prisons can best be met.
Managers have the first challenge, namely setting the ethos, the overall “feel” of the 
prison. In the context of HIV, three overarching issues need to guide action in prisons.
The first is the need for a comprehensive approach, which aims both:
T " o prevent the prevalence of high risk behaviour; and
T " o reduce the risk of transmission of infections when such behaviour does 
take place. 
Sex and drug use in prison are against prison rules and against the criminal law. Prisons 
must do all they can to prevent drug use and unsafe sex in prisons, and to reduce levels 
of violence—in particular sexual violence. However, it is important to recognize that 
efforts to stop these activities, such as the use of drugs in prisons, will not always be suc-
cessful. Illegal drugs are available in prisons worldwide despite the sustained efforts of 
prison systems to prevent illegal drug use by prisoners—by doing what they can to pre-
vent the entry of drugs into prisons, tightly controlling distribution of prescription medi-
cations, and enforcing criminal prohibitions on illegal drug possession and use among 
prisoners. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), 
“whether the authorities admit it or not—and however much they try to repress it—drugs 
are introduced and consumed by inmates in many countries… Denying or ignoring these 
facts will not help solve the problem of the continuing spread of HIV”.
Therefore, taking measures to try to prevent sex and drug use in the first place is not 
enough. Knowing that sex and drug use cannot be completely stopped, prisons also need 
to implement measures to reduce the dangers to health associated with these activities, 
in particular unsafe injecting drugs and unsafe sex. This does not mean condoning these 
activities. Rather, it means adopting a pragmatic approach that acknowledges that risk 
activities occur in prisons and reduces the potential harms to prisoners, staff, and the 
community. 
The second key issue is that effective HIV programmes in prisons need to be available 
to prison staff as well as to prisoners. Implementing programmes only for prisoners, or 
only for staff, would not be enough to address the issues raised by HIV in prisons. Both 
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prisoners and prison staff have a right to health, and the prison system has an obliga-
tion to protect it. Without a workplace programme for prison officers, staff who are 
responsible for administering a programme for prisoners may be unwilling to do so. 
Prison staff may not understand why prisoners need access to certain HIV prevention 
measures, or may be prejudiced against prisoners or fellow staff living with HIV or 
AIDS. If they are not provided with information, education, and protective equipment, 
they may feel that more is done to protect the health of prisoners than to protect their 
own health. 
Third, certain groups of prisoners have particular needs that must be addressed in prison 
HIV programmes. These include those with particular vulnerability to exploitation, such as 
women, juveniles and children, and those with high-risk behaviour, including people who 
use illegal drugs, sex workers, the mentally ill, and men who have sex with men.
Finally, measures to prevent the spread of HIV and to provide care and treatment to pris-
oners living with HIV or AIDS must be incorporated into a broader framework for the 
prevention of disease and promotion of health in prison.
How is HIV transmitted in prisons? 
Sharing of injecting equipment
In many countries, a large number of prisoners come to prison with established drug 
habits. In fact, many prisoners are in prison in the first place because of offences related 
to drugs. 
People who used drugs prior to imprisonment often find a way to continue using them 
inside the prison, although prevalence and frequency rates for most—but not all—prisoners 
decline with imprisonment. Some people discontinue using drugs while in prison, while 
other prisoners start using drugs, often as a means to release tensions and to cope with 
being in an overcrowded and often violent environment.
Injecting drug use is also prevalent in many prisons and is of particular concern with 
regard to transmission of HIV (and other blood borne diseases such as hepatitis B and C). 
This is because those who inject drugs in prisons often share needles and syringes (and 
other equipment needed for injecting), which is a very efficient way of transmitting HIV.
Because it is more difficult to smuggle needles and syringes into prisons than it is to 
smuggle drugs into them, needles and syringes are very scarce. Often, only a handful of 
needles and syringes will circulate among a large population of prisoners who inject 
drugs. As a result, sharing of injecting equipment is frequent, and 15 to 20 people may 
inject using the same equipment. A needle and syringe may be owned by one prisoner 
and rented to others for a fee, or it may be used exclusively by one prisoner, reused again 
and again over a period of months. Sometimes, the equipment is home-made, and needle 
substitutes are fashioned out of hardened plastic and ball-point pens, often causing 
damage to veins, scarring, and severe infections. 
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A large number of studies from countries around the world report high levels of injecting 
drug use, including among female prisoners. Studies also show that:
T " he extent and pattern of injecting and needle sharing vary significantly among 
prisons;
M " any people who inject before imprisonment reduce or stop injecting when they 
enter prison, but many resume injecting upon release;
S " ome people start injecting in prison; and
T " hose who inject in prison will usually inject less frequently than outside, but are 
much more likely to share injecting equipment than are drug injectors in the com-
munity. Furthermore, they are sharing injecting equipment with a population—
fellow prisoners—that often has a high rate of HIV and HCV infections.
Box 16. Drug use in a prison in Thailand
A study conducted among prisoners in Bangkok’s Klong Prem Central Prison found that 25 per cent 
of the surveyed prisoners were HIV-positive. Half of the prisoners surveyed were regular injecting drug 
users, and 70 per cent of them had injected drugs while jailed. Almost all the users (95 per cent) had 
shared injecting equipment at some point.
Taking drugs inside prison is obviously unlawful and in many countries strenuous efforts 
are made to keep prisons drug-free. These include preventive measures such as regular 
searching of prisoners, staff and visitors, the use of specially trained dogs and other secu-
rity checks. They also include strict punishments for those who take drugs in prison and 
those who smuggle them in (for more details about these measures, see below the section 
on drug supply reduction efforts).
Despite these measures, no prison system—even systems with large financial resources—
has been able to prevent drugs from entering and being used in prisons. 
Transmission through sexual activity 
Unprotected sex in prisons poses a risk of transmission of HIV. Sex in prison may be con-
sensual or it may be forced or coercive. Sex may also be used as a form of currency within 
the prison and exchanged for money, protection, or drugs. Violent forms of unprotected 
anal or vaginal intercourse, including rape, carry the highest risk for transmission of HIV, 
particularly for the receptive partner who is more likely to suffer damage or tears in the 
membranes of the anus or vagina. 
The extent of consensual and non-consensual sexual activity in prisons is difficult to 
determine because studies must rely on self-reporting, which is distorted by embarrass-
ment or fear of reprisal or additional punishment. Sex is prohibited in most prison sys-
tems, leading prisoners to deny their involvement in sex, and in some countries, sex 
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between men is in itself a crime, punishable by imprisonment. Sex in prison often takes 
place in situations of violence or intimidation, thus both perpetrators and victims are 
disinclined to discuss its occurrence. Nevertheless, studies in countries throughout the 
world have shown that sex does occur, including both non-consensual and consensual sex 
between prison staff and prisoners.
Box 17. Prevalence of sexual activity in prisons
Studies from many countries in different regions of the world provide evidence that sex is prevalent 
in prisons. The following are some examples:
In Nigeria, in a study of prisoners using an anonymous risk-factors identification questionnaire,  "
5.2 per cent of respondents admitted having had sex in prison.
In a study in Zambia, 4 per cent of prisoners agreed in one to one interviews that they had sexual  "
relations with other prisoners.
In Brazil, in a study of 1,059 prisoners in 2 prisons, 66 per cent of prisoners reported sex with  "
female visitors, and 10 per cent reported sexual practices with other prisoners of the same sex.
In the Russina Federation, a study of 1.044 prisoners found that 9.7 per cent of prisoners had ever had  "
sex in prison.
In Thailand, in a cohort of 689 male prisoners in a Bangkok central prison, more than 25 per cent  "
of prisoners reported ever having had sex with men, of which more than 80 per cent continued 
having sex, or started having sex, with men in prison during the study period. 
In a survey carried out in six European prisons (France, Germany, Italy, Netherlands, Scotland and  "
Sweden), 1 per cent of 871 prisoners reported that they had ever had intercourse with someone 
of the same sex in prison.
In Canada, 6 per cent of federal prisoners surveyed in the mid-1990s reported sex with another  "
prisoner. 
In Australia, a prisoner survey involving 530 randomly selected male New South Wales prisoners  "
found 5 per cent had engaged in consensual sex while in prison, with 2 per cent reporting 
non-consensual sex.
A number of factors are believed to affect prevalence and type of sexual activity in prison, 
including: 
W " hether the accommodation is single-cell or dormitory;
T " he duration of the sentence;
T " he extent to which conjugal visits are permitted;
T " he size of the prison and system (sex tends to be more frequent in large sys-
tems that provide anonymity than in those where prisoners know each other’s 
neighbourhoods and families;)
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W " hether prison policy or practice allows children and young people to be housed 
with adults, thus increasing the risk of sexual abuse; 
S " taffing levels and levels of supervision.
Tattooing
Tattooing amongst prisoners is a common practice in many countries. It can be a sign of 
allegiance to a particular gang or group.
Because tattooing involves breaking the skin with a needle, it is an activity that poses a 
risk of transmission of blood-borne diseases though the sharing and reuse of tattooing 
equipment such as needles and inks—both of which come into contact with large amounts 
of blood during the tattooing process. While tattooing is not generally recognized as a risk 
factor for HIV, the possibility of HIV transmission remains, and a number of cases in 
which HIV was apparently transmitted by tattooing in prison have been reported. The 
greater risk, however, is that of transmission of hepatitis C. 
Tattooing and the possession of tattooing equipment are prohibited by prison authorities 
in many countries, and those found to be engaging in tattooing are subject to punitive 
sanctions. As a result, tattooing in prisons is an activity that takes place secretively, often 
in unhygienic environments, using homemade equipment and inks, and as quickly as 
possible so as to minimize the risk of detection by prison staff. All these factors increase 
the risk of negative health consequences via tattooing in prisons.
Other risk behaviours
Several other behaviours represent risk factors for transmission of blood-borne infections 
in prisons. Body piercing and ear piercing are prevalent in some prisons. Studies have 
found that both are major risk factors for viral hepatitis. Sharing of shaving equipment is 
commonly reported in developing countries and countries in transition. Sharing of tooth-
brushes also occurs and puts prisoners at risk of contracting blood-borne infections. 
Box 18. Prevalence of other risk activities in prisons
Studies from countries in different regions of the world provide evidence that other risk activities are 
prevalent in prisons. The following are some examples:
One Australian study indicated that about 10 per cent of females and 5 per cent of males engage  "
in self harm in prison where blood is drawn.
A study of Canadian female federal prisoners showed that 9 per cent were engaging in slashing  "
or other forms of self-injury.
A study in Armenia showed that 5.2 per cent of prisoners had taken part in blood sharing (brother-  "
hood) rituals in prison.
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What do we know about HIV transmission in prison?
The high rates of risk behaviour, particularly injecting drug use and unprotected sex, if 
coupled with lack of access to HIV prevention measures, can result in quick spread of HIV. 
There were early indications that extensive HIV transmission could occur in prisons. In 
Thailand, the first epidemic outbreak of HIV in the country likely began among injecting 
drug users in the Bangkok prison system in 1988.
Box 19.  The Thai example: how prisons can contribute  
to the spread of HIV
The first epidemic outbreak of HIV in Thailand likely began among injecting drug users (IDUs) in the 
Bangkok prison system in 1988. HIV infection among IDUs rose from two per cent to 43 per cent 
between 1987 and 1988. The increase closely followed, and is believed to be due to, the release of 
hundreds of prisoners (including many IDUs) in an amnesty on the King’s birthday.
The first risk assessment among a large cohort of Bangkok IDUs found only two risk factors to be 
independently associated with HIV infection: having shared needles with two or more individuals in 
the previous 6 months and having been in prison. Bangkok IDUs with a history of prison were about 
twice as likely to be HIV-infected as those who had never been jailed. In terms of absolute risks, 
70 per cent of all IDUs in this study had been incarcerated at least once, and 80 per cent of all those 
with HIV infection had ever been jailed.
Later studies have confirmed that Bangkok IDUs continue to be at high risk for HIV infection related 
to needle sharing and incarceration.
In addition, HIV outbreaks in prison have been documented in a number of places, 
including in prisons in Scotland, Australia, the Russian Federation and Lithuania.
Box 20.  The example of Lithuania: what can happen if there is an 
outbreak of HIV in prison
In Lithuania, sharing of needles and syringes in one of the country’s 14 penal establishments—
Alytus correctional facility—resulted in a rapid HIV outbreak. Between 17 May and 20 June 2002, 
the Correctional Affairs Department and the Lithuanian AIDS Centre carried out a survey at the 
prison and identified 207 cases of HIV-positive prisoners. The survey was repeated in July 2002 
and a further 77 prisoners were identified as HIV-positive. 44 of these 77 prisoners had been 
found to be HIV-negative during the previous survey in May 2002. In total, during the period 
between May and August, 299 new HIV-positive cases were identified. The cause of this HIV 
outbreak was established to be a result of injecting drug use in the prison.
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The high degree of mobility between prisons and the general community means that 
communicable diseases transmitted in prison do not remain there. When people living 
with HIV are released from incarceration, prison health issues necessarily become 
community health issues. 
What other factors contribute to making prisons high-risk environments for 
HIV, and how can they be addressed?
In addition to these high-risk activities, there are a number of factors that make people in 
prison particularly vulnerable to HIV infection. These factors include:
V " iolence;
O " vercrowding;
G " angs and gang activities;
C " orruption;
P " oor medical practice involving the use or re-use of non sterile medical or dental 
equipment.
Violence
Prisons are often places of violence. Exposure to human blood and body fluids through 
fights, assaults and accidents has the potential for transmitting infections. Both prisoners 
and staff may be exposed to human blood or other body fluids as a result of assaults and 
fights, accidental needle stick injuries from hidden syringes, or when providing first aid. 
While the risk of HIV transmission during violence is small, there are case reports of pris-
oners contracting hepatitis C virus from physical assaults, with two possible cases occur-
ring in New South Wales in Australia. There has also been one report of a prison officer 
acquiring hepatitis C from a blood splash resulting from two prisoners fighting.
Prisons should therefore look to find ways of reducing levels of interpersonal violence. 
Ways to reduce violence may include introducing or improving prisoners’ access to pur-
poseful activity such as education, work or vocational training and proper classification 
of prisoners to avoid placing together those with potential conflicts as well as housing 
prisoners vulnerable to abuse and violence separately. Access to sport and recreational 
activities can also contribute to a reduction in tensions amongst prisoners.
Overcrowding
Overcrowding or congestion is an endemic problem in many prison systems around the 
world. In Africa, there is an average of 150 prisoners for every 100 berths and in some 
countries the problem is greater still with insufficient space in dormitories for all the 
prisoners to sleep.
Overcrowding can impede efforts to deal with HIV in that it exacerbates the health prob-
lems of those who are already ill, and also leads to increased high risk behaviours. Condi-
tions of overcrowding in prisons are linked to the spread of tuberculosis (TB). Because it 
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is an airborne communicable disease, TB is easily spread wherever conditions combine 
a large number of people and low sanitary standards.  
Prison overcrowding has a direct bearing on many aspects of a prisoner’s life in that it 
inevitably leads to a deterioration of hygiene, care and supervision. In addition to the 
basic health and sanitation risks, the incidence of rape within a prison varies with the 
intensity of overcrowding.
Box 21.  A few examples: how overcrowding in South African prisons 
impacts on HIV and AIDS in prisons
In South African prisons, overcrowding can lead to high risk behaviour in that the increasing scarcity 
of simple items such as blankets and shoes are then used as commodities which can be exchanged 
for sexual acts. One former prisoner explained that in the particularly crowded cells there are fewer 
beds than there are people. It is not surprising that sharing a bed with another prisoner can lead to 
homosexual activity, sometimes in exchange for the privilege of having a bed to sleep in. The only 
other option for some prisoners is to sleep in the shower or toilet as sometimes even floor space is 
not available. 
Even if enough beds are available, the practical reality of fitting 50 beds in a space intended for 18 
means that beds are not only triple or even quadruple bunked, but placed right next to each other so 
that they are touching other beds on almost all sides. In a typical South African prison cell, the prison-
ers fortunate enough to have beds are literally sleeping side by side and toe to toe. It is not hard to 
imagine the implications of this lack of defined or sufficient personal space on the incidence of high 
risk sexual behaviour.
KC Goyer (2003). HIV/AIDS in Prison. Problems, Policies and Potential. Pretoria: Institute for Security Studies 
(Monograph No 79). Available at www.iss.co.za/Pubs/Monographs/No79/Content.html
The overuse of incarceration of people who use drugs is of particular concern. In many 
countries, a significant percentage of the prison population is comprised of individuals 
who are convicted of offences directly related to their own drug use (i.e. those incarcer-
ated for the possession of small amounts of drugs for personal use, those convicted of 
petty crimes specifically to support drug habits). The incarceration of significant numbers 
of people who use drugs increases the likelihood of drug use inside prisons, leading to 
increasing unsafe injecting practices and the risk of HIV transmission.
Action to reduce prison populations and prison overcrowding should therefore accom-
pany—and be seen as an integral component of—a comprehensive strategy to prevent HIV 
transmission in prisons, to improve prison health care, and to improve prison conditions.
The best long-term solution to overcrowding is to reduce the number of prisoners by 
making changes to criminal procedure and sentencing policies and establishing 
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government targets for reducing prison overcrowding. In the short-term, overcrowd-
ing can be reduced by amnesties, reviewing the legality of detention status so that 
those held unlawfully can be released and removing groups inappropriately held, 
such as prisoners with mental disorders.
However, prison managers can also play a role and mitigate the effects of overcrowding 
by making better use of the overall space available, reviewing security levels, classifying 
prisoners by security risk so that lower risk prisoners can be accommodated in less 
secure accommodation, and introducing activities that generate income and produce food 
within the prison.
Gangs
Gangs and gang activities present a particular problem in certain prisons. This is relevant 
to HIV because gang activities can involve rape and sexual assault. Gangs can also engage 
in unprotected sex to initiate members and often require that members get tattooed while 
in prison to demonstrate gang affiliation.
Gangs that operate on the streets can continue their activities in prison when their 
members are imprisoned. Joining one of the gangs then becomes essential for a pris-
oner to survive and be protected from violence, and battles between gangs become a 
regular feature of prison life. Gangs can also play a part in the distribution of drugs 
within prisons.
Box 22. How gang activity impacts on HIV in prisons
The power of the 26s and 28s gangs inside South African prisons pervades nearly every issue related 
to HIV/AIDS in prison. Many high risk behaviours are directly related to gang activity. Membership in 
both gangs frequently includes tattooing, and it is not uncommon for more than one inmate to be 
tattooed at a time using the same needle. Violence between prisoners which leads to bleeding is also 
a product of gang activity. Prisoners may be required to attack another prisoner and draw blood in 
order to be initiated into a gang. For members of the 26s, the practice of stabbing another person, 
usually a non-gang member, is referred to as phakama and allows the gang member to move up in 
rank depending on the severity of the attack and the situation of the person who is attacked. 
While the 26s engage in stabbings, the primary activity of the 28s is sex and prostitution.
KC Goyer (2003). HIV/AIDS in Prison. Problems, Policies and Potential. Pretoria: Institute for Security Studies 
(Monograph No 79). Available at www.iss.co.za/Pubs/Monographs/No79/Content.html
Dealing with gangs in prisons usually involves measures such as:
H " ousing gang leaders in different prisons;
U " sing segregation for gang members and only allowing a return to the normal 
prison if gang membership is renounced;
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E " ducational measures to break down the gang culture;
E " ngaging gang leaders in the fight against HIV and using them as peer educators;
I " nvolving civil society organizations in work with gangs in prison and the 
community.
Corruption
Aspects of corruption particularly relevant to HIV include prison staff’s active involve-
ment or complicity in the smuggling of drugs; requesting bribes to allow prisoners to see 
a doctor; or engaging in sex with prisoners. Dealing with corruption is part of a wider 
process of bringing the rule of law into prisons. 
Action is required on many fronts simultaneously. It includes the following measures:
I " mproving the pay and working conditions of staff—corruption thrives when staff 
pay is so low that staff expect to receive extra money from prisoners in order to 
survive;
D " eveloping a code of conduct for staff;
Box 23. An example: a code of conduct for prison staff
Relationships with prisoners 
Staff must exercise particular care to ensure that their dealings with prisoners, former prisoners and 
their friends and relations are not open to abuse, misrepresentation or exploitation on either side. Staff 
relationships with prisoners must be professional. In particular staff must not: 
Provoke, use unnecessary or unlawful force or assault a prisoner. "
Use offensive language to a prisoner. "
Have any sexual involvement with a prisoner. "
Give prisoners or ex-prisoners personal or other information about staff, prisoners or their friends  "
and relatives which is held in confidence.
Have any contact in or outside work with prisoners or ex-prisoners that is not authorized. "
Accept any approaches by prisoners for unauthorized information or favours and must report any  "
such incidents. 
Corruption 
Corrupt behaviour is not acceptable. Staff must not solicit or accept any advantage, reward or prefer-
ential treatment for themselves or others by abusing or misusing their power and authority.
Excerpt from: HM Prison Service Order. Professional Standards: Preventing and Handling Staff Wrongdoing. 
Order number 1215 (17 February 2003). Appendix 1: Professional Standards Statement.
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P " rotecting those who reveal corrupt practices—setting up a corruption hotline can 
be effective.
Practical measures include:
M " inimizing the opportunities individuals have to become involved in corrupt prac-
tices, for example by moving staff regularly to a different part of the prison so that 
it is more difficult to build up corrupt relationships with other staff and with pris-
oners. However, this system has the disadvantage that positive work and good 
relationships with prisoners can be disrupted. 
S " earching prison staff when arriving and leaving work, if carried out sensitively, 
can be effective and help staff to resist pressure from other staff and prisoners to 
bring in or take out illicit items. 
I " ntroducing a cashless system in the finance department of prisons. 
Poor medical practice
In some countries, the use of improperly sterilized, or re-use of disposable medical and 
dental equipment can also be a source of transmission of HIV and other blood-borne 
diseases. Such practices may result from several factors such as under-funding of the 
prison health service, problems of supply of materials, poor training and low staff moti-
vation. Therefore, improving prison health services and increasing funding, training 
and staff motivation are important elements of overall efforts to prevent the spread of 
infections in prisons.
What HIV prevention measures should be adopted in prisons?
In view of the high risk of HIV (and HCV and TB) transmission and the experience in some 
countries of major outbreaks of HIV in prisons, governments worldwide are recognizing 
the need to adopt a comprehensive approach to prevent the spread of HIV in prisons. 
Although prison administrators disapprove strongly of drug use and sex in their prisons, 
they have increasingly accepted that eradicating these activities is impossible and that a 
realistic approach is needed. This comprises the following elements:
I " nformation, education, and communication programmes for prisoners and for 
staff;
P " roviding access to voluntary HIV counselling and testing;
P " roviding condoms and undertaking measures to prevent rape, sexual violence and 
coercion;
P " roviding substitution therapy and other forms of drug dependence treatment;
U " ndertaking other measures to reduce the demand for drugs;
U " ndertaking measures to reduce the supply of drugs;
P " roviding sterile needles and syringes or bleach or other disinfectants.
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Particular attention needs to be given to women and juveniles, and programmes have 
to be tailored to respond to their needs.
In addition, a number of measures should be taken to reduce the risk of other infections 
such as sexually transmitted infections, hepatitis, and tuberculosis.
Finally, measures to reduce the risk of infection to staff also need to be taken.
Information, education and communication programmes for prisoners and for staff
Information, education and communication programmes on HIV and how to prevent its 
transmission are the least controversial and most widely used ingredients of an effective 
HIV prison policy.
Prisons are important settings for HIV education efforts because of:
H " igh prevalence among prisoners of HIV-infected persons and persons with risk 
factors for HIV infection;
H " igh potential for HIV transmission in prisons, particularly through sexual activity 
and sharing of drug-injecting equipment;
E " ventual release of almost all adult prisoners and confined juveniles to the 
community;
H " igh rates of re-incarceration and re-confinement; and
T " he feasibility of providing HIV education programmes in prisons.
Box 24. The Boma AIDS Education Collective in Suriname
An education and support programme involving activities for prisoners, staff, and non-prison personnel 
and organizations was developed by the Suriname National AIDS Programme. Male prisoners and 
prison warders were selected for training as peer educators. Male prisoners formalized their status by 
forming the Boma AIDS Education Collective (BAEC). Female prisoners were not included in the training 
because most of them served short sentences and were instead involved in educational sessions which 
focused on sexual and mother-to-child transmission of sexually transmitted infections. BAEC produced 
HIV education leaflets in three languages for new and discharged prisoners for all prisoners in Suriname. 
The leaflets were then pre-tested and modified based on comments from 17 prisoners. The Programme 
was officially introduced in April 1992 when BAEC organized an AIDS/STD week. The week’s activities 
included HIV educational sessions, video shows, discussions, and HIV testing. A manual was produced 
for peer educators, and AIDS/STD education has since been included in the prison warder training 
curriculum. A number of collaborative activities with non-prison organizations were organized to dem-
onstrate that prisoners are part of a wider community concerned about HIV.
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At the same time, HIV education efforts in the prison environment do have specific chal-
lenges. In particular, many prisoners are suspicious of anything “official” or government 
related, which means that programmes created by the prison administration or prison 
staff without prisoner input can be ineffective.
Box 25. Radio broadcasting in Russian prisons
A partnership project in the Urals between the BBC World Service Trust, London; the Foundation for 
Independent Radio, Moscow; Eurasia Media Centre, Yekaterinburg, and Helping Hand, Chelyabinsk is 
establishing fixed line radio networks in six selected penal colonies in the Sverdlovskaya and Chelyab-
inskaya oblasts. Specialists in educational programming will then produce a total of 45 radio packages 
aimed at raising awareness of health issues (particularly HIV and tuberculosis) as well as legal ques-
tions and the rehabilitation process. These programmes will be broadcast in the six target colonies 
and further disseminated to other prisons across the region.
Information and education programmes should:
I " deally be part of a broader health education and health promotion programme;
P " rovide the facts about HIV and about how HIV is (and how it is not) transmitted, 
as well as information on other diseases that are common in prisons, in particular 
sexually transmitted diseases, hepatitis B and C and tuberculosis;
C " ontain accurate, non-judgemental, accessible and relevant information;
R " aise awareness among prisoners and staff of the health issues related to risk 
activities such as drug injecting, unprotected sex, tattooing, and body piercing;
E " ducate prisoners about how they can protect themselves from infections, including 
education about correct use of condoms and lubricants, how to inject safely, how 
to clean needles and syringes, and how to clean skin piercing equipment;
E " ducate prison staff about the use of so-called “universal precautions” to prevent 
HIV transmission during their work within the prisons;
C " ounter stigma and discrimination against people living with HIV or AIDS and 
those vulnerable to it in prison, particularly people who use drugs and men who 
have sex with men;
E " xplain how HIV and other diseases manifest themselves, and what treatments 
are available.
The education can include a variety of pedagogical approaches and use brochures or 
videos. Paper documents can be handed out to new prisoners, and these documents 
should be available in the prison for consultation at any time. These documents should be 
written in several languages, according to the local context. Despite this, they may be 
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difficult to understand for prisoners from foreign countries or those who cannot read. 
Therefore, these documents should have as many pictures as possible to make them easy 
to understand.
Prisoners often react well to videos and to oral presentations. Experience shows that 
education sessions are much more effective if they are interactive. Peer education—
designed and delivered by prisoners for prisoners—is particularly effective. 
Box 26. Peer education works! An example from Siberia
An evaluation of the effectiveness of an HIV peer training programme conducted in a prison colony 
for drug dependent male prisoners in Siberia found that the programme resulted in improved HIV 
knowledge. In particular, a significantly higher proportion of prisoners reported better knowledge of 
both how HIV can and cannot be transmitted. The evaluation concluded that the “provision of educa-
tional materials and training peer educators can be an inexpensive way to reach a population that is 
difficult to access outside prison”.
Peer educators play a vital role in educating other prisoners, since most of the behaviours 
that put prisoners at risk of HIV in prisons involve illegal or forbidden and stigmatized 
practices. Therefore, peers may be the only persons able to speak candidly to other pris-
oners about ways to reduce the risk of contracting infections. As well, peer educators’ 
input is not likely to be viewed with the same suspicion as the information provided by 
the prison hierarchy. Peer educators are more likely to be able to realistically discuss the 
alternatives to risk behaviour that are available to prisoners, and are better able to judge 
which educational strategies will work within their prison and the informal power 
structure among prisoners.
Box 27.  The importance of involving youth in the design  
of education activities
A study among incarcerated male adolescents in Brazil found that initial efforts to develop an HIV 
prevention intervention for them generated limited participation. However, when the educators worked 
with the adolescents to develop interventions based on their interests and needs, using modalities 
such as music, hip-hop arts, graffiti, and helping them to create an HIV prevention compact disk, they 
responded with enthusiasm. The study concluded that interventions for incarcerated youth are better 
received when developed in collaboration with them and based on their beliefs, aspirations, and culture. 
The intervention that resulted went beyond HIV to include issues such as violence, drugs, sexuality 
and human rights.
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Alongside peer approaches, experience suggests that non-governmental organizations 
and other professionals from outside the prison system can best provide education. Expe-
riences with HIV prevention initiatives show that prisoners can develop more trust with 
staff from non-governmental organizations and other professionals from outside the 
prison than with staff who are part of the prison hierarchy.
Checklist 3. Information and education programmes
The following factors influence the effectiveness of informational and educational interventions in pris-
ons. Check here whether the programme in your prison conforms to best practice:
Is the programme comprehensive? (For example, does it include information on safer drug use  "
and safer sex and demonstrations about how a condom is properly used, or how drug injecting 
equipment can be cleaned? Does it include advice for people who use drugs on how to avoid 
overdose after release?)
Is it linguistically and culturally appropriate? "
Does it respond to the needs of different populations (if present in your prison), in particular  "
female prisoners and youth, but also cultural minorities?
Is it appropriate to the average prisoners’ reading and comprehension level? "
Has it been developed and designed with the inputs and participation of prisoners? "
Has the prison staff component been developed with the inputs and participation of prison staff? "
Is peer education promoted and encouraged? (Have selection criteria for training peer educators  "
been established? Have peer educators been trained and provided with specific tasks/responsibili-
ties to be performed as peer educators? Are there opportunities for peer educators to continuously 
upgrade their knowledge on HIV and relevant issues? Has a peer education sustainability plan 
been developed?) 
Are all prisoners (including detainees awaiting trial) provided with an information package on HIV  "
and AIDS and other relevant issues upon admission? Are ongoing refresher courses and education 
sessions offered to sustain and reinforce the HIV-related health message?
Are interactive educational sessions offered, in addition to distribution of pamphlets or the show- "
ing of a video?
Are activities organized to raise awareness on calendar days relevant to HIV, such as World AIDS  "
Day (December 1)?
Are modern educational methods used (such as interactive sessions)? "
Is the education programme part of a more comprehensive prevention programme that includes  "
drug dependence treatment, the provision of condoms and bleach, a needle and syringe pro-
gramme, and other measures?
For female prisoners, does the education programme contain information on mother-to-child trans- "
mission, and is it linked to access to comprehensive reproductive health services for HIV positive 
female prisoners?
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HIV counselling and testing
Counselling and testing are important for two reasons:
A " s part of an HIV prevention programme (it provides information and support for 
behaviour change for those who may be engaging in risky behaviours); and
A " s a way to diagnose those living with HIV and offer them appropriate treatment, 
care and support.
HIV testing should always be voluntary, and prisoners should have easy access to HIV 
testing and counselling throughout their imprisonment. It is important that efforts to 
improve access to HIV testing and counselling in prisons be undertaken, as they reach 
a clientele at high risk of HIV infection that often has not used counselling and testing 
services on the outside.
Therefore, prisoners should have various options for HIV testing:
H " IV testing should be offered to all prisoners at the time of their medical examina-
tion upon entry.
I " n addition, because entry is a stressful time and many prisoners may not want 
to have an HIV test at that time, HIV testing should be available to prisoners at 
any time during imprisonment. During HIV education sessions and by health care 
staff, prisoners should regularly be reminded that HIV testing is available to them, 
and should be encouraged to be tested.
For more details (and full references) on information and education programmes and the 
other HIV prevention measures discussed in this module, see:
WHO, UNODC, UNAIDS (2007). [Comprehensive review.] Effectiveness of Interventions to 
Address HIV in Prisons. Evidence for Action Technical Papers. Available via www.who.int/hiv/
idu/prison/en/index.html.
!
Finally, information and education activities must be tailored to the needs of particular 
prison contexts, particularly women’s prisons or prisons for young offenders.
To be effective, information and education campaigns need to be embedded in a commu-
nication strategy with clear and measurable objectives and an evaluation component. It 
is not good enough to put some posters on a wall and distribute from time to time some 
leaflets. Information and education must be made available upon entry in and exit from 
the prisons, and periodically refreshed. Programmes should be monitored and evaluated 
to find out whether prisoners and staff understand the information and whether the 
interventions reduce risk behaviour.
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Many of the benefits of HIV testing are dependent on, or enhanced by, pre-and post-test 
counselling. Prisoners who receive positive results should receive counselling and refer-
ral to treatment, care and support. Post-test counselling can also deliver important health 
and risk-reduction information to the majority of prisoners who will access testing and 
have a negative test result.
HIV testing and counselling should be closely linked to access to treatment, care and sup-
port for those testing positive. HIV testing (and counselling) is not a goal in and of itself, but 
a means to enable people to access care, treatment, and support if they test HIV-positive, 
and to take measures to reduce the risk of transmitting infection to others. Linkage of HIV 
testing with care and treatment according to standards prevalent in the outside community 
is essential to encouraging prisoners to participate in HIV testing programmes.
Checklist 4. HIV counselling and testing programmes
The following factors influence the effectiveness of HIV counselling and testing interventions in pris-
ons. Check here whether the programmes in your prisons conform to good practice:
Is HIV testing offered to all prisoners upon entry? "
In addition, is it easily accessible to prisoners at any time during imprisonment? "
Is it free of charge? "
Are prisoners regularly reminded, through educational activities and/or by health care staff, that  "
they can access HIV testing, and are the potential benefits explained to them?
Is HIV testing always voluntary? (Mandatory testing, without the prisoner’s informed consent, is  "
unnecessary and ethical).
Does everyone being tested receive pre-and post-test counselling? "
Have health care professionals been trained to deliver HIV counselling and testing services? "
Does counselling for female prisoners include discussion of mother-to-child transmission? "
Is confidentiality of test results guaranteed? "
Are test results delivered confidentially by health care personnel? "
Are prisoners testing positive protected against discrimination? In particular, are they kept in the  "
general population and are they able to participate in the same programmes as other prisoners? 
(Prisoners with HIV should not be prohibited from any work, recreational or social activities 
because of their HIV status).
Is HIV testing and counselling closely linked to access to treatment, care and support? Is everyone  "
who tests positive immediately referred to treatment and support?
Is HIV testing and counselling part of a comprehensive HIV prevention programme that includes  "
access to prevention measures, so that prisoners who test positive can take steps to prevent 
transmission of HIV to others?
HIV and AIDS in places of detention
A toolkit for policymakers, programme managers, prison officers and health care providers in prison settings
66
Attention must be paid to ensuring that confidentiality of medical information is protected 
and to avoiding stigma and the negative consequences of testing: prisoners will not agree 
to participate in HIV testing and counselling if they face discrimination or abuse if they 
test positive.
In addition to access to HIV testing and counselling, prisoners need access to the means 
to protect themselves. As shown above, many prisoners, including prisoners who are 
aware of their HIV status, engage in activities that carry a risk of HIV transmission. 
Knowledge of HIV status alone is not sufficient to prevent HIV transmission when the 
means that would enable a person to take steps to reduce that risk, short of being able to 
stop the behaviour that creates the risk, are not accessible in prison. 
Provision of condoms and prevention of rape, sexual violence, and coercion
Recognizing the fact that sex occurs in prisons and given the risk of disease transmission 
that it carries, providing condoms (and water-based lubricants) has been widely recom-
mended. The World Health Organization, in its 1993 Guidelines on HIV infection and 
AIDS in prisons, recommends that condoms be made available to prisoners “throughout 
their period of detention” and “prior to any form of leave or release”. 
Provision of condoms
As early as 1991, a World Health Organization study found that 23 of 52 prison systems 
surveyed provided condoms to prisoners. By August 2001, 18 of the 23 prison systems in 
the pre-expansion European Union were making condoms available. Today, many prison 
systems in other parts of the world, including in Canada, Australia, some prisons in the 
United States, parts of Eastern Europe and Central Asia, Brazil, South Africa, Iran (Islamic 
Republic of) and Indonesia, also make condoms available to prisoners.
In some prison settings, there have been obstacles to condom distribution, including 
opposition to male-to-male sex from prison officers and authorities, based on a combina-
tion of factors including cultural objections, workload, institutional prohibition of sexual 
activity, and security concerns. Critics of condom distribution to prisoners have argued 
that the provision will lead to an increase in sexual activity among prisoners, or that con-
doms will be used to conceal drugs.
These obstacles can be overcome, however, and the fears have proven unfounded. The 
experience of the many countries in which condoms have been made available in prisons 
has shown that provision of condoms is feasible in a wide range of prison settings—
“Unfortunately, there still exists a strong current of denial in many places about male-to-male sex (especially in 
prison) and a corresponding refusal to do anything which might be seen as condoning it. These attitudes will have 
to change if societies want to see the rate of HIV infection—inside prison and outside of it—decrease.”
Prisons and AIDS. UNAIDS Point of View, April 1997
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including in countries in which same-sex activity is criminalized—and that prisoners use 
condoms to prevent infection during sexual activity when condoms are accessible in 
prison. 
Condoms need to be easily and discreetly available, ideally in areas such as toilets, shower 
areas, waiting rooms, workshops, or day rooms where prisoners can pick up a condom 
without being seen by others. Distribution can be done by health staff, by dispensing 
machines, by trained prisoners (peers) or in a combination of these ways. Each prison 
should determine how best to make condoms available, to ensure easy and discreet 
access. Prisoners should not have to ask for condoms, since few prisoners will do so 
because they do not want to disclose that they engage in same-sex sexual activity. Con-
doms should be provided free of charge, and can be made available to all prisoners in a 
“health kit” given to them at entry, and containing HIV and other health information, but 
also other items such as a shaver, toothbrush, soap, etc. Water-based lubricant should 
also be provided since it reduces the probability of condom breakage and/or rectal tear-
ing, both of which contribute to the risk of HIV transmission. 
No prison system allowing condoms has reversed its policy, and none has reported 
security problems or any other relevant major negative consequences. In particular, it 
has been found that access to condoms is unobtrusive to the prison routine, repre-
sents no threat to security or operations, does not lead to an increase in sex within 
prisons, and is accepted by most prisoners and correctional officers once it is intro-
duced. Usually support for condom provision increases once a condom programme 
has started.
Box 28. Evaluations of condom programmes show positive results
A survey to measure the acceptability of the condom distribution programme at the Washington, D.C. 
Central Detention Facility found condom access to be unobtrusive to the jail routine, no threat to 
security or operations, no increase in sexual activity, and accepted by most prisoners and correctional 
officers. The survey concluded that the model would be easily replicable in other institutions.
The evaluation of the condom distribution programme in New South Wales prisons, Australia, 
found that:
84 per cent of the prisoners supported the provision of condoms; "
The reported level of harassment of prisoners using condom distribution machines was low; "
Most importantly, prisoners were using condoms when having anal sex. "
From October 1997 to September 1998, 294,853 condoms were dispensed in New South Wales pris-
ons, These figures are the equivalent of each prisoner obtaining one condom a week. Overall, there 
were no indicators of negative consequences as a result of the condom distribution programme.
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However, in Kingston, Jamaica, in 1997 a strike and prison riot by correctional officers 
followed a governmental announcement to provide condoms to prisoners and officers, 
resulting in six deaths. Offence to the implication of same-sex sexual activity reportedly 
fuelled the strike and riot. This shows that in some countries where legal sanctions against 
sodomy exist in the community outside prison, and where there are deeply held beliefs 
and prejudices against homosexuality, introduction of condoms into prisons as an HIV 
prevention measure may have to be particularly well prepared through education and 
information about the purpose of the introduction of condoms, as well as initiatives to 
counter the stigma that people engaging in same-sex activity face. 
Prevention of rape, sexual violence and coercion
While providing condoms (together with water based lubricants) in prisons is important, 
it is not enough to address the risk of sexual transmission of HIV.
There is evidence that violence, including sexual abuse, is common in prisons. In many 
prison systems prisoners live in overcrowded conditions, with little supervision and pro-
tection, and are vulnerable to sexual abuse.
Therefore, HIV prevention depends also on measures taken to prevent rape, sexual vio-
lence and coercion in prisons. Some of these measures—such as penal reform needed to 
reduce prison populations, so that the often few and underpaid guards are able to protect 
the vulnerable prisoners from violence and sexual coercion—need to be taken by policy-
makers and legislators, but prison authorities are also responsible for prevention of rape, 
sexual violence, and coerced sex.
For example, the World Health Organization Guidelines on HIV infection and AIDS in 
prisons and the International Guidelines on HIV/AIDS and Human Rights highlight that 
prison authorities are responsible for combating aggressive sexual behaviour such as 
rape, exploitation of vulnerable prisoners and all forms of prisoner victimization by 
providing adequate staffing, effective surveillance, disciplinary sanctions, and educa-
tion, work and leisure programmes. Structural interventions such as better lighting, 
better shower and sleeping arrangements are also needed. In particular, vulnerable 
prisoners need to be provided with protection and juvenile prisoners kept separate 
from adults.
For more details and references, see: WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Prevention of Sexual Transmission. Evidence for Action Technical Papers. 
Available at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-
aids/publications.html.
!
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Checklist 5. Condom distribution and prevention of non-consensual sex
The following factors influence the effectiveness of condom distribution programmes and the prevention 
of non-consensual sex. Check here whether the interventions in your prisons conform to good practice:
Before a condom programme is introduced: Have educational and informational activities been  "
prepared to explain why it is important to start condom distribution in prison? (Introduction 
of the programmes should be carefully prepared, particularly in prisons that could face initial 
opposition to the provision of condoms.)
Are condoms easily and discreetly accessible to prisoners so that they can pick them up at various  "
locations in the prison, without having to ask for them and without being seen by others?
Are supplies regularly checked and, if necessary, replenished? "
Are condoms provided to prisoners at entry to prison, in a “health kit” containing other health  "
protection information and tools, such water-based lubricant, disinfectant, shaver, toothbrush, 
soap, a pamphlet on HIV, other infectious diseases, and on drug use, etc?
Are conjugal visits allowed, and are condoms provided for such visits? "
Are condoms provided to prisoners upon release from prison? "
Are they free of charge? "
Is water-based lubricant also available? "
Are measures undertaken to increase acceptance and use of condoms among prisoners, for exam- "
ple by encouraging peer-to-peer discussions? 
Does the HIV education programme instruct prisoners about the correct use of condoms and  "
lubricants?
Do on-going staff training programmes contain sections on HIV and, specifically, on why it is  "
important to make condoms available in prison?
Do female prisoners have access to condoms as well as dental dams? (Dental dams are small,  "
thin, square pieces of latex that are used for oral-vaginal or oral-anal sex. They get their name 
from their use in dental procedures. Dental dams help to reduce the transmission of sexually 
transmitted infections during oral sex by acting as a barrier to vaginal and anal secretions that 
contain bacteria and viruses.) 
Are measures being implemented to combat aggressive sexual behaviour such as rape, exploita- "
tion of vulnerable prisoners, and all forms of prisoner victimization?
Has a plan with clear goals, objectives, and timelines been established to further decrease such  "
behaviour?
In particular, are juvenile prisoners always kept separate from adult prisoners? Is protection  "
provided to vulnerable prisoners?
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Opioid substitution therapy and other forms of drug dependence treatment
As shown above, many prisoners in countries around the world use drugs while in prison, 
including by injecting. At least in part this is due to the fact that a substantial proportion 
of prisoners are drug dependent.
In order to reduce transmission of HIV through the use of contaminated injecting equip-
ment, prisoners should be encouraged:
N " ot to use drugs at all;
I " f they continue to use, not to inject; and
I " f they inject, not to share injecting equipment.
Providing both drug dependence treatment and programmes to reduce the risk of infec-
tion in prison is therefore essential.
With regard to drug dependence treatment, there is a growing consensus that it can be 
effective in prison if it responds to the needs of prisoners, is of sufficient length and 
quality, and if aftercare is provided upon release.
There are many types of drug dependence treatment, but they basically fall into two 
categories:
O " pioid substitution therapy (OST)
A " bstinence-based programmes
Opioid substitution therapy
All forms of drug dependence treatment have some impacts on risks of HIV transmission, 
but opioid substitution treatment (OST) programmes have the greatest potential to reduce 
injecting drug use and the resulting risk of spread of infection. 
OST programmes entail prescribing a drug with a similar action to the illegal drug used, 
but with a lower degree of risk. They are used as an HIV-prevention strategy that pro-
vides people dependent on drugs with an additional option for getting away from needle 
use and sharing. 
Why substitution treatment? 
The most commonly used form of OST is methadone maintenance treatment (MMT). 
Methadone has been used to treat heroin and other opiate dependence for decades and 
was added to the World Health Organization list of “essential drugs” in 2005. The more 
recently-developed buprenorphine is also quite commonly used in a number of countries. 
Both have been proven to greatly reduce the risk of HIV infection by reducing drug injec-
tion and improving the health and quality of life of opiate-dependent people.
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Community OST programmes have rapidly expanded since the mid-1990s. Today, more 
than half a million people receive OST worldwide. In a common position paper, UNAIDS, 
WHO and UNODC stated that:
Substitution maintenance therapy is one of the most effective treatment options for 
opioid dependence. It can decrease the high cost of opioid dependence to individuals, 
their families and society at large by reducing heroin use, associated deaths, HIV risk 
behaviours and criminal activity. Substitution maintenance therapy is a critical com-
ponent of community-based approaches in the management of opioid dependence 
and the prevention of HIV infection among injecting drug users.
There are ample data supporting the effectiveness of OST programmes in reducing high-
risk injecting behaviour and in reducing the risk of contracting HIV. There is also evi-
dence that OST is the most effective treatment available for heroin-dependent injecting 
drug users in terms of reducing mortality, heroin consumption, and criminality. The con-
cerns raised about OST have been shown to be unfounded. In particular, OST has not 
been shown to be an obstacle to the cessation of drug use, and in fact, OST has been 
found to be more effective than detoxification programmes in promoting retention in drug 
treatment programmes and abstinence from illegal drug use. Finally, there is evidence 
that people who are on OST and who are forced to withdraw from methadone because 
they are incarcerated often return to narcotic use, often within the prison system, and 
often via injection. It has therefore been widely recommended that prisoners who were 
on OST outside prison be allowed to continue it in prison. 
As in the community, OST, if made available to prisoners, has the potential of reducing 
injecting and syringe sharing in prisons.  The World Health Organization Guidelines on 
HIV/AIDS in Prisons therefore recommend: “Prisoners on methadone maintenance 
prior to imprisonment should be able to continue this treatment while in prison. In 
countries where methadone maintenance is available to opiate-dependent individuals 
in the community, this treatment should also be available in prisons.”  
Where  is it being offered? 
Worldwide, an increasing number of prison systems are offering OST to prisoners, 
including prison systems in Canada and Australia, some systems in the United States, 
most of the systems in the 15 “old” European Union (EU) member States, and systems 
in other countries, including Iran (Islamic Republic of) and Indonesia. In Spain, 
18 per cent of all prisoners, or 82 per cent of people with a drug problem in prison, 
receive this treatment. 
OST programmes also exist in prisons in some of the “new” EU member States (Hungary, 
Malta, Slovenia and Poland), although they often remain small and benefit only a small 
number of prisoners in need. Finally, an increasing number of systems in Eastern Europe 
and the former Soviet Union have started OST programmes (such as Moldova) or are plan-
ning to do so soon (such as Kyrgyzstan), but OST remains unavailable in prisons in other 
countries in the region. 
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Evidence of benefits 
Some prison systems are still reluctant to make OST available, or to extend availability 
to those prisoners who were not receiving it prior to incarceration. Some consider 
methadone or buprenorphine as just another mood-altering drug, the provision of 
which delays the move beyond a drug-centred existence. Some also object to OST on 
moral grounds, arguing that it merely replaces one drug of dependence with another. 
However, in recent years, evaluations of prison OST programmes have provided clear 
evidence of their benefits.
Studies have shown that, if dosage is adequate (at least 60 mg of methadone) and 
treatment is provided for the duration of imprisonment, such programmes reduce 
drug injecting and needle sharing and the resulting spread of HIV and other blood 
borne infections. In addition, they have additional and worthwhile benefits, both for 
the health of prisoners participating in the programmes, and for prison systems and 
the community. For example:
S " ubstitution therapy has a positive effect on institutional behaviour by reducing 
drug-seeking behaviour and thus improving prison safety and security;
R " e-incarceration is significantly less likely among those prisoners who receive 
OST;
O " ST in prison significantly facilitates entry and retention in post-release treatment 
compared to prisoners enrolled in detoxification programmes;
A " lthough prison administrations often initially raise concerns about security, violent 
behaviour, and diversion of methadone, these problems do not emerge once the 
OST programme is implemented;
B " oth prisoners and prison staff report about the positive impact OST has on life 
in prison;
O " ST offers a daily contact between health care services and patients, often leading 
to a relationship that can help address other health issues and create a link with 
other HIV prevention strategies. 
Box 29.  Canada: evaluation of opioid substitution treatment (OST) 
demonstrates benefits in prison
In Canada, the federal prison system expanded access to MMT after evaluation demonstrated that 
MMT has a positive impact on release outcome and on institutional behaviour. Participants in such a 
treatment programme were less likely to commit crimes and return to prison. This is important because 
the cost of the institutional OST programme may be offset by the cost savings of offenders success-
fully remaining in the community for a longer period of time than equivalent offenders not receiving 
such treatment.
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In addition, OST may help to reduce risk of overdose for those released from prison. 
Many prisoners resume injecting once released from prisons, but do so with increased 
risk for fatal overdose as a result of reduced tolerance to opiates. Extensive research has 
noted a large number of deaths during the first weeks after discharge from prison that 
are attributed to drug overdose. This points to the utility and necessity of prison through 
care of drug treatment to counteract such risk situations and highlights the importance of 
OST not only as an HIV prevention strategy in prisons, but as a strategy to reduce over-
dose deaths upon release. 
Box 30.  Positive results: methadone maintenance treatment  
in prisons in Iran (Islamic Republic of)
In order to prevent high-risk behaviour, the first methadone project was initiated in 2003 in Ghezel-
Hesar prison located in Tehran province. In the following 18 months it was implemented in 12 other 
provinces of Iran. 1,400 prisoners underwent methadone maintenance treatment in an early stage of 
methadone provision in prison and this number subsequently grew rapidly. Results of the treatment 
include a significant reduction in injecting drug use, which plays a crucial role in HIV prevention, and 
a more than 90 per cent decrease in self-injury and fighting.
Another reason why opioid substitution therapy is important
Antiretroviral therapy (ART) for HIV is becoming available in many low and middle-
income countries in which this treatment was, until recently, inaccessible. In many coun-
tries, particularly in Eastern Europe and Central Asia, the majority of people who need 
ART are people who inject drugs. Many of them will spend time in prison, and they need 
to be able to access both OST and ART without interruption, since OST has proven effec-
tive in facilitating delivery of and adherence to ART among people who inject drugs.
For additional information on OST, see: 
WHO, UNODC, UNAIDS (2007). Interventions to Address HIV in Prisons: Drug Dependence Treat-
ments. Evidence for Action Technical Papers. Available at www.who.int/hiv/idu/prison/en/
index.html or www.unodc.org/unodc/en/hiv-aids/publications.html.
World Health Organization (2004). WHO/UNODC/UNAIDS position paper—substitution mainte-
nance therapy in the management of opioid dependence and HIV/AIDS prevention. Available in 
English and Russian at www.who.int/substance_abuse/publications/treatment/en/. A joint 
position statement on maintenance therapy for opioid dependence.
!
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World Health Organization (2005). Evidence for action technical papers. Effectiveness of drug 
dependence treatment in preventing HIV among injecting drug users. Available via www.who.
int/hiv/idu/en/. Reviews the evidence on substitution treatment and concludes that “policy-
makers need to be clear that the development of drug substitution treatment is a critical 
component of the HIV prevention strategy among injecting opioid users.”
Corrections Victoria (2003). Victorian Prison Opioid Substitution Therapy Programme: clinical and 
operational policy and procedures. Available via www.justice.vic.gov.au/. An excellent document 
with policy and procedures providing a framework for managing substitution treatments.
Correctional Service Canada (2003). Specific guidelines for methadone maintenance treatment. 
Ottawa: CSC. Available at www.csc-scc.gc.ca/text/pblct/methadone/index-eng.shtml. 
These guidelines provide a general background on prisoners and drug use, a section detailing 
the goals and objectives of methadone maintenance treatment (MMT), admission criteria and 
quality assurance for MMT, and the role of the methadone intervention team (MIT); a section 
about the specific responsibilities of each MIT member; a section on dosing issues; a section 
on urine drug screening; a section on drug dependence treatment interventions accompanying 
MMT; and a number of appendices.
Other forms of drug dependence treatment
In contrast to opioid substitution treatment, which has become increasingly available 
in many prison systems at least in part because of its potential to reduce injecting 
drug use and the resulting risk of spread of infection, other forms of drug dependence 
treatment have not usually been introduced in prison with HIV prevention as one of 
their objectives. It is therefore not surprising that there is little data on the effective-
ness of these forms of treatment as an HIV prevention strategy. There is an urgent 
need for examining their effectiveness in the context of HIV. More generally, with some 
exceptions, independent and systematic outcome evaluations of these interventions are 
lacking.
Nevertheless, in addition to substitution treatment, providing abstinence-based treat-
ment programmes, in which prisoners abstain totally from taking drugs, is also impor-
tant. Such programmes reinforce the aim of prison by trying to enable the prisoners 
to lead a life without committing criminal offences after release.
There is a great variety of abstinence-based programmes, but all of them start with 
an assessment phase, and all of them have a phase of detoxification. Examples for 
abstinence-oriented programmes include cognitive behavioural therapy, relapse preven-
tion therapy or a therapeutic community approach. 
Good quality, appropriate, and accessible treatment can improve prison security, as 
well as the health and social functioning of prisoners, and it can reduce reoffending, 
as long as it provides ongoing treatment and support, post-release care and meets the 
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individual needs of prisoners. To run such a programme, it is always necessary to 
employ specialists who can introduce and run it. Such treatment in prison can work 
and help reduce the amount of drug use in prisons and upon release. Given that many 
prisoners have severe problems with illegal drug use, it is important to utilize the 
opportunity that imprisonment provides for treatment and rehabilitation. 
There is also a need to ensure that investments made in prison-based treatment are not 
lost because of the lack of effective aftercare. Unless treatment is maintained in the 
community, offenders are likely to relapse. In addition to drug dependence treatment 
needs, many ex-prisoners have housing and financial difficulties and even psychiatric 
problems. They may be released to either poor family support or indeed deeply dys-
functional families and friends. For this reason, aftercare should not be limited to drug 
treatment. Ideally, within a few months before release from prison, correctional staff 
need to help prisoners with a drug dependence problem plan for continued treatment, 
identify other needs, and locate appropriate community-based services to address those 
needs. Released prisoners might, for example, require drug-free housing, literacy train-
ing, HIV information and education, job placement, long-term relapse management, 
and social services. Efforts to help resettle offenders are often made by civil society 
organizations. It is important for prisons to engage in partnerships with these groups.
Checklist 6.  Opioid substitution therapy (OST) and other forms of drug 
dependence treatment
The following factors influence the effectiveness of substitution treatment and other forms of drug 
dependence treatment in prisons. Check here whether the programmes in your prisons conform to 
good practice:
Are OST guidelines in prison consistent with the OST guidelines applicable in the community? "
Are people on OST in the community prior to imprisonment able to continue such treatment  "
without interruption upon arrest and incarceration?
In countries in which OST is available to opiate-dependent individuals in the community, is it also  "
available to prisoners who want to start it in prison, under the same conditions as in the 
community? 
Does the OST programme contain a comprehensive discharge planning system for prisoners near- "
ing release, including a system for referral to OST in the general community?
Have prison staff members and prisoners been provided with factual information about OST? "
Are other, abstinence-based forms of drug dependence treatment also available to prisoners who  "
request them?
Are these forms of treatment evidence-based? "
Do they contain a discharge planning and aftercare component to ensure that prisoners will  "
receive continued help and support with their dependence and reintegration upon release?
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In some countries probation officers provide aftercare. In some cases, part of the sen-
tence is served under supervision in the community. Alternatively offenders may be 
released early on parole or some other form of conditional release. In these cases, there 
is an opportunity to include conditions, which can help to keep an offender away from 
drug taking and other high risk behaviour. 
Other measures to reduce the demand for drugs
In addition to drug dependence treatment, other strategies to reducing the demand for 
drugs can also assist efforts to prevent HIV transmission in prisons. However, it is impor-
tant to note from the outset that such efforts are unlikely to eliminate drug use in prisons. 
In fact, even prison systems that have devoted large financial resources to such efforts 
have not been able to eliminate drug use. Therefore, such efforts cannot replace the other 
measures described above, but rather should be undertaken to complement them.
Provision of information on drugs and drug use
On its own, the provision of information on drugs and drug use has not been found to 
change drug use behaviour. However, substantial and correct information is necessary to 
make healthy choices and all drug dependence programmes should include an education 
component.
Work, study and other activities
Research shows that one of the reasons why some prisoners take drugs when they are in 
prison is to combat boredom and alienation, and promote relaxation. This suggests a 
need for more purposeful activities in prisons. Providing prisoners with opportunities to 
work and/or study while in prison, or activities such as sports, theatre and spiritual and 
cultural enhancement aimed at providing people with challenging and healthy ways to 
employ their time, can have a positive effect on risky behaviours, particularly when com-
plemented by appropriate drug use prevention education (which might include both 
information and life skills provision).
Life-skills education
Providing life skills education is also important. Life skills are the abilities for adaptive 
and positive behaviour that enable individuals to deal effectively with the demands and 
challenges of everyday life. These include: self-awareness, empathy, communication 
skills, interpersonal skills, decision-making skills, problem-solving skills, creative think-
ing, critical thinking, and coping with emotions and stress. Such personal and social 
competencies, together with appropriate information about drugs and drug use, help 
people make healthier choices.
Establishing so-called “drug-free” units
Another strategy to reduce the demand for drugs used by an increasing number of prison 
systems, mainly in resource-rich countries, is to establish so-called “drug-free” units. 
Typically, “drug-free” units or wings are separate living units within a prison that focus 
on limiting the availability of drugs and are populated with prisoners who have voluntar-
ily signed a contract promising to remain drug free. In some instances, they focus solely 
77
Module 3
 Issues for prison authorities and prison managers
on drug interdiction through increased searching, while some systems provide a multi-
faceted approach combining drug interdiction measures with treatment services. “Drug-
free” units could assist efforts to combat the spread of HIV in prison if they resulted in 
decreased drug use, particularly injecting drug use. There is some evidence from a small 
number of studies that so-called “drug-free” units do indeed significantly reduce levels of 
drug use among residents in these units. Such units appeal to a large number of prison-
ers, including prisoners who do not have any drug problems and want to live in a “drug-
free” environment. However, the studies do not say anything about whether “drug-free” 
units appeal to, and are successful in retaining, the most problematic drug users, in par-
ticular prisoners who inject drugs. Currently, there is therefore no data on the effective-
ness of drug-free units as an HIV prevention strategy.
Checklist 7. Other measures to reduce the demand for drugs
The following factors influence the effectiveness of measures to reduce the demand for drugs in 
prisons. Check here whether the programmes in your prisons conform to good practice:
Are prisoners provided with opportunities to work and/or study? "
Are other activities such as sports, theatre and spiritual and cultural enhancement provided? "
Is substantial and correct information provided to prisoners about drugs and drug use? "
Is life skills education provided to prisoners? "
Do prisoners have the option of living in “drug-free” living units? "
Is additional support available to prisoners living in such units, during imprisonment and upon  "
release?
Measures to reduce the supply of drugs
A broad range of search and seizure techniques and procedures can be used in an attempt 
to reduce the availability of drugs in prisons. These supply reduction measures include: 
random searches by security personnel; prison staff and visitor entry/exit screening and 
searches; drug detection dogs; closed-circuit monitoring; perimeter security measures 
(netting over exercise yards, higher internal fences to prevent projectiles, rapid response 
vehicles patrolling the prison perimeter); purchasing of goods only from approved suppli-
ers; intelligence analysts at every institution; drug detection technologies (such as ion 
scanners, x-ray machines, etc); modifications to the design and layout of visiting areas 
(use of fixed and low-level furniture); and drug testing (also called urinalysis).
Many prison systems, particularly in resource-rich countries, have placed considerable 
emphasis on these measures to reduce the supply of drugs. While such measures are not 
aimed at addressing HIV in prisons, they may result in unintended consequences for HIV 
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(and HCV) prevention efforts. Drug interdiction measures may assist HIV prevention 
efforts by reducing the supply of drugs and injecting in prisons. At the same time, they 
could make such efforts more difficult.
For example, many resource-rich prison systems regularly or randomly test prisoners’ 
urine for illegal drug use. Prisoners who are found to have consumed illegal drugs can 
face penalties. From a public health perspective, concerns have been raised that these 
programmes may increase, rather than decrease, prisoners’ risk of HIV infection. There 
is evidence that implementing such programmes may contribute to reducing the demand 
for and use of cannabis in prisons. However, such programmes seem to have little effect 
on the use of opiates. In fact, there is evidence that a small number of people may switch 
to injectable drugs to avoid detection of cannabis use through drug testing. Cannabis is 
traceable in urine for much longer (up to one month) than drugs administered by inject-
ing, such as heroin and other opiates. Some prisoners choose to inject drugs rather than 
risk the penalties associated with smoking cannabis simply to minimize the risk of detec-
tion and punishment. Given the scarcity of sterile needles and the frequency of needle 
sharing in prison, the switch to injecting drugs may have serious health consequences for 
prisoners. 
Generally, despite the fact that many prison systems make substantial investments in 
drug supply reduction measures, there is little solid and consistent empirical evidence 
available to confirm their efficacy in reducing levels of drug use. In particular, there is no 
evidence that these measures may lead to reduced HIV risk. 
Prison systems facing resource constraints should therefore not implement costly meas-
ures such as drug detection technologies and drug testing that may use up a substantial 
Checklist 8. Measures to reduce the supply of drugs
The following questions need to be considered by prisons in resource-poor settings when they under-
take measures to reduce the supply of drugs:
Are measures to reduce the supply of drugs preceded, or at least accompanied, by measures to  "
improve prison conditions and working conditions and pay of staff, recognizing that they are 
unlikely to be successful without those measures?
Are measures such as random searches by security personnel and staff and visitor entry/exit  "
screening and searches being undertaken?
Would other measures to reduce the supply of drugs—in particular, drug detection technolo- "
gies and urinalysis—be feasible in your prisons? What pre-conditions would need to be in 
place for such measures to be implemented? Would they take valuable resources away from 
proven and cost-effective HIV prevention measures or from efforts to improve prison condi-
tions and staff pay?
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amount of resources that could otherwise be used for managing HIV and AIDS in prisons. 
Instead, they should focus on the proven and cost-effective HIV prevention measures 
described above and on efforts to improve prison conditions and working conditions and 
pay for prison staff, without whom other drug supply reduction strategies are unlikely to 
be successful.
For more details on the effectiveness of measures to reduce the supply of drugs, see WHO, 
UNODC, UNAIDS (2007). Interventions to Address HIV in Prisons: Drug Dependence Treatments. 
Evidence for Action Technical Papers. Available at www.who.int/hiv/idu/prison/en/index.html 
or www.unodc.org/unodc/en/hiv-aids/publications.html.
!
Bleach and decontamination strategies
Provision of bleach or other disinfectants to prisoners is one of the options to reduce the 
risk of HIV transmission through sharing of injecting equipment, particularly where sterile 
injecting equipment is not available. Many prison systems have adopted programmes that 
provide disinfectants, as well as instruction on how to disinfect injecting equipment before 
re-using it, to prisoners who inject drugs. Evaluations of such programmes have shown 
that distribution of bleach is feasible in prisons and does not compromise security.
However, studies in the community have raised doubts about the effectiveness of 
bleach in decontamination of injecting equipment. Today, disinfection as a means of 
HIV prevention is regarded only as a second-line strategy to needle and syringe pro-
grammes. Cleaning guidelines recommend that injecting equipment be soaked in fresh 
full strength bleach (5 per cent sodium hypochlorite) for a minimum of 30 seconds. 
More time is needed for decontamination if diluted concentrations of bleach are used. 
Furthermore, a review of the effectiveness of bleach in the prevention of hepatitis C 
infection concluded that, “although partial effectiveness cannot be excluded, the pub-
lished data clearly indicates that bleach disinfection has limited benefit in preventing 
HCV [hepatitis C virus] transmission among injection drug users”.
In prisons, the effectiveness of bleach as a decontaminant may be reduced even further. 
There are at least three reasons for this:
T " he type of injecting equipment available in prisons, often consisting of whatever 
can be fashioned into something that pierces the skin, may be more difficult to 
effectively disinfect with bleach than the syringes used outside prison (on which 
the studies were undertaken).
E " ven when bleach is made available in some locations in prison, prisoners may 
have problems accessing it.
C " leaning is a time consuming procedure and prisoners are unlikely to engage in any 
activity that increases the risk that prison staff will be alerted to their drug use.
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Therefore, bleach programmes should be available in prisons, but only as a second-line 
strategy to needle and syringe programmes, until opposition to such programmes can be 
overcome, or in addition to them.
Where bleach programmes are implemented, full-strength household bleach should be 
made easily and discreetly accessible to prisoners in various locations in the prison, 
together with information and education about how to clean injecting equipment and 
information about the limited efficacy of bleach as a disinfectant for inactivating HIV 
and particularly HCV.
For more details on bleach and decontamination strategies, and accompanying references, 
see WHO, UNODC, UNAIDS (2007). Interventions to Address HIV in Prisons. Needle and Syringe 
Programmes and Decontamination Strategies. Evidence for Action Technical Papers. Available at 
www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-aids/publica-
tions.html.
!
Checklist 9. Bleach and decontamination strategies
The following factors influence the effectiveness of bleach and decontamination strategies. Check here 
whether the programmes in your prisons conform to good practice:
Is full-strength, household bleach made available? (Diluted bleach is even less effective than full- "
strength bleach.)
Is bleach or another disinfectant made easily and discreetly accessible to prisoners so that they  "
can pick it up at various locations in the prison, without having to ask for it and without being 
seen by fellow prisoners or prison staff?
Is bleach or another disinfectant provided to prisoners at entry to prison, in a “health kit” contain- "
ing other health protection information and tools, such condoms, water-based lubricant, shavers, 
a toothbrush, soap, a pamphlet on HIV, other infectious diseases, and on drug use, etc?
Is it free of charge? "
Are prisoners provided with information and education about how to clean injecting  "
equipment?
Are prisoners informed about the limited efficacy of bleach as a disinfectant for inactivating HIV  "
and particularly HCV?
Is bleach provided in addition to a needle and syringe programme, or while such a programme is  "
being prepared?
If a needle and syringe programme does not yet exist, are efforts underway to prepare for the  "
implementation of such a programme?
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Needle and syringe programmes
Box 31. Sample guideline for bleach distribution in prisons
Guidelines 821-2 − Bleach Distribution of the Correctional Service of Canada, issued in 2004, provide 
details on how bleach shall be made accessible to prisoners. The guidelines are available via 
www.csc-scc.gc.ca/text/plcy/cdshtm/821-2-gl-eng.shtml.
Among other things, the guidelines state that:
Full-strength (between 5.25 per cent and 7 per cent) household bleach shall be utilized as the  "
disinfecting agent;
Bleach kits shall consist of: "
One 1-ounce opaque plastic bottle of bleach, labelled with a notice reading “Bleach, Do Not a. 
Drink or Inject”; 
One 1-ounce empty opaque plastic bottle for water; andb. 
Instructions on the proper cleaning of syringes and needles;c. 
Every newly-admitted prisoner shall be issued one bleach kit following reception into federal custody  "
and shall be offered a kit on each occasion of reception upon transfer to another institution;
There will be a minimum of three designated locations in each institution where prisoners can  "
refill an empty bottle with bleach or obtain a bottle of bleach. Appropriate locations are those 
affording the prisoner privacy to the extent possible. In no instance shall a prisoner be required 
to approach a staff member in order to obtain refills;
A prisoner in possession of quantities of bleach in excess of the one-ounce bottle is considered  "
to be in possession of contraband unless prior authorization has been obtained;
The possession of a one-ounce bottle of bleach is not in itself sufficient evidence of drug usage  "
or other activity constituting a disciplinary offence.
Distribution of bleach should always be accompanied by a warning about the limited efficacy of bleach 
as a disinfectant for inactivating HIV and particularly HCV.
A note about terminology 
In this document we use the term needle and syringe programmes (NSPs) to refer to programmes that 
provide people who inject drugs with access to sterile injecting equipment (needles and syringes, but 
also other equipment required for injecting, such as swabs and vials of sterile water, since hepatitis C 
can be transmitted if such equipment has to be shared) and most often also to health education, refer-
rals, counselling and other services. This term has grown in popularity and is increasingly replacing 
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Particularly because of the questionable efficacy of bleach and other disinfectants in 
destroying HIV and other viruses, providing sterile injecting equipment to prisoners has 
been widely recommended. Access to sterile drug-injecting equipment would ensure that 
prisoners would not have to share their equipment. As early as 1993, the World Health 
Organization, in its Guidelines on HIV Infection and AIDS in Prisons, recommended that 
“in countries where clean syringes and needles are made available to injecting drug users 
in the community, consideration should be given to providing clean injecting equipment 
during detention and on release”. The same recommendation was made by the Joint 
United Nations Programme on HIV/AIDS and many other national and international 
bodies. The International Guidelines on HIV/AIDS and Human Rights also specifically 
state that prison authorities should provide prisoners with means of HIV prevention, 
including “clean injecting equipment”. 
The rationale for establishing needle and syringe programmes in prisons where injecting 
drug use takes place is even stronger than in communities. In prisons where injecting 
drug use takes place the risk of blood-borne viral infections is increased due to the often 
large number of prisoners who share injecting equipment. Although injecting in prison is 
usually less frequent than in the community outside prisons, each episode of injecting is 
more risky due to the scarcity of injecting equipment and the higher prevalence of needle 
sharing. The rapid turnover of prison populations also results in far more changes in 
injecting partners than in community settings and there is considerable interaction 
between prisoner and injecting populations in the community outside prisons.
The first prison needle and syringe programme in the world was established in Switzer-
land in 1992. Since then, programmes have been introduced in various prison settings in 
over 50 prisons in Western and Eastern Europe and in Central Asia.
In some countries, only a few prisons have needle and syringe programmes, but in Spain 
and in Kyrgyzstan programmes have been rapidly scaled up and operate in a large 
number of prisons, with the intention to make them available in all prisons.
Programmes were first introduced in small Swiss prisons, but they have since been imple-
mented in prisons for men and for women, in small, medium, and large institutions, in 
prisons of all security classifications, in civilian and military prison systems, in different 
forms of custody (remand and sentenced, open and closed), and in institutions that house 
prisoners in individual cells as well as in those that house prisoners in barracks.
earlier terms like “needle exchange programmes” or “syringe exchange programmes.” It is more accu-
rate and reflects the move of most programmes away from simple exchange of equipment to distribu-
tion of equipment with or without a return of used equipment. In prisons, in some programmes used 
injecting equipment is exchanged against new injecting equipment, for example through automated 
machines. However, in most programmes, as in the community, injecting equipment is distributed and 
additional services are also offered. 
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Significantly, after having been introduced in well resourced prison systems in Western 
Europe, programmes have since been established in systems with very limited financial 
resources in Eastern Europe and in Central Asia. Programmes were typically first imple-
mented on a pilot basis and later expanded to other prisons. Several models of distribu-
tion of sterile injecting equipment have been used, including automatic dispensing 
Box 32.  Needle and syringe programmes in prisons in the  
Kyrgyz Republic: a model of pragmatic action
In the Kyrgyz Republic, a pilot project started in one prison in October 2002. It was decided that inject-
ing equipment should be made available in a location where prisoners could not be seen by guards; it 
therefore was made available in the medical wards. The pilot also provided another way of distributing 
equipment, using prisoners as peer volunteers, as in Moldova. The project coordinators found that both 
options were needed. In early 2003, an order was issued approving the provision of sterile injecting 
equipment in all Kyrgyz prisons, and by April 2004 they were available in 11 prisons. In all institutions, 
distribution of injecting equipment is done using prisoners trained as peer outreach workers who work 
with the medical unit. In April 2004, approximately 1,000 people who use drugs were accessing the 
needle and syringe programme. People who use drugs are provided with one syringe and three extra 
needle tips. This allows prisoners who inject drugs to inject more—up to three times a day without 
having to reuse a needle tip. This also reduces the cost of the programme, since tips cost less than 
complete needles and syringes.
Box 33. Needle and syringe programmes in prisons in Spain
Needle and syringe programmes were introduced in 1998-1999 in two prisons in Spain as a pilot study. 
Following positive results, nine other prisons joined voluntarily. Evaluation showed that:
Implementation in a prison setting is feasible and can be adapted to the conditions of a prison. "
Needle and syringe programmes in prison produce changes in the behaviour of prisoners that lead  "
to less risky injection practices.
Needle and syringe programmes in prisons help to persuade prisoners to take up drug treatment. "
Implementation of a needle and syringe programme does not lead to an increase in heroin or  "
cocaine use.
In 2001 prison authorities issued a directive requiring all prisons to implement needle and syringe 
programmes as part of the prison regime. As of 2005 these programmes were working in 33 prisons 
in Spain.
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machines, hand-to-hand distribution by prison physicians, other prison health-care staff 
or drug counsellors, or by external community health workers, and distribution by 
prisoners trained as peer outreach workers.
Evidence of the effectiveness of prison-based needle and syringe programmes
The most important findings from the evaluation studies and from the experience of the 
other prisons in which programmes have existed include:
P " rison-based needle and syringe programmes are effective in reducing needle shar-
ing and transmission of HIV infection. Evaluations have shown that syringe sharing 
either ceased after implementation of the programme or significantly dropped.
N " eedle and syringe programmes do not undermine abstinence-based programmes. 
Drugs have remained prohibited within prisons where such programmes are in 
place. Security staff remain responsible for locating and confiscating illegal drugs. 
However, it is recognized that if and when drugs find their way into the prison 
and are used by prisoners, the priority must be to prevent the transmission of HIV 
and HCV via unsafe injecting practices. Therefore, while drugs themselves remain 
illegal, needles that are part of the official needle and syringe programme are not. 
Evaluations have found that needle and syringe programmes in prisons actually 
facilitate referral of people who use drugs to drug dependence treatment pro-
grammes, and have led to an increase in the number of prisoners accessing such 
programmes.
O " ther benefits include a reduction in abscesses, a reduction in stress, improved 
relationship between prisoners and staff, and increases in awareness about disease 
transmission and risk behaviours. 
S " ince the first programme started in 1992, there have been no reports of syringes 
ever having been used as weapons in any prison with a needle and syringe pro-
gramme. In fact, there are reports of an increase in staff safety in prisons with 
needle and syringe programmes, due to the fact that accidental injuries to staff 
from hidden syringes during cell searches have been reduced. The decrease in the 
possibility of injury is due to the fact that prisoners are permitted to store injecting 
equipment in a particular area and therefore do not hide it, thus reducing the risk 
of needle-stick injury during searches. Staff have also reported that the introduc-
tion of needle and syringe programmes makes injecting equipment more easy to 
control. 
A " vailability of injecting equipment does not result in an increased number of drug 
injectors, an increase in overall drug use, or an increase in the amount of drugs 
in prisons. In a few prisons, evaluations actually found that reported levels of drug 
use or injecting decreased.
B " efore their implementation, prison staff regularly had to be convinced to accept 
or at least tolerate the needle and syringe programmes. Nevertheless, once in place, 
acceptance increased and was generally high among prison staff, as well as among 
prisoners who use drugs and non-drug using prisoners.
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A "  key determinant of the success of prison-based needle and syringe programmes 
is ensuring that all prisoners have easy and confidential access to the programmes 
and develop trust that they can access syringes when they need them and without 
having to fear any negative consequences from prison staff. If prisoners have lim-
ited access to the programme or lack trust in it, sharing of injecting equipment 
will continue, and benefits for prison staff will also be reduced, as needles and 
syringes will continue to be hidden, thus increasing the risk of needle stick injuries 
for staff. In many prisons, this means that distribution by prison nurses or physi-
cians or even by non-governmental organizations or health professionals who come 
to the prison for this purpose will not be the best option, as access to the pro-
gramme would be too limited. In such prisons, distribution through peers has led 
to much greater access. For example, in Moldova only a small number of prisoners 
accessed the programme when it was located within the health-care section of the 
prison. It was only when prisoners could obtain injecting equipment from fellow 
prisoners trained to provide harm-reduction services that the number of injecting 
equipment distributed increased significantly.
S " upport by prisoners and prison staff is important, and both prisoners and staff 
should receive information and education about the programmes and their expected 
benefits, and be involved in their design and implementation.
Checklist 10. Needle and syringe programmes
The following factors influence the effectiveness of needle and syringe programmes. Check here 
whether the programmes in your prisons conform to good practice:
Before a programme is introduced: Have educational and informational activities been prepared  "
to explain why it is important to start the programme? Have prisoners and staff been involved 
in the setting up of the programme? 
Do prisoners have trust in the needle and syringe programme? Can they access needles and  "
syringes without fearing any negative consequences?
Do prisoners have adequate access to the programme? "
Do prisoners have access to different types of syringes and to other injecting equipment such as  "
swabs and vials of sterile water?
Can prisoners obtain sterile injecting equipment from fellow prisoners, without having to self- "
identify as drug users to prison authorities?
Is the programme part of a more comprehensive prevention programme, including drug depend- "
ence treatment? 
Does management show support of the programme and support the staff and prisoners involved  "
in it?
Is the programme regularly monitored so that adjustments can be made, if necessary, to make it  "
respond better to the needs of prisoners and of staff?
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Because of their demonstrated benefits and lack of negative consequences, needle and 
syringe programmes should be introduced urgently in prisons in which injecting drug use 
occurs. 
As with other controversial measures, or those measures that apparently run counter to 
accepted orthodoxy within a system, it is crucial to have supportive leaders and manag-
ers to successfully create and implement prison needle and syringe programmes. 
For more details and references on needle and syringe programmes, see WHO, UNODC, 
UNAIDS (2007). Interventions to Address HIV in Prisons: Needle and Syringe Programmes and 
Decontamination Strategies. Evidence for Action Technical Papers. Available at www.who.int/
hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-aids/publications.html.
For a detailed plan and guidelines used for the implementation of needle and syringe pro-
grammes, see: Ministerio Del Interior/Ministerio De Sanidad y Consumo (2003). Needle 
Exchange in Prison. Framework Programme. Madrid: Ministerio Del Interior/Ministerio De Sani-
dad y Consumo. Essential for anyone wishing to learn how a successful programme can be 
established in a prison. Available in Spanish, English, and French. Another, less comprehen-
sive, document on the same issues, entitled “Elements key for the installation of programs 
of exchange ok (sic) syringes in prison” (Elementos clave para la implantacion de Programas 
de Intercambio de Jeringuillas en Prision) is available at www.msc.es/ciudadanos/enfLesiones/
enfTransmisibles/sida/prevencion/progInterJeringuillas/PIJPrisiones/elemClavePIJIng.htm.
!
Other measures
Detection and treatment of sexually transmitted infections
Early detection and treatment of sexually transmitted infections (STIs) is important because 
these infections increase the chances of an individual acquiring and transmitting HIV. 
Checklist 11. Management of sexually transmitted infections
The following factors influence the effectiveness of efforts to manage sexually transmitted infections 
(STIs) in prisons. Check here whether the programmes in your prisons conform to good practice:
Have health care workers been trained on management of STIs? "
Are prisoners screened for STIs on admission? "
Is STI treatment available and offered to all prisoners who need it? "
Are all prisoners provided with the necessary information on STIs? "
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Controlling the spread of tuberculosis
It is estimated that tuberculosis is 100 times more common in prisons than in the com-
munity. Wherever tuberculosis is evident in prisons it is a significant health problem. 
Sub-standard prison living conditions, including overcrowding, poor ventilation and 
inadequate nutrition, make the attempts to control the spread of tuberculosis in prisons 
more difficult. Moreover, prisons in geographically disparate places (from Thailand to 
New York State to Russia) have reported high levels of drug-resistant tuberculosis. Tuber-
culosis poses a substantial danger to the health of all prisoners, prison staff, and the com-
munity outside prisons. Prisoners living with HIV are at particular risk. HIV infection is 
the most important risk factor for the development of tuberculosis, and tuberculosis is the 
main cause of death among people living with HIV.
For these reasons, prison managers must implement comprehensive tuberculosis control 
programmes along with HIV programmes.
For comprehensive information about tuberculosis control in prisons, see: World Health 
Organization and International Committee of the Red Cross (2001). Tuberculosis Control in 
Prisons: A Manual for Programme Managers. Available in English, Spanish, and Russian via 
www.who.int/docstore/gtb/publications/prisonsNTP/; World Health Organization. Interim 
policy on collaborative TB/HIV activities (2004). Available in English, French, Russian, and Span-
ish at www.who.int/tb/publications/tbhiv_interim_policy/en/.
!
Hepatitis B vaccination
Hepatitis B is easily spread in prisons. In contrast to HIV, the risk of infection can be 
reduced through the administration of a vaccine. All staff and prisoners should have 
easy access to free hepatitis B vaccination. In addition, consideration should be given to 
providing hepatitis A vaccination to prisoners at risk.
Hepatitis C prevention
In addition to contributing to reduced risk of HIV transmission in prisons, most of the 
measures described above also contribute to reducing the risk of hepatitis C virus (HCV) 
transmission. However, as explained above, in box 5, HCV is much more easily spread 
than HIV, including through sharing of shavers and toothbrushes, as well as through 
tattooing and body piercing. It is therefore important that prisons make information 
available to all prisoners and to staff about the risks of HCV transmission in prison and 
educate them about the ways to reduce that risk. In addition, shavers and toothbrushes 
should be made available to prisoners so that they do not have to share them with fellow 
prisoners; and prisons should consider implementing measures to reduce the spread of 
HCV through tattooing and body piercing, such as making sterile tattooing equipment 
available to prisoners. 
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Protecting staff
Protection of staff from infectious diseases is a duty and also part of good management. 
High rates of HIV and other infectious diseases in prisons make them more stressful 
places in which to work. High rates of staff turnover, whether due to ill health or lack of 
job satisfaction have a major impact on the management of prisons.
It is essential that staff receive initial and ongoing training to enable them to do their 
duties in a healthy and safe manner, and to feel secure themselves and be able to give 
prisoners appropriate guidance and support. This training should enable them to antici-
pate and manage situations in which they may be exposed to HIV or hepatitis. Staff 
should also be trained in the safe provision of first aid.
When on duty, relevant prison staff should have access to personal protective equipment, 
such as latex gloves, masks for use in mouth-to-mouth resuscitation, protective eyewear, 
soap, and mirrors for use in searching.
Safe work procedures should be developed, including searching procedures. Post-expo-
sure procedures also must be in place. The procedures should address immediate action, 
follow-up action, record keeping and confidentiality. Finally, staff should have access to 
appropriate professional counselling and follow-up services after possible and definite 
exposures to blood and body fluids.
Finally, ample space, adequate lighting, and optimum levels of staff are important to 
ensure safe work practices, and measures are required to improve the general work 
conditions of prison staff.
Checklist 12. Measures to protect prison staff 
Do staff receive initial and ongoing training to enable them to do their duties in a healthy and  "
safe manner?
Are prison staff trained in the provision of first aid? "
Do prison staff have access to protective equipment, such as latex gloves, masks for mouth-to- "
mouth resuscitation, etc?
Have safe work procedures been developed and adopted? Do they include searching procedures? "
Has a protocol for managing exposure to blood and/or body fluids been developed and adopted? "
Do prison staff have access to post-exposure prophylaxis treatment? "
Is hepatitis B vaccination accessible to all staff, free of charge? "
Is lighting in the work areas adequate? Is there enough space for staff to carry out their work  "
safely?
Are staffing levels adequate? "
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In contrast, it is not important to know the HIV status of prisoners (and prison staff), and 
all must be handled equally—as if they were HIV positive, both for safety reasons and in 
order to avoid discrimination.
For more information, see: Worksafe Australia (1995). Infectious disease control—police, prison 
officers, other workers in correctional facilities and emergency response workers. This fact sheet 
provides examples of what workplaces must do to make work safe for prison staff. Avail-
able at www.worksafe.nt.gov.au/corporate/ bulletins/pdf/01-05/01.01.06.pdf.
For an example of a policy on managing exposure to blood and/or body fluids, see: 
Correctional Service Canada, Commissioner’s Directive 821-1. Available at www.csc-
scc.gc.ca/text/plcy/cdshtm/821-1protocol-eng.shtml. 
!
Providing treatment, care and support to prisoners living with HIV or AIDS
In addition to providing comprehensive prevention programmes, prisons have a respon-
sibility to provide prisoners with treatment, care and support equivalent to that available 
in the outside community.
The right to medical care in prisons includes the provision of antiretroviral therapy (ART) 
in the context of comprehensive HIV/AIDS care. The advent of combination ART has sig-
nificantly decreased mortality due to HIV infection and AIDS in countries around the 
world where ART has become accessible. There has been a parallel decrease in the mor-
tality rate among incarcerated individuals in prison systems in those countries.
Providing access to ART for those in need in prisons is a challenge, but it is necessary and 
feasible. Studies have documented that, when provided with care and access to medica-
tions, prisoners respond well to antiretroviral treatment.The right to enjoyment of the 
highest attainable standard of physical and mental health, in concert with the principle of 
equivalence, dictates that prisoners should have access to the same standard of care 
available to people in the community outside prison.
In September 2003, the WHO, UNAIDS, and the Global Fund to Fight AIDS, TB and 
Malaria launched an initiative to make effective HIV treatments available in developing 
countries and countries in transition (the so-called “Treat 3 Million by 2005 (3 by 5) Ini-
tiative”), partly out of the recognition that HIV was exacerbating inequities between rich 
and poor countries, and the conviction that the right to health and life should not be 
dependent on ability to pay for medicines. Although the ambitious target of 3 by 5 was 
not reached, at the 2005 World Summit and the 2006 High Level Meeting on AIDS, world 
leaders committed to pursue all necessary efforts towards the goal of universal access to 
comprehensive HIV prevention programmes, treatment, care and support by 2010. 
In support of this, additional resources to fund an expanded response have become 
available, including through the Global Fund to Fight AIDS, Tuberculosis and Malaria.
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Through these initiatives, ART is increasingly becoming available in low and middle-
income countries, and countries are moving towards the goal of universal access to HIV 
treatment, care and support by 2010. Therefore, it will be critical to ensure that treat-
ment also becomes available to all prisoners who need it.
As prisons need to provide prisoners with a standard of treatment equivalent to that 
available in the outside community, more and more prisons over the next years will 
have to be ready to provide ART to prisoners with HIV, including enabling treatment 
without interruption upon arrest and ensuring treatment can continue without inter-
ruption upon release. There are many important management issues related to this (see 
supra, module 2, for actions required by policymakers, legislators, and parliamentari-
ans). In addition to ensuring that prisons are involved in all aspects of the national 
treatment scale-up efforts and participating in meetings of national AIDS committees 
responsible for these efforts, prisons should form partnerships with health clinics, hos-
pitals and universities and civil society organizations (including organizations of people 
living with HIV or AIDS) to provide health care and other services for prisoners, and 
develop integrated rather than parallel treatment, care and support programmes.
Checklist 13. Providing treatment to prisoners with HIV or AIDS 
Do prison authorities have a place within the national HIV/AIDS coordinating committees? "
Are prison issues part of the agreed HIV action framework and country-level monitoring and  "
evaluation system?
Are prison authorities involved in all aspects of treatment scale-up, from applications for funding  "
(to ensure that funds are specifically earmarked for prisons), to development, implementation, 
and monitoring and evaluation of treatment roll-out plans?
Have policies or guidelines been developed specifying that people with HIV or AIDS are allowed  "
to keep their HIV medication upon them, or are to be provided with their medication, upon arrest 
and incarceration and at any time they are transferred within the system or to court hearings?
Have police and prison staff been educated about the importance of continuity of HIV  "
treatment?
At the regional and local level, have prisons formed partnerships or entered into agreements with  "
health clinics, hospitals and universities and civil society organizations (including organizations of 
people living with HIV) to provide health care and other services for prisoners, and developed 
integrated rather than parallel care and treatment programmes? (Ideally, prisoners should be able 
to access antiretroviral medication through public health facilities during their incarceration).
Has health care staff received training in the comprehensive management of HIV and AIDS, includ- "
ing the provision of antiretroviral therapy?
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Compassionate or early release 
Prisoners who enter the later stages of chronic or terminal illnesses—including but not 
limited to HIV—require specialized end of life care. However, prisons—even in high 
income countries—are ill-equipped to provide such care.
End of life care is unique and demanding, and prison staff often lacks the necessary train-
ing and resources. The prison environment itself—with its security-focused architecture 
and routines, lack of comfort and privacy, barriers to access for family and friends, lack 
of adequate training and resources for staff, etc.—is also generally non-conducive to com-
passionate and responsive end of life care. End of life care—particularly in the context of 
HIV—often involves large doses of pain management medications, which may conflict 
with the “drug free” ethos of the prison system.
For these reasons, many prison systems have introduced compassionate release pro-
grammes to allow terminally ill prisoners to be released from prison earlier in their 
sentence. Such early release programmes fulfil not only a compassionate role, but in 
many cases can also serve a health promotion function in recognition that the life 
expectancy of the terminally ill prisoner may be lengthened as a result of receiving care 
in the community. 
Compassionate release of terminally ill prisoners is recommended by the World Health 
Organization Guidelines on HIV infection and AIDS in prisons, acknowledging that a 
Are people who are on antiretroviral treatment before arrest and incarceration able to continue  "
their treatment without interruption?
Are people who are transferred within the system or to court hearings able to continue their  "
treatment without interruption?
Are prisoners who need to start antitretroviral treatment able to do so in prison? Are the eligibility  "
criteria the same as in the community?
Is information and education on access to treatment provided to all prisoners who are eligible to  "
be on antiretroviral therapy and treatment of opportunistic infections?
Do health care workers screen offenders (including detainees awaiting trial) on admission to  "
determine if treatment for any HIV-related illness or opportunistic infection, such as tuberculosis, 
is necessary? Do they refer them appropriately, if necessary?
Have treatment literacy campaigns and sessions been undertaken in prisons? "
Has a “buddy system” been established to facilitate adherence to treatment?  "
Does the treatment programme contain a comprehensive discharge planning system for prisoners  "
nearing release, including a system for referral to treatment in the general community?
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person should be allowed to die in dignity, either in their own home or with their family, 
rather than forced to die isolated and alone in prison. The guidelines state:
51. If compatible with considerations of security and judicial procedures, prisoners 
with advanced AIDS should be granted compassionate early release, as far as possi-
ble, in order to facilitate contact with their families and friends and to allow them to 
face death with dignity and in freedom.
52. Prison medical services should provide full information on such prisoners’ 
health status, treatment needs and prognosis, if requested by the prisoner, to the 
authorities competent to decide upon early release. The needs of those prisoners 
without resources in the community should be taken into account in any early 
release decision.
Checklist 14. Compassionate or early release 
Does prison policy state that where appropriate, namely where the prisoner’s state of health  "
indicates that it is necessary, prisoners with AIDS will be released on medical parole?
Does the policy emphasize the obligation on the part of the prison authorities to act expeditiously  "
and that there should be no unnecessary delays in initiating and processing these applications?
Does health care staff in prison seek to actively identify those prisoners whose state of health  "
would qualify them for early release? (Due to their state of health, prisoners are not always in a 
position to initiate applications for early release. When prisoners become eligible for this option, 
they should be informed of the possibility of early release and assisted in such applications, where 
they unable to do so themselves).
Has the early release policy been brought to the attention of all prisoners? "
Does the policy provide for a health care staff or social worker to contact the family and to ensure  "
that appropriate care is available upon release? (Early identification of the relatives and other 
service providers for prisoners with AIDS is important to facilitate placement after release.)
In all cases of referrals to other care providers, is the offender required to give informed consent? "
Does the decision for early release involve the input of the nurses who care for the prisoner on  "
a day-to-day basis, confirmed by a medical practitioner? (Separate medical examinations by two 
medical practitioners should not be a requirement as this delays the application. Only where it 
is deemed necessary for a proper consideration for the application, should a specialist be required 
to conduct an examination.) 
Do all officials in charge of determining early release on medical grounds receive adequate educa- "
tion about HIV and AIDS and its treatment?
Are urgent applications fast-tracked? "
Is palliative care available in prison for prisoners at the end stages of life who cannot be released? "
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Whenever this is compatible with considerations of security and judicial procedures, pris-
oners with advanced AIDS should therefore be granted compassionate early release, in 
order to facilitate contact with their families and friends and to allow them to face death 
with dignity and in freedom. For those prisoners who cannot be released, prisons must 
provide adequate palliative care.
Box 34. Prisoners with AIDS in Italy
Italian law prevents anyone with “overt” AIDS from being held in prison custody. The definition of 
“overt AIDS” is clinically established with reference to the blood cell count. To determine this, the 
prisoner is administered two consecutive tests, 15 days apart. Other alternatives suggest that prisoners 
with AIDS be released from prison but held under house arrest, admitted to a public health institution, 
or that the sentence be remitted indefinitely.
Moving towards implementation
The checklists above provide the key elements of a comprehensive strategy to address 
HIV in prisons. By recognizing that HIV (and HCV and TB) represent serious issues requir-
ing urgent and pragmatic action to protect the health of prisoners, prison staff, and the 
community, and by acknowledging the reality that risk behaviours occur in prisons and 
cannot be eliminated, prison authorities and prison management can set the tone and 
signal that they take their responsibilities seriously. By developing a clear action plan, 
identifying activities, timelines and responsibilities, for adopting all elements of the com-
prehensive strategy, prison authorities and managers can be leaders in the fight against 
HIV in countries, and demonstrate that they have a clear vision and a determination to 
ensure that prisons will do their part in preventing infection and providing care and 
treatment to people living with HIV or AIDS. 
Frequently asked questions
Should prisoners be mandatory tested for HIV and segregated from the rest of the 
prison population? 
No. Some prison staff have called for mandatory HIV testing and segregation of prisoners 
testing HIV-positive. They have said that this is necessary to protect them from infection. 
But in reality, it is not necessary and could even be counterproductive, for a number of 
reasons:
H " IV is not transmissible via casual contact (as is active TB, for example). Therefore 
segregation of people living with HIV or AIDS is not necessary.
T " he nature of HIV antibody testing means that a prison will never be able to cor-
rectly identify and therefore isolate all prisoners infected with HIV. Because of the 
“window-period” inherent in the testing technology, which means that it may take 
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up to 14 weeks—and perhaps longer—for a person infected with HIV to develop 
HIV antibodies in sufficient concentration to trigger a positive test result, false 
negative test results are unavoidable.
M " andatory testing and forced segregation undermine HIV prevention by creating 
the unrealistic and dangerous assumption that all prisoners living with HIV or 
AIDS are segregated, and that therefore there is no HIV in the general prison 
population. This can lead prison staff to believe that they need not use universal 
precautions.
I " gnoring universal precautions when interacting with HIV-negative prisoners may 
increase the risk of occupational exposure to hepatitis B and C.
In addition, mandatory HIV testing and segregation increases and entrenches HIV-related 
stigma and discrimination among prisoners and prison staff.
Instead of being subjected to testing without consent, prisoners should have easy access 
to voluntary HIV counselling and testing and should be provided with the means neces-
sary to act responsibly and to protect themselves and others from the risk of contracting 
HIV, such as access education, counselling, condoms, bleach, sterile needles and syringes, 
substitution treatment and other drug treatment.
Should we keep some prisoners apart?
Although prisoners with HIV or AIDS should not be segregated, effective prison man-
agement should ensure that some groups of prisoners are kept apart. Prison staff are 
trained to protect society from serious adult criminals. It should not be part of their 
task to take care of the small number of children and young people who have commit-
ted offences that require that they be deprived of their liberty. Such young people 
should be held in the care of welfare or social care agencies. Although this is the prin-
ciple, the reality is that in several countries a number of children and young people 
are committed to prison custody. 
When this happens the prison administration has an obligation to care for them in a man-
ner that takes account of their age and special needs. There are two main reasons for this 
special treatment.
C " hildren and young people are more vulnerable than adults and need to be 
protected from violence or abuse by older prisoners or even by staff.
Y " oung people are generally more likely to respond to positive influences, to 
training and to educational opportunities.
For these reasons any children and young people who are in the care of the prison 
administration should be held in separate institutions and not in prisons for adults.
Should prisoners with HIV or AIDS be allowed to do the same activities as everyone else?
Yes. Segregation, isolation, and restrictions on occupational activities, sports, and recrea-
tion are not considered useful or relevant in the case of HIV-positive people in the 
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community. The same attitude should be adopted towards HIV-positive prisoners. They 
should have equal access to workshops and to work in kitchen, farms and other work 
areas, and to all programmes available to the general prison population. HIV cannot be 
transmitted through such activities.
Should prison staff be told who has HIV?
No. Some staff claim that they need to know which prisoners live with HIV so that they 
can take adequate precautions to protect themselves from contracting the infection. How-
ever, for their own sake, staff need to take universal precautions and treat all prisoners 
as if they might be HIV-positive. Knowing will not help them protect themselves, but will 
create a false sense of security and may increase, rather than decrease, the risk of infec-
tion, particularly with other infections such as hepatitis C.
Does making condoms and needles and syringes available to prisoners have a 
negative impact on security in prisons?
No. The promotion of health in prisons does not entail lessening of the safety and the 
security of prisons. The interest of prisoners in being given access to the means necessary 
to protect them from contracting HIV and/or HCV are compatible with the interest of staff 
in their security in the workplace and of prison authorities in the maintenance of safety 
and order in the institutions. The evidence from the many prisons in which condoms and/
or needles and syringes have been made available shows that this can be done safely and 
without unintended negative consequences for prison security and without creating any 
danger for staff.
In fact, any measure undertaken now to prevent the spread of HIV and HCV will benefit 
not only prisoners and prison staff, but also society in general.
F " irst, it will protect the health of prisoners, who should not, by reason of their 
imprisonment, be exposed to the risk of contracting HIV and HCV.
S " econd, it will protect prison staff. Lowering the prevalence of infections in prisons 
means that the risk of exposure to these infections will also be lowered among 
prison staff.
F " inally, measures to prevent the spread of HIV and HCV in prisons also protect 
the general community. Most prisoners are in prison only for relatively short peri-
ods of time and are then released into their communities. In order to protect the 
general population, HIV and HCV prevention measures at least equivalent to the 
ones available in the outside community need to be available in prisons.
Are we not condoning drug use in prison by making needles and syringes available 
to prisoners?
No. Many prisoners are in prison because of drug offences or because of drug-related 
offences. Preventing their drug use is an important part of their rehabilitation. Some say 
that acknowledging that drug use is a reality in prisons, would be to acknowledge that 
prison staff and prison authorities have failed. Others say that making needles and syringes 
available to prisoners would mean condoning behaviour that is illegal in prisons.
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However, making available to prisoners the means that are necessary to protect them 
from HIV and HCV transmission does not mean condoning drug use in prisons. Introduc-
ing needles and syringes is not incompatible with a goal to reduce drug use in prisons. 
Evidence shows that making needles and syringes available to people who use drugs does 
not lead to an increase in drug use, but appears to be effective in reducing HIV infections 
resulting from injecting drug use.
On the other hand, refusing to make needles and syringes available to prisoners, knowing 
that activities likely to transmit HIV and HCV are prevalent in prisons, could be seen as 
condoning the spread of HIV and HCV among prisoners and to the community at large.
Instead of making HIV prevention commodities like condoms and needles and 
syringes available to prisoners, should we not rather adopt a zero tolerance  
approach and eliminate drugs and sex from prisons?
No. It is important to undertake measures to decrease the prevalence of drug use, and it 
is important to fight non-consensual sex in prisons. However, no prison system—even the 
systems with large financial resources devoted to this—has been able to keep drugs out 
of prisons and to eliminate sexual activity. Therefore, it is necessary to do both—take 
measures to reduce drug use and non-consensual sex, and also provide HIV prevention 
measures recognizing that drug use and sexual activity will still occur.
A toolkit for policymakers, programme managers, prison officers  
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This module is intended primarily for people who work in prisons and provide security 
or programmes for prisoners on a day-to-day basis. We hope it will be useful to:
P " rison officers;
T " eachers and instructors;
C " ivil society organizations, including staff and volunteers of non-governmental 
organizations and members of faith-based organizations, who visit prisons and 
undertake activities there.
The key objectives of the module are to:
B " riefly explain why prison staff have a key role in combating the spread of HIV 
in prison (“Prison staff are key”);
E " xplain how prison staff can protect themselves from contracting HIV (“HIV at 
work in prison”);
E " xplain the HIV prevention measures that need to be implemented in prisons, 
and show that their introduction does not negatively affect the safety of prison 
staff, but contributes to their protection as well (“HIV prevention in prisons—for 
everyone’s benefit”);
P " rovide answers to frequently asked questions.
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Prison staff are key!
Prison staff are responsible for the safeguard and care of people who are vulnerable to 
HIV infection and AIDS, as well as to hepatitis and tuberculosis. The rate of these infec-
tions among prisoners is usually much higher than in the general community. In some 
countries (mainly where injecting drug use is a problem and HIV is widespread among 
injecting drug users, many of whom spend time in prison), HIV rates in prison are up to 
one hundred times higher than in the community. But also in other countries rates of HIV 
(and other infections) in prison tend to be high, partly because many prisoners are drawn 
from the poorest and most marginalized parts of the population that are most at risk of 
HIV, and partly because conditions in prison can encourage the spread of infection. 
A healthy prison cannot be created without the contribution of each member of its staff. Given the current 
health problems in prisons, staff members need to know and understand what the health problems are, how 
infections can spread, how they can be better controlled and how health and well-being can be promoted.
Promoting health in prisons—the essentials. A WHO guide. WHO Europe, 2006
Prisoners are at greatest risk of infection, but prison staff also run a risk of infection in 
prisons, particularly if they do not receive training or do not use adequate precautions 
with all prisoners. Governments have a responsibility for ensuring health and safety of 
prison staff while at work. 
People who work in prisons should do all they can to protect themselves and prisoners 
from contracting HIV and other infections.
T " hey should participate in workplace training programmes about HIV, hepatitis, 
and tuberculosis and about how these infections are, and are not transmitted in 
prison. Where prison staff are not properly trained, they more likely react with 
fear to people with HIV or AIDS. This can lead to stigma and discrimination against 
people living with HIV or AIDS and those perceived to be at risk of HIV. Ignorance 
of HIV, as well as fear and stigma, greatly hamper efforts to stop the spread of 
HIV.
T " hey should use precautions to reduce the risk that they will contract infections.
F " inally, they should actively support prevention programmes for prisoners. Meas-
ures to protect prisoners will ultimately also protect staff and can be introduced 
in prison without compromising security.
This toolkit should help considerably to provide the knowledge that is necessary, but 
there should be further opportunities for prison staff to develop the understanding which 
is so important in dealing with issues relating to HIV and other health issues, including 
ethical aspects.
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HIV at work in prison 
How can I avoid becoming infected?
Particularly if prison staff are adequately trained and equipped, the risk of being infected 
with infections like HIV that are spread only through contact with blood or other body 
fluids (and not as a result of casual contact) is very small. However, other diseases that 
are prevalent in prisons and that are much more easily spread than HIV—particularly 
tuberculosis—pose a much greater threat not only to the prison staff directly, but also to 
their families and to the wider community.
It is usually safe to work with prisoners or fellow staff who are infected with HIV because 
HIV cannot be transmitted as a result of casual contact.
However, sometimes prison staff have to deal with assaults (between prisoners and 
between prisoners and prison staff), self-mutilation by prisoners, traps set by prisoners, 
and objects concealed by prisoners, such as needles and syringes. In these and all other 
situations where there is a potential risk of exposure to blood or body fluids, all prison 
staff—just like health care workers—must adopt an attitude that all of these fluids and 
substances are potentially infectious and should be treated as such.
Preventing transmission of HIV (and hepatitis) in the workplace, therefore, means 
preventing:
I " njuries from sharps and other instruments contaminated with blood or body fluids; 
and
C " ontact between blood or body fluids and the eye, or other mucous membranes, 
and broken skin or cuts.
So-called “universal precautions” are based on the concept that all blood, blood products 
and body fluids of all persons are potential sources of infection, independent of diagnosis 
or perceived risk.
All prison staff must adhere rigorously to protective measures that minimize exposure to 
these agents. The use of universal precautions involves placing a barrier (such as latex 
gloves, protective eyewear, or masks for use in mouth-to-mouth resuscitation) between 
staff and all blood and body fluids.
Safe work practices
It is important that all areas of the prison are kept clean to prevent transmission of dis-
ease—HIV cannot be transmitted through lack of cleanliness, but other infections can. In 
prisons where it may be difficult to provide all prisoners with other work or training 
activities, it is possible to offer some of them work as cleaners. This is a good way of keep-
ing the prison clean as well as providing additional work.
Prison staff should follow safe work procedures (if such procedures do not exist, prison 
management should develop them, and involve prison staff in the development). At the 
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beginning of a shift, staff should wash their hands in order to clean them and identify any 
cuts or breaks in the skin. If any are present, they should be covered with a waterproof 
dressing.
Work practices in emergency situations need to take into account the unpredictable nature 
of exposures to blood and body fluids that may occur. Particular care should be taken 
where staff are likely to come into contact with glass pieces or any other sharp materials 
or instruments. 
Violence
Violence is common in prisons around the world. Prison staff confronted by prisoners 
exhibiting physical violence towards them should follow established operational guide-
lines for dealing with such situations (if such guidelines do not exist, prison management 
should develop them, and involve prison staff in the development). The risk of HIV trans-
mission during violence (such as when prisoners splash prison staff with blood or spit at 
them) is very low, but there are reports of prisoners contracting hepatitis C virus from 
physical assaults, with two possible cases occurring in New South Wales in Australia. 
There has also been one report of a prison officer acquiring hepatitis C from a blood 
splash resulting from two prisoners fighting. Even if the risk is low, after any exposure 
post-exposure guidelines should be followed (see below).
Blood/body fluid spillages
Although the risk of transmission of HIV is very low, all such spillages should be treated 
as though the blood or body fluid is potentially infected. Latex gloves should be worn 
when cleaning up spillages, and appropriate cleaning materials should be used. Clothing 
contaminated with blood should be removed as soon as possible.
Conducting searches/unlocking cells
Prison staff involved in searches should follow searching procedures to ensure their 
health and safety (if such procedures do not exist, prison management should develop 
them, and involve prison staff in their development). Some techniques that should be 
used in searching procedures are:
A " lways wear latex gloves or other suitable gloves when searching;
D " o not run fingers along or under tables, beds and other surfaces where sharp 
objects may be concealed;
U " se pens, rulers etc or a mirror to view areas that cannot be seen; 
W " hen searching bags etc, hands must not be placed inside—the contents should 
be tipped out onto a flat surface for examination;
U " se torches to illuminate dark areas;
S " afely remove any items contaminated with blood or body fluids;
P " romptly discard used needles, shavers and other sharp instruments using a non 
permeable container.
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Post-exposure procedures
If a staff has a significant exposure, post-exposure procedures should be followed (if such 
procedures do not exist, prison management should develop them). An exposure is 
significant when a person has:
C " ome in contact with body fluids capable of transmitting HIV, hepatitis B or hepa-
titis C, including blood, serum, plasma, and all body fluids visibly contaminated 
with blood; uterine/vaginal secretions or semen; or saliva; and
O " ne of the fluids comes into contact with the following:
T − issue under the skin (needle stick type injuries, bites breaking the skin, stab 
wounds);
N − on-intact skin (cut, chapped, or scraped skin); or
M − ucous membranes (eyes, nose, mouth). 
Fluids coming into contact with intact skin do not represent a significant exposure. 
The person who has had an exposure shall immediately:
R " emove all contaminated clothing;
A " llow bleeding of the wound;
W " ash the injured area well with soap and water (although the application of anti-
septics is of no proven benefit, their use is not contraindicated; it is advised, 
however, that the exposed skin or wound is decontaminated with soap and water 
before the application of antiseptics);
I " f the eyes, nose or mouth are involved, flush them with large amounts of water.
Following these steps, staff who have suffered a significant exposure should immediately 
see the medical practitioner or the officer in charge of post-exposure procedures and 
arrangements for post-exposure prophylaxis treatment should be made.
HIV prevention in your prison—for the benefit of all 
Prison staff have a key role in helping to minimize the spread of HIV in prisons. This can-
not be achieved simply by enforcing a zero tolerance approach to sexual activity and drug 
use in prison. Experience has shown that a comprehensive approach is needed, which 
aims both:
T " o prevent the prevalence of high risk behaviour; and
T " o reduce the harm caused by such behaviour when it does take place. 
Many of the activities that can transmit HIV in prison are against prison rules and in 
some cases against the criminal law. Prisons must do all they can to prevent drug use and 
unsafe sex in prison, and to reduce levels of violence—in particular sexual violence. How-
ever, it is important to recognize that efforts to stop these activities, such as the use of 
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drugs in prisons, will not always be successful. Illegal drugs are available in prisons 
worldwide despite the sustained efforts of prison systems and prison staff to prevent 
illegal drug use by prisoners—by doing what they can to prevent the entry of drugs into 
prisons, tightly controlling distribution of prescription medications, and enforcing 
criminal prohibitions on illegal drug possession and use among prisoners. 
But taking measures to try to prevent the activities in the first place is not enough. Know-
ing that the activities—in particular injecting drug use and sex—cannot be completely 
monitored and stopped, prisons also need to implement measures to reduce the risk to 
health associated with these activities, for example by making condoms and needles and 
syringes available to prisoners. This does not mean condoning these activities. Rather, it 
means adopting a pragmatic approach that acknowledges that risk behaviours occur in 
prisons and reduces the potential harms to prisoners, staff, and the general community.
Elements of the comprehensive approach to prevent the spread of HIV in prisons that 
have proven to be effective in reducing risks of HIV and at the same time have not created 
any risk for prison staff include: 
I " nformation, education, and communication programmes;
P " roviding condoms and undertaking measures to prevent rape, sexual violence and 
coercion;
P " roviding opioid substitution therapy and other forms of drug dependence 
treatment;
U " ndertaking measures to reduce the demand for, and the supply of, drugs;
P " roviding sterile needles and syringes and bleach or other disinfectants. 
Prison staff may be required to participate in overseeing some of these measures. But 
even when programmes are implemented by health care staff, the programmes often 
cannot work if other staff do not support them or at least tolerate them and allow them to 
work without interference.
HIV education and information
HIV education is an essential precondition to the implementation of HIV prevention meas-
ures in prisons. At the same time, HIV education efforts in prisons present specific chal-
lenges. In particular, many prisoners are suspicious of anything “official” or government 
related, which means that programmes created by the prison administration or prison 
staff without inputs and participation from prisoners can be ineffective.
Experience has shown that peer education—education designed and delivered by prison-
ers for prisoners—is particularly effective. Peer educators play a vital role in educating 
other prisoners, since most of the behaviours that put prisoners at risk of HIV in prisons 
involve illegal or forbidden and stigmatized practices. Therefore, peers may be the only 
persons able to speak candidly to other prisoners about ways to reduce the risk of con-
tracting infections. As well, peer educators’ input is not likely to be viewed with the same 
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suspicion as the information provided by the prison hierarchy. Peer educators are more 
likely to be able to realistically discuss the alternatives to risk behaviour that are available 
to prisoners, and are better able to judge which educational strategies will work within 
their prison and the informal power structure among prisoners.
Alongside peer approaches, experience suggests that non-governmental organizations 
and other professionals from outside the prison system can best provide education. Expe-
riences with HIV prevention initiatives show that prisoners can develop more trust with 
staff from civil society organizations and other professionals from outside the prison than 
with staff who are part of the prison hierarchy.
Therefore, prison staff should facilitate the work of peer educators, as well as that of civil 
society organizations or other professionals from outside the prison system. 
Finally, information and education are important, but not sufficient responses to HIV in 
prisons. In particular, they are not of much use to prisoners if they do not have the means 
to act on the information provided.
For more details (and full references) on information and education programmes and the 
other HIV prevention measures discussed in this module, see:
WHO, UNODC, UNAIDS (2007). [Comprehensive review.] Effectiveness of Interventions to Address 
HIV in Prisons. Evidence for Action Technical Papers. Available via www.who.int/hiv/idu/prison/
en/index.html. 
!
Providing condoms and preventing sexual violence, rape and coercion
Many prison systems in different parts of the world, including in Europe, Canada, Australia, 
some prisons in the United States, parts of Eastern Europe and Central Asia, Brazil, South 
Africa, Iran (Islamic Republic of) and Indonesia, make condoms available to prisoners.
In some prison settings, staff have opposed condom distribution, citing security con-
cerns and opposition to male-to-male sex. Some have argued that condom provision 
will lead to an increase in sexual activity among prisoners, or that condoms would be 
used to conceal drugs.
However, these fears have proven unfounded. The experience of the many countries in 
which condoms have been made available in prisons has shown that condoms can be 
provided in a wide range of prison settings—including in countries in which same-sex 
activity is criminalized—without any security problems or any other relevant major nega-
tive consequences. In particular, it has been found that condom access represents no 
threat to security or operations, does not lead to an increase in sexual activity, and is 
accepted by most prisoners and prison staff once it is introduced. Usually support for 
condom provision increases once a condom programme is started.
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Condoms need to be easily and discreetly available and accessible, ideally in areas such 
as toilets, shower areas, waiting rooms, workshops, or day rooms where prisoners can 
pick up condoms without being seen by fellow prisoners or prison staff. Distribution can 
be done by health staff, by dispensing machines, by trained prisoners (peers) or in a com-
bination of these ways. Each prison should determine how best to make condoms avail-
able, to ensure easy and discreet access. Prisoners should not have to ask prison staff for 
condoms, since few prisoners will do so because they do not want to disclose that they 
engage in sex in prison. 
While providing condoms in prisons is important, it is not enough to address the risk of 
sexual transmission of HIV. HIV prevention also depends on measures taken to prevent 
rape, sexual violence and coercion in prison. All prison staff have a role in combating 
aggressive sexual behaviour of prisoners and should bring such behaviour to the atten-
tion of prison authorities whenever they become aware of it. 
Finally, it is important to recognize that sometimes prison staff themselves participate in 
risk behaviours in prison, or make them possible. Some staff have sexual relationships 
with prisoners, which is not only against prison rules, but also represents an abuse of 
their power and authority. In the context of HIV, it carries a risk of HIV transmission. 
Other staff have reportedly procured young prisoners for the sexual gratification of older 
prisoners. All staff have a responsibility to prevent such activity and to inform prison 
authorities and the police if they are aware that it occurs.
For more details and references, see: WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Prevention of Sexual Transmission. Evidence for Action Technical Papers. 
Available at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-
aids/publications.html.
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Drug dependence treatment
One of the ways of reducing transmission of HIV through the sharing of injecting equip-
ment is to reduce the prevalence of injecting drug use. This can be achieved by provid-
ing drug dependence treatment programmes in prison. There are two main forms of 
treatment:
A " bstinence-based treatment in which prisoners are supposed to abstain totally from 
taking drugs; and
O " pioid substitution therapy, which involves prescribing a drug with a similar action 
to the illegal opiates used, but with a lower degree of risk.
Opioid substitution therapy
All forms of drug dependence treatment have some impacts on risks of HIV transmission, 
but opioid substitution therapy (OST) programmes have the greatest potential to reduce 
injecting drug use and the resulting risk of spread of infection. 
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Nevertheless, some prison systems are still reluctant to make ST available. Some prison 
staff consider methadone or buprenorphine as just another mood-altering drug, the pro-
vision of which delays the move beyond a drug-centred existence. Some also object to ST 
on moral grounds, arguing that it merely replaces one drug of dependence with another. 
However, evaluations of prison ST programmes have provided clear evidence of their 
benefits. Studies have shown that, if dosage is adequate (at least 60 mg of methadone) 
and treatment is provided for the duration of imprisonment, such programmes reduce 
drug injecting and needle sharing and resulting spread of HIV and other blood borne 
infections. In addition, they have additional and worthwhile benefits, both for the health 
of prisoners participating in the programmes, and for prison staff and the general 
community. For example:
O " pioid substitution therapy has a positive effect on institutional behaviour by 
reducing drug-seeking behaviour and thus improving prison safety;
R " e-incarceration is significantly less likely among those prisoners who receive OST;
A " lthough prison staff often initially raise concerns about security, violent behaviour, 
and diversion of methadone, these problems do not emerge once the ST programme 
is implemented;
B " oth prisoners and prison staff report about the positive impact OST has on life 
in prison. 
Other forms of drug dependence treatment
Other forms of drug dependence treatment are usually less controversial than OST in 
prisons, but there is little data on their effectiveness as an HIV prevention strategy. This 
is not surprising since they have not usually been introduced in prison with HIV preven-
tion as one of their objectives—in contrast to OST, which has become increasingly avail-
able in many prison systems at least in part because of its potential to reduce injecting 
drug use and the resulting risk of spread of infections. 
Nevertheless, in addition to substitution therapy, providing abstinence-based programmes 
is important. Good quality, appropriate, and accessible treatment can improve prison 
security, as well as the health and social functioning of prisoners, and can reduce re-
offending, as long as it provides ongoing treatment and support, post-release care and 
meets the individual needs of prisoners. 
But even in prison systems with large resources, drug dependence treatment only reaches a 
relatively small portion of those who need it and is not always effective. That is why HIV preven-
tion measures such as needle and syringe programmes need to be made available as well.
For more details and references on OST and other forms of drug dependence treatment, 
see: WHO, UNODC, UNAIDS (2007). Interventions to Address HIV in Prisons: Drug Dependence 
Treatments. Evidence for Action Technical Papers. Available at www.who.int/hiv/idu/prison/en/
index.html or www.unodc.org/unodc/en/hiv-aids/publications.html.
!
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Drug demand and drug supply reduction strategies 
In addition to drug dependence treatment, adopting other strategies to reduce the demand 
for, and the supply of, drugs in prisons can also assist efforts to prevent HIV transmission 
in prisons. However, it is important to note from the outset that such efforts are unlikely 
to eliminate drug use in prisons. In fact, even prison systems that have devoted large 
financial resources to such efforts have not been able to eliminate drug use. Therefore, 
such efforts cannot replace the other measures described above, but rather should be 
undertaken to complement them.
Drug demand reduction strategies
Research shows that one of the reasons why a relatively large number of prisoners in 
many prison systems take drugs when they are in prison is to combat boredom, aliena-
tion, and stress, and to promote relaxation. This suggests that, in addition to drug treat-
ment, one of the most effective ways to reduce the demand for drugs is to improve prison 
conditions and to offer more purposeful activities in prisons. Providing prisoners with 
opportunities to work and/or study while in prison, or activities such as sports, theatre 
and spiritual and cultural enhancement aimed at providing people with challenging and 
healthy ways to employ their time, can have a positive effect on risky behaviours, 
particularly when complemented by appropriate drug use prevention education.
Another strategy to reduce the demand for drugs used by an increasing number of prison 
systems, mainly in resource-rich countries, is to establish so-called “drug-free” units. 
Typically, “drug-free” units or wings are separate living units within a prison that focus 
on limiting the availability of drugs and are populated with prisoners who have voluntar-
ily signed a contract promising to remain drug free. In some instances, they focus solely 
on drug interdiction through increased searching, while some systems provide a multi-
faceted approach combining drug interdiction measures with treatment services. “Drug-
free” units could assist efforts to combat the spread of HIV in prison if they resulted in 
decreased drug use, particularly injecting drug use. There is some evidence from a small 
number of studies that so-called “drug-free” units do indeed significantly reduce levels of 
drug use among prisoners in these units. Such units appeal to a large number of prison-
ers, including prisoners who do not have any drug problems and want to live in a “drug-
free” environment. However, the studies do not say anything about whether “drug-free” 
units appeal to, and are successful in retaining, the most problematic users, in particular 
prisoners who inject drugs. Currently, there is therefore no data on the effectiveness of 
drug-free units as an HIV prevention strategy.
Drug supply reduction strategies
A broad range of search and seizure techniques and procedures can be used in an attempt 
to reduce the availability of drugs in prisons. These supply reduction measures include: 
random searches by security personnel; staff and visitor entry/exit screening and searches; 
drug detection dogs; closed-circuit monitoring; perimeter security measures (netting over 
exercise yards, higher internal fences to prevent projectiles, rapid response vehicles 
patrolling the prison perimeter); purchasing of goods from approved suppliers only; intel-
ligence analysts at every institution; drug detection technologies (such as ion scanners, 
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x-ray machines, etc); modifications to the design and layout of visiting areas (use of fixed 
and low-level furniture); and drug testing (also called urinalysis).
Many prison systems, particularly in high-income countries, have placed considerable 
emphasis on these measures to reduce the supply of drugs. While such measures are not 
aimed at addressing HIV in prisons, they may result in unintended consequences for HIV 
and HCV prevention efforts. Drug interdiction measures may assist HIV prevention efforts 
by reducing the supply of drugs and injecting in prisons. At the same time, they could 
make such efforts more difficult.
For example, many resource-rich prison systems regularly or randomly test prisoners’ 
urine for illegal drug use. Prisoners who are found to have consumed illegal drugs can 
face penalties. From a public health perspective, concerns have been raised that these 
programmes may increase, rather than decrease, prisoners’ risk of HIV infection. There 
is evidence that implementing such programmes may contribute to reducing the demand 
for and use of cannabis in prisons. However, such programmes seem to have little effect 
on the use of opiates. In fact, there is evidence that a small number of people may switch 
to use injectable drugs to avoid detection of cannabis use through drug testing. Cannabis 
is traceable in urine for much longer (up to one month) than drugs administered by inject-
ing, such as heroin and other opiates. Some prisoners choose to inject drugs rather than 
risk the penalties associated with smoking cannabis simply to minimize the risk of detec-
tion and punishment. Given the scarcity of sterile needles and the frequency of needle 
sharing in prison, the switch to injecting drugs may have serious health consequences for 
prisoners. 
Generally, despite the fact that many prison systems make substantial investments in 
drug supply reduction measures, there is little solid and consistent empirical evidence 
available to confirm their efficacy in reducing levels of drug use. In particular, there is no 
evidence that these measures may lead to reduced HIV risk. 
Prison systems facing resource constraints should therefore not implement costly meas-
ures such as drug detection technologies and drug testing that may use up a substantial 
amount of resources that could otherwise be used for addressing HIV in prisons. Instead, 
they should focus on the proven and cost-effective HIV prevention measures described 
above and on efforts to improve prison conditions and working conditions and pay for 
prison staff, without whom other drug supply reduction strategies are unlikely to be 
successful.
Finally, it is important to recognize that sometimes drugs are smuggled into prison by 
prison staff, either because of pressure applied by prisoners or because of corruption. All 
staff have a responsibility to prevent such activity and to inform prison authorities and 
the police if they are aware that it occurs.
Providing needle and syringe programmes and bleach or other disinfectants
Many prison systems have adopted programmes that provide disinfectants, as well as 
instruction on how to disinfect injecting equipment before re-using it, to prisoners who 
109
Module 4
Issues for prison staff
inject drugs. Evaluations of such programmes have shown that distribution of bleach 
does not compromise security. However, studies in the general community have raised 
doubts about the effectiveness of bleach in decontamination of injecting equipment. In 
particular, bleach disinfection has limited benefit in preventing hepatitis C virus trans-
mission among injecting drug users.
Therefore, a growing number of prisons is making needles and syringes available to 
prisoners who inject drugs. Prison needle and syringe programmes have been imple-
mented in both men’s and women’s prisons, in institutions of varying sizes, in both 
civilian and military systems, in institutions that house prisoners in individual cells and 
those that house prisoners in barracks, in institutions with different security ratings, 
and in different forms of custody (remand and sentenced, open and closed). 
Several models of distribution of sterile injecting equipment have been used, including 
automatic dispensing machines, hand-to-hand distribution by prison physicians, other 
prison health-care staff or drug counsellors, or by external community health workers, 
and distribution by prisoners trained as peer outreach workers.
Making needles and syringes available to prisoners is probably the most controversial 
HIV prevention measure in prison. Often prison staff have opposed it, saying that needles 
could be used as weapons against staff and/or fellow prisoners and that making them 
available would be tantamount to condoning prisoners’ drug use and giving up on efforts 
to prevent drugs from coming into the prisons.
However, the experience of the many prisons in which programmes have been imple-
mented has been positive not only for prisoners, but also for prison staff:
P " rison-based needle and syringe programmes are effective in reducing needle 
sharing and resulting HIV infection. 
N " eedle and syringe programmes do not undermine abstinence-based programmes. 
Drugs have remained prohibited within prisons where such programmes are in 
place. Security staff remain responsible for locating and confiscating illegal drugs. 
However, it is recognized that if and when drugs find their way into the prison 
and are used by prisoners, the priority must be to prevent the transmission of HIV 
and HCV via unsafe injecting practices. Therefore, while drugs themselves remain 
illegal, needles that are part of the official needle and syringe programme are not. 
Evaluations have found that needle and syringe programmes in prisons actually 
facilitate referral of drug users to drug dependence treatment programmes, and 
have led to an increase in the number of prisoners accessing such programmes.
S " ince the first programme started in 1992, there have been no reports of syringes 
ever having been used as weapons in any prison with an operating programme. 
In fact, there are reports of an increase in staff safety in prisons with needle 
and syringe programmes, due to the fact that accidental injuries to staff from 
hidden syringes during cell searches have been reduced. The decrease in the 
possibility of injury is due to the fact that prisoners are permitted to store inject-
ing equipment in a particular area and therefore do not hide it, thus reducing 
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the risk of needle-stick injury during searches. Staff have also reported that the 
introduction of needle and syringe programmes makes injecting equipment more 
easy to control. 
A " vailability of syringes does not result in an increased number of drug injectors, 
an increase in overall drug use, or an increase in the amount of drugs in the 
institutions. In a few prisons, evaluations actually found that reported levels of 
drug use or injecting decreased.
B " efore their implementation, prison staff regularly had to be convinced to accept 
or at least tolerate the needle and syringe programmes. Nevertheless, once in place, 
acceptance increased and was generally high among staff, as well as among pris-
oners who use drugs and non-drug using prisoners. Staff attitudes towards the 
programmes were least positive in those prisons in which prisoners experienced 
problems accessing syringes and/or did not trust that they could obtain them 
without suffering negative consequences, leading to continued illegal trade with 
syringes in the prison and generally, to reduced benefits of the programme.
S " upport by prisoners and prison staff is important, and both prisoners and staff 
should receive information and education about the programmes and their expected 
benefits, and be involved in their design and implementation.
Box 35. Staff support needle and syringe programmes
At the end of 2000, needle and syringe programmes had been successfully introduced in seven prisons 
in Germany, and other prisons were looking at how to implement them. However, since then six of the 
programmes were closed down, not because of any problems with the programmes, but as a result 
of political decisions by newly elected state governments. In each of these cases, the decision to cancel 
the programmes was made without consultation with prison staff, and without an opportunity to 
prepare prisoners for the impending loss of access to the programmes. It has been reported that since 
the programmes closed, prisoners have gone back to sharing needles and to hiding them, increasing 
the likelihood of transmission of HIV and HCV, as well as the risk of accidental needle stick injuries for 
staff. Staff have been among the most vocal critics of the governments’ decision to close down the 
programmes, and have lobbied the governments to reinstate the programmes.
For more details and references, see WHO, UNODC, UNAIDS (2007). Interventions to 
Address HIV in Prisons: Needle and Syringe Programmes and Decontamination Strategies. Evi-
dence for Action Technical Papers. Available at www.who.int/hiv/idu/prison/en/index.html 
or www.unodc.org/unodc/en/hiv-aids/publications.html.
!
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Frequently asked questions
Should prisoners be mandatory tested for HIV and segregated from the rest of the prison 
population? 
Should prisoners with HIV or AIDS be allowed to do the same activities as everyone else? 
Should staff be told who has HIV? 
Does making condoms and needles and syringes available to prisoners have a negative 
impact on security in prisons? 
Are we not condoning drug use in prison by making needles and syringes available to 
prisoners? 
Instead of making prevention tools such as condoms and needles and syringes available 
to prisoners, should we not rather adopt a zero tolerance approach and eliminate drugs 
and sexual activity from prisons?
For detailed answers to these questions, see the section on “frequently asked questions” 
in module 3.
Checklist 15. Prison staff are key!
Have you been trained to enable you to do your duties in a healthy and safe manner? "
Have you been trained in the provision of first aid? "
Do you have access to protective equipment, such as latex gloves, masks for mouth-to-mouth  "
resuscitation, etc?
Do you follow safe work procedures and, in particular, safe searching procedures? "
Are you familiar with the protocol for managing exposure to blood and/or body fluids? "
Have you been vaccinated against hepatitis B? "
Do you facilitate the work of peer educators and external civil society organizations and professionals? "
Do you actively support making condoms available to prisoners, or at least tolerate it and do not  "
interfere with distribution?
Do you support measures against sexual abuse in your prison, by taking active measures to  "
protect vulnerable prisoners and denouncing abuse whenever it comes to your attention?
Do you actively support making bleach and needles and syringes available to prisoners, or at least  "
tolerate it and do not interfere with distribution?
Finally, do you protect yourself against HIV and other infections outside your work hours? "
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This module is intended primarily for health care staff who work in prisons. We hope it 
will be useful to medical doctors, nursing staff, and paramedical and ancillary workers.
The module provides health workers in prisons with information on:
I " nternational norms and standards guiding prison healthcare;
W " hy prisoners are particularly vulnerable to HIV;
W " hat they can do to reduce the risk of HIV transmission in prison and to provide 
equitable access to treatment and care to prisoners living with HIV or AIDS;
P " ractical questions about working in prison;
C " onstraints on providing effective health care in a prison setting.
It will not provide detailed medical information about diagnosis and treatment proto-
cols of HIV or AIDS or the most effective ways of running health care initiatives such as 
opioid substitution therapy or needle and syringe programmes. However, in the rele-
vant sections it will refer to source materials that provide such additional information. 
In addition to treating individual patients, health care workers in prisons have a number 
of other important roles in dealing with HIV and AIDS.
These roles include:
I " nforming, educating or updating your own medical knowledge on scientific evi-
dence and best practice on HIV, AIDS and harm reduction measures;
C " ontributing to prison policy and prison regulations that respect human rights, and 
in particular the right to health; and 
P " roviding information and education to prisoners and prison staff with the aim of 
raising awareness, addressing discrimination and stigmatization, and changing 
behaviour.
The special leadership role of health staff
Physicians and nurses and other professionals working in prisons have a unique leadership role in producing 
the healthy prison. They should start from a sound basis of professional training in which issues such as 
confidentiality, patient rights and human rights have been fully covered and discussed. They should also have 
some knowledge of epidemiology, of how diseases spread and of how lifestyles and socioeconomic background 
factors can influence ill health. They should also be aware of human nutrition and of the importance of exercise 
and fresh air in promoting health. They should be alert to potential threats to health and able to detect early 
signs of mental health problems.
Promoting health in prisons — the essentials. A WHO guide. WHO Europe, 2006
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The roles must also include the development and promotion of specific measures to 
reduce the risk factors for the spread of HIV and other blood borne diseases in prison, 
including:
C " ontributing to voluntary counselling and testing (VCT) programmes;
M " aking condoms (and lubricants) available;
I " nitiating or continuing drug dependence treatment;
S " upervising bleach distribution as well as needle and syringe programmes;
A " ssessing patients’ eligibility for early release on medical grounds.
The precise role health care staff can play depends on the framework of laws, policies and 
practices in any given country. As health care providers, you may be able to influence that 
framework and ensure that, as far as possible, the approach to HIV prevention and treat-
ment that is used in the wider community is also implemented in prisons. One starting 
point for providing equivalent and equitable health services in prisons is to create close 
links between the prison health service and the health services in the community.
International norms and standards guiding prison health care
Prison health is part of public health 
The vast majority of people committed to prison eventually return to the wider society. 
Therefore any diseases contracted in prison, or any medical conditions made worse by 
poor conditions of confinement, become issues of concern for the wider community when 
people are released. This relationship between prison health and overall public health is 
fundamental. Reducing the transmission of HIV in prisons is an important element in 
reducing the spread of infection in the broader society, and should not be left to prison 
authorities alone to address. Improving the health status of prisoners, and reducing the 
incidence of disease in prisons, benefits not only the prisoners, but also benefits prison 
staff and is an integral part of enhancing workplace health and safety. 
Therefore, HIV and AIDS, but also hepatitis and tuberculosis and all other aspects of 
physical and mental health in prisons, must be the concern of health professionals on 
both sides of the prison walls. As stated in the so-called Moscow Declaration, “prison 
health is part of public health.”
The Moscow Declaration expresses the need for all health-care professionals, as well as 
prison administrations, policymakers and governments, to strive for closer integration 
between public health services and prison health services. The ethical obligations of 
health staff working in prisons dictate that, although they are working in an environment 
where control and security are usually the first priority, their first priority is the health of 
their patients. In countries with a well functioning public health service there is a strong 
case for moving responsibility for prison health to the Ministry of Health. However, this is 
not a straightforward hand-over of responsibility and requires detailed and careful assess-
ment of the feasibility on a case by case basis. 
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Closer integration between community health services and prison health services will: 
H " elp to protect the independence of the clinical judgement of the prison health staff;
I " mprove the continuity of treatment and care between prison and the community, 
in particular for the provision of anti-retroviral treatment, and for other treatment 
programmes such as tuberculosis;
P " rovide support and training from other health professionals to their colleagues 
working in prisons;
P " rovide strong support for public health measures such as provision of condoms, 
bleach, and needles and syringes, even when these may be perceived to cause 
problems in the prison environment;
I " ncrease the trust between prisoners and prison health staff, and thus facilitate 
the introduction of health prevention and promotion activities.
The full text of the Moscow Declaration is available via the website of the WHO Europe 
“Health in Prisons” project: www.euro.who.int/prisons!
The principle of equivalence
As explained above, prisoners should not be seen as separated from the general commu-
nity, but as part of that community. The punishment of imprisonment is the deprivation 
of liberty and the punishment does not extend to the deprivation of other fundamental 
human rights, such as the right to life, the right to be free from torture and other ill-
treatment, and the right to freedom from discrimination. In particular, prisoners do not 
lose the right to health.
Health in prison is a right guaranteed in international law, as well as in international 
rules, guidelines, declarations, and covenants. The right to health includes the right to 
medical treatment and to preventive measures and to standards of health care equivalent 
to those available in the community. This means not only that prisoners should have 
access to an equivalent level of health care should they become ill while in prison, but also 
that those treatments or programmes that were started before entering prison should be 
available and should continue while in prison and after release. This last point is particu-
larly relevant in relation to drug dependence treatment programmes and HIV prevention 
and treatment, as will be explained in the following sections. 
The World Health Organization Guidelines on HIV infection and AIDS in prisons also state 
that all prisoners have the right to receive health care, including preventive measures, 
equivalent to that available in the community without discrimination, in particular with 
respect to their legal status or nationality. In addition, they contain the following other 
recommendations related to care and support of HIV-positive prisoners:
34. At each stage of HIV-related illness, prisoners should receive appropriate medi-
cal and psychosocial treatment equivalent to that given to other members of the 
117
Module 5
Issues for health care staff in prisons
community. Involvement of all prisoners in peer support programmes should be 
encouraged. Collaboration with health care providers in the community should be 
promoted to facilitate the provision of medical care.
35. Medical follow-up and counselling for asymptomatic HIV-infected prisoners 
should be available and accessible during detention.  
36. Prisoners should have access to information on treatment options and the same 
right to refuse treatment as exists in the community. 
37. Treatment for HIV infection, and the prophylaxis and treatment of related ill-
nesses, should be provided by prison medical services, applying the same clinical 
and accessibility criteria as in the community.  
38. Prisoners should have the same access as people living in the community to 
clinical trials of treatments for all HIV/AIDS-related diseases. Prisoners should not be 
placed under pressure to participate in clinical trials, taking into account the princi-
ple that individuals deprived of their liberty may not be the subjects of medical 
research unless they freely consent to it and it is expected to produce direct and 
significant benefit to their health.  
39. The decision to hospitalize a prisoner with AIDS or other HIV-related diseases 
must be made on medical grounds by health personnel. Access to adequately equipped 
specialist services, on the same level available in the community, must be assured.  
40. Prison medical services should collaborate with community health services to 
ensure medical and psychological follow-up of HIV-infected prisoners after their 
release if they so consent. Prisoners should be encouraged to use these services.  
A human rights approach to prison health
A human rights approach to prison health respects, protects, and promotes the prisoners’ 
right to health, seeks closer integration of prison health and community health services, 
and upholds the principle of equivalence of health care. It is the responsibility of health 
care staff, as well as other prison staff, to protect and promote the health of prisoners. 
This goes beyond the practice of simply diagnosing and treating disease as it appears in 
individual prisoners and includes issues of hygiene, nutrition, access to meaningful activ-
ities, recreation and sport, absence of violence, contact with family etc. Health staff who 
take an active role in the prevention, as well as the care, of mental and physical health 
problems, provide the foundation of a healthy environment, which should reduce the 
harm that imprisonment can cause to an individual. 
Prison health staff should be aware of the various provisions of human rights instruments 
that are relevant to establishing and maintaining a healthy environment.
All persons deprived of their liberty have the right to be treated with respect and dignity 
and not to be subjected to cruel, inhumane or degrading treatment or torture. Prisoners 
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must not be discriminated against, but must be separated according to their sex, age and 
whether or not they have been convicted. Accommodation in which prisoners live must 
be conducive to maintaining good health, provide access to bathing and sanitary facili-
ties, and have adequate lighting, ventilation, heating and floor space. Prisoners must 
have a diet sufficient for health and be provided with clean drinking water.
In order to best protect and promote the health of prisoners, prison health personnel 
should be independent of the prison administration and law enforcement agencies and 
must not participate in administering the prison regime and in the decision about, or 
infliction of, any punishment. 
Why are prisoners particularly vulnerable to HIV?
There are several reasons why prisoners are particularly vulnerable to HIV (and hepatitis):
T " hose most at risk of contracting HIV are over-represented in prison;
H " igh risk activities are prevalent in prison;
P " rison conditions contribute to the spread of HIV;
M " edical practice may involve the use or re-use of non sterile medical or dental 
equipment and therefore not be safe.
For all these reasons, serious outbreaks of HIV and HCV infection have been documented 
in prisons in a number of countries.
Those most at risk of contracting HIV are over-represented in prison
In general, those groups of people who are more at risk of contracting HIV (as well as 
hepatitis, sexually transmitted diseases, and tuberculosis) while in the community are 
over-represented in prison. This includes socially and educational disadvantaged groups, 
problem drug and alcohol users, sex workers, and others who generally have poor access 
to health care and health prevention measures. As a result, the prevalence of HIV in 
prisons is often much higher than in the community.
High risk activities are prevalent in prisons
Inside prison, people may continue (or start) their involvement in behaviours such as drug 
use and sex, with reduced access to HIV prevention measures (such as condoms and sterile 
injection equipment) and health education that are available to the general population. 
Unsafe sexual behaviours are widespread, with prisoners having sex (forced or consen-
sual) with each other and, at times, with prison staff. The high prevalence of sexually 
transmitted infections (STIs) increases the vulnerability to HIV infection. 
Drug use is also widespread in prisons in most countries, including injecting drug use and 
the sharing of contaminated injecting equipment. Even in countries with strict “zero 
tolerance policies” and where authorities devote huge financial resources to efforts to 
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reduce the supply of drugs in prisons and claim that drug use in prison does not exist, 
anonymous surveys show that drug use still happens. Indeed, some of the measures intro-
duced to deter drug use have increased rather than reduced the risk of HIV infection.
The culture of drug use may be associated with gang hierarchies, and closely linked to 
physical and sexual violence.
Additional risk factors include the sharing or reuse of tattooing and body piercing equip-
ment, the sharing of razors for shaving, blood sharing/“brotherhood” rituals and the 
improper sterilization or reuse of medical or dental instruments.
Other factors contribute to making prisons high-risk environments
Factors related to the prison infrastructure and prison management contribute to HIV 
vulnerability indirectly. They include overcrowding, violence, gang activities, lack of pro-
tection for weak or young prisoners, and corruption. For example, prisoners may turn to 
drug use because they are constantly bullied, or prisoners may be raped or engage in 
sexual activities under threat as a form of “payment” to gain “protection”. Prison 
gangs may also use rape, as well as blood sharing rituals, to initiate new members. In 
overcrowded prisons violence tends to be even more common. Prison health staff can 
help reduce violence by impartially documenting and reporting (with the consent of 
the individual victim) cases of violence, be it psychological, physical or sexual. 
Poor medical practices
Finally, HIV, as well as hepatitis, can be easily spread in prison through the use of con-
taminated medical or dental material, such as re-using material that is disposable, or 
through inadequate sterilization procedures. The use of blood and blood products that 
have not been properly screened can also be a source of HIV, hepatitis and other blood 
borne viruses. Health-care staff must ensure the implementation of sound practice for the 
use of medical material, and monitor this on a regular basis. If necessary, health-care 
staff must advocate for increased funding to ensure that infections cannot occur through 
provision of medical services.
What can health-care staff do to reduce the risk  
of HIV transmission in prison?
The prevention of HIV transmission in prisons is often hampered by the denial of national 
governments of the existence of injecting drug use and unsafe sexual practices in prisons. 
Therefore, official acknowledgement of the reality of high-risk behaviours and HIV trans-
mission in prisons is an essential first step in raising public awareness and in implementing 
effective responses.
As health staff, you have a pivotal role in persuading the decision makers of the absolute 
necessity of introducing HIV prevention, treatment, care and support programmes into 
the prisons. The need stems from the fact that prisoners are an integral part of the com-
munity, and that prison health is a part of public health. There is strong evidence about 
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what can be done in prisons to reduce the rate of HIV transmission, and how this can 
translate into reduced transmission within the broader community. Due to the necessity 
not to interrupt on-going treatments for HIV (as well as TB) any treatment that is started 
in the community must be made available inside the prison, and continued upon release 
back to the community.
Health-care staff should be proactive and work with the prison administration, but also 
with the ministry responsible for prisons, the ministry of health, and other government 
ministries and bodies, in particular the National AIDS Commission or Programme, and 
civil society organizations (including support groups for people living with HIV or AIDS, 
and groups working on drug use, HIV and infectious diseases in the community), to reduce 
HIV transmission in prisons. High-risk behaviour will be best addressed using a compre-
hensive approach that is also incorporated into a broader strategy for health promotion 
in prisons. For example, since tuberculosis is one of the leading causes of morbidity and 
mortality in people living with HIV or AIDS, and HIV itself fuels tuberculosis, collaborative 
TB-HIV activities should be a priority for tackling both diseases.
Inform and educate yourself on best practices
As health staff, people will turn to you for advice and example on sensitive subjects such 
as HIV, sex in prisons, drug use etc. Health staff, as other prison staff, often harbour fears 
and prejudices about HIV, drug use and sex in prison which can prevent the introduction 
of measures to reduce the risk of transmission of disease, and of measures to improve the 
general conditions within prisons. Since health-care staff are responsible for health in 
prisons, you have a duty to inform and educate yourself on the latest medical practice for 
the prevention and treatment of HIV. In particular you should familiarize yourself with 
the evidence and best practice for the use of HIV prevention measures in prisons. It is 
only through educating yourself that these barriers can be broken down.
There are many ways to keep your knowledge of specific health subjects up to date. By 
ensuring your own continuing education is up to date, you will be in a position to share 
this knowledge with other prison staff, design and implement information and education 
sessions for staff and prisoners, and thus help to raise awareness among all those work-
ing and held in prisons and help to break down the misperceptions and prejudices that 
surround HIV.
As well as reading scientific journals, you can obtain a wealth of information from the 
Internet (assuming you have good access). You should also learn about the policies, prac-
tices and strategies of the national AIDS Commission of your country so that you can 
introduce or update the same policies and practices in your prison. These national poli-
cies should follow international guidelines and standards. Where possible you should 
attend local, national, and regional seminars on the topic where you can share your expe-
riences with other health professionals. Through establishing professional networks you 
may also be able to arrange study tours for health staff and prison administration of 
neighbouring countries prison services in which examples of best practice can be observed 
in action.
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Contributing to prison policy and prison regulations that respect human rights, and 
in particular the right to health
You have a central role in encouraging the introduction of the same levels of services for 
HIV prevention, treatment, care, and support within the prison, as exist outside in the 
community. Any strategy for addressing HIV must be incorporated into a broader strat-
egy for health prevention and promotion in prisons, since health in prisons incorporates 
issues of conditions of detention, nutrition, hygiene, exercise, meaningful activity etc. 
as well as programmes addressing specific diseases such as hepatitis, sexually trans-
mitted infections, and tuberculosis. For example, you should consider how to initiate, 
implement, and monitor collaborative HIV-TB activities aimed at the joint prevention, 
treatment, care and support of both diseases. 
Affecting the health strategy in your prison will necessitate representation of prison 
physicians at the policy level of the national prisons organization, as well as close coop-
eration with the ministry of health, to ensure the inclusion of health issues in policies 
and regulations, and in elaborating standard operating procedures for implementation 
at the prison level. You should seek out a body that represents prison health staff, and 
enquire how they are addressing this issue at all levels of the prison system—central, 
regional and local—from policy to practice. If there is no body specifically representing 
prison physicians you can contact your National Medical Association or the World 
Medical Association, which represents many of the national medical associations 
globally (www.wma.net). 
These measures are based on a human rights approach to prisons and prison health care 
that should be reflected in the relevant parts of prison policy, regulations and standard 
operating procedures. One such example is that prison policy should not permit the seg-
regation of HIV positive prisoners. There is no public health rationale for isolating HIV 
positive prisoners, and it would be unethical to promote or support segregation of people 
simply because they are HIV-positive. In some cases you may be able to promote innova-
tive measures that have yet to be introduced into the community, and in this way be at the 
forefront of measures to reduce the spread of HIV.
If you have access to the internet, consult the internet course for prison doctors at 
www.lupin-nma.net/
For more information on Health in Prison in general and on HIV prevention, care treatment 
and support see:
WHO (2007) Health in prisons. A WHO guide to the essentials in prison health. www.euro.who.
int/InformationSources/Publications/Catalogue/20070521_1
WHO, UNODC, UNAIDS (2007). [Comprehensive review.] Effectiveness of Interventions to Address 
HIV in Prisons. Evidence for Action Technical Papers. Available via www.who.int/hiv/idu/prison/
en/index.html.
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Providing information and education to prisoners and prison staff 
Having informed yourself about prevention of HIV you are in a strong position to dis-
seminate information and provide education to all members of the prison community. 
This includes other health staff, prison officers/guards, prison administrators and the 
prisoners themselves. The aim is to raise awareness, prevent stigmatization and dis-
crimination, and to change behaviour connected to drug use, drug-related infectious dis-
eases and drug injecting, sexually transmitted infections, tattooing and piercing and the 
various forms of violence, especially sexual violence, found in prisons.
The process of informing prisoners should begin at the point of reception into the prison. 
As part of the general health screening on entry, prisoners should be asked about existing 
high-risk behaviour and thus possible exposure to HIV, and be provided with clear and 
simple initial information about the risks associated with HIV infection in prison.
In addition to information provided to prisoners on entry, various mediums can be used 
to continue to spread information, and also to educate prisoners and staff on specific 
issues in more detail. This may be through the production of short leaflets, posters, the 
showing of videos, or the broadcast of radio messages (in those institutions with prison 
radio stations), and even through theatre plays. One of the most effective ways of provid-
ing information to prisoners may be through peer educators—fellow prisoners who have 
themselves received training, and who may be viewed with less suspicion than the prison 
staff themselves. 
You will usually not have to write and produce the education materials yourself. In most 
countries, the National AIDS Commission or Institution and civil society organizations 
will have produced information and educational material in different formats. Some of 
the material may need to be adapted to the prison setting. You should also ask these 
same external organizations to enter the prisons and directly provide the information 
and training, and supervise any peer educators. 
Better understanding the problem
The more familiar you are with the life and conditions inside your prison, the greater will 
be your understanding of the nature and level of risk that exists. You can address the 
issue during your confidential medical consultations, for example if a prisoner presents 
with an issue that may relate to drug use, or has been the victim of sexual violence. But 
you cannot only rely on prisoners coming to the health centre. Conducting regular tours 
of the prison to directly observe and interact with the daily life of the prisoners will not 
only increase the trust of the prisoners, but will increase your own understanding of the 
nature of prison life and how this can increase or encourage high risk behaviour. For 
example, directly observing the nature of overcrowding will allow a better comprehen-
sion of the effects.
One additional activity that can be undertaken to better understand the existing percep-
tions and practices relating to high risk behaviour is conducting anonymous studies of 
the knowledge, attitudes and behaviour of both prison staff and prisoners. Such studies 
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usually address the extent and nature of drug use (types of drugs used and how they are 
taken), sex within the prison (consensual and/or forced), tattooing and other piercing or 
blood sharing practices, understanding or misunderstanding of the modes of transmis-
sion of HIV and hepatitis, and the attitudes towards people living with HIV or AIDS. In 
some prisons, these types of studies have been carried out in conjunction with voluntary, 
anonymous testing for HIV, hepatitis B and hepatitis C. 
Such studies are usually undertaken by independent organizations with expertise in this 
area from outside the prison, ensuring that the studies are truly independent from the 
prison administration and thus more confidential. Obviously, explaining to the prisoners 
and staff the nature of such a study, and in particular the complete anonymity of the 
results, is an essential part to its success.
Voluntary HIV counselling and testing
As health-care providers, you will be approached by prisoners who would like to know 
their HIV status. The World Health Organization has clearly stipulated that mandatory 
testing of prisoners for HIV should not be conducted as it is unethical and ineffective. 
The prison health service should offer voluntary HIV counselling and testing to all prison-
ers at the time of their medical examination upon entry. In addition, because entry is a 
stressful time and many prisoners may not want to have an HIV test at that time, HIV 
testing should be available to prisoners at any time during imprisonment. During HIV 
education sessions and during prisoner visits to health care services, you should regularly 
remind prisoners that HIV counselling and testing is available to them, and encourage 
them to be tested. Special efforts should be made to offer HIV counselling and testing to 
TB patients.
Many of the benefits of HIV testing are dependent on, or enhanced by, pre and post-test 
counselling. Prisoners who receive positive results should receive counselling and refer-
ral to treatment, care and support. Post-test counselling can also deliver important health 
and risk-reduction information to the majority of prisoners who will access testing and 
have a negative test result. Information that a prisoner is HIV positive can lead to various 
forms of discrimination and to physical and psychological violence. Therefore, as with 
any personal medical information, the results of HIV tests must remain confidential.
Box 36. What is counselling?
Counselling are interactive and collaborative confidential sessions between a person and a care provider. 
The objective of these sessions is to allow staff or prisoners to cope with the stress and take personal 
decisions about HIV. The counselling process will address issues such as the personal risk of HIV transmis-
sion, facilitation of preventive behaviours and the evaluation of coping mechanism should one be con-
fronted with a positive result. Counselling takes place before and after the HIV test and is done regardless 
of the result. Continued counselling and support should also be available to staff and prisoners.
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HIV testing and counselling should be closely linked to access to treatment, care and 
support for those testing positive, and you should make sure that such support is 
available to prisoners and schedule appointments for provision of such support. 
Providing condoms and preventing rape, sexual violence and coercion
Many prison systems in different parts of the world, including in Europe, Canada, Aus-
tralia, some prisons in the United States, parts of Eastern Europe and Central Asia, Brazil, 
South Africa, Iran (Islamic Republic of) and Indonesia, make condoms available to prison-
ers (together with lubricants which reduce the risk of the condom splitting, especially in 
anal intercourse).
The provision of condoms in prisons confronts many of the taboos surrounding men hav-
ing sex with men, and directly challenges the common view of the control associated with 
prison life. In some prison settings, prison staff have opposed condom distribution, citing 
security concerns and opposition to male-to-male sex. Some have argued that condom 
provision will lead to an increase in sexual activity among prisoners, or that condoms 
would be used to conceal drugs. 
However, these fears have proven unfounded. The experience from many countries in 
which condoms have been made available in prisons has shown that condoms can be 
provided in a wide range of prison settings—including in countries in which same-sex 
activity is criminalized—without any security problems or any other relevant major nega-
tive consequences. In particular, it has been found that condom access represents no 
threat to security or operations, does not lead to an increase in sexual activity, and is 
accepted by most prisoners and prison staff once it is introduced. Usually support for 
condom provision increases once a condom programme is started.
Health-care staff will usually be responsible for managing the condom programme and as 
such need to make sure that condoms (and lubricant) are always available. Condoms 
need to be easily and discreetly accessible, ideally in areas such as toilets, shower areas, 
waiting rooms, workshops, or day rooms where prisoners can pick up a condom without 
being seen by fellow prisoners or prison staff. Distribution can be done by health services 
(either directly from health staff, or freely available in the health clinic), by dispensing 
machines, by trained prisoners (peers), by civil society organizations that have access to 
the prison, or in a combination of these ways. Each prison should determine how to best 
make condoms available, to ensure easy and discreet access. Prisoners should not have 
to ask prison staff for condoms, since few prisoners will do so because they do not want 
to disclose that they engage in same-sex sexual activity.
While providing condoms in prisons is important, it is not enough to address the risk of 
sexual transmission of HIV. HIV prevention also depends on measures taken to prevent 
rape, sexual violence and coercion in prison. All prison staff have a role in combating 
aggressive sexual behaviour. You should bring such behaviour to the attention of prison 
authorities whenever it comes to your attention. 
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Drug dependence treatment
One of the ways of reducing transmission of HIV through the sharing of injecting equipment 
is to reduce the prevalence of injecting drug use. This can be achieved by providing drug 
dependence treatment programmes in prison. There are two main forms of treatment:
A " bstinence-based treatment in which prisoners are supposed to abstain totally from 
taking drugs; and
O " pioid substitution therapy, which involves prescribing a drug with a similar action 
to the illegal opiates used, but with a lower degree of risk (since the dose is strictly 
controlled and the drug is not administered intravenously).
Opioid substitution therapy
All forms of drug dependence treatment have some impacts on risks of HIV transmission, 
but opioid substitution therapy (OST) programmes have the greatest potential to reduce 
injecting drug use and the resulting risk of spread of infection. 
Nevertheless, some prison systems are still reluctant to make OST available. Some prison 
staff consider methadone (a synthetic opiate that is taken orally) or buprenorphine (a 
more recently developed OST that is taken sub-lingually) as just another mood-altering 
drug, the provision of which delays the necessary personal growth required to move 
beyond a drug-centred existence. Some also object to OST on moral grounds, arguing that 
it merely replaces one drug of dependence with another. However, evaluations of prison 
OST programmes have provided clear evidence of their benefits. Studies have shown 
that, if dosage is adequate (at least 60 mg of methadone) and treatment is provided for 
the duration of imprisonment, such programmes reduce drug injecting and needle shar-
ing and the resulting spread of HIV and other blood borne infections. In addition, they 
have additional and worthwhile benefits, both for the health of prisoners participating 
in the programmes, and for prison staff and the community. For example:
S " ubstitution therapy has a positive effect on institutional behaviour by reducing 
drug-seeking bahaviour and thus improving prison safety;
R " e-incarceration is significantly less likely among those prisoners who receive 
OST;
A " lthough prison staff often initially raise concerns about security, violent behav-
iour, and diversion of methadone, these problems do not emerge once the OST 
programme is implemented;
B " oth prisoners and prison staff report about the positive impact OST has on life 
in prison;
H " ealth care staff report that regular provision of OST provides a further opportunity 
for them to address other health problems of the prisoners and to pass additional 
health information to them.
As a health-care intervention, opioid substitution therapy is usually administered by 
health-care staff at health-care services. Procedures ranging from eligibility for such 
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treatment to storage and administration of the treatment to disciplinary sanctions in case 
of infringements of the rules have to be established.
Corrections Victoria (2003). Victorian Prison Opioid Substitution Therapy Programme: clinical and 
operational policy and procedures. Available via www.legalonline.vic.gov.au/CA2569020010C266/
All/5DED7F4C63FC14F8CA256E530082DE2C?OpenDocument&1=Legal+System~&2=Prisons~
&3=Opioid+Substitution+Therapy+Programme~. An excellent document with policy and proce-
dures providing a framework for managing substitution treatments.
Correctional Service Canada (2003). Specific guidelines for methadone maintenance treat-
ment. Ottawa: CSC. Available at www.csc-scc.gc.ca/text/pblct/methadone/index_e.shtml. 
These guidelines provide a general background on prisoners and drug use, a section detail-
ing the goals and objectives of methadone maintenance treatment (MMT), admission cri-
teria and quality assurance for MMT, and the role of the methadone intervention team 
(MIT); a section about the specific responsibilities of each MIT member; a section on dosing 
issues; a section on urine drug screening; a section on drug dependence treatment interven-
tions accompanying MMT; and a number of appendices.
A Kastelic. Substitution treatment in prisons. In: Promoting health in prisons—The essentials. 
A WHO guide. World Health Organization, Regional Office for Europe, 2006.
WHO, UNODC, UNAIDS (2007). Interventions to Address HIV in Prisons: Drug Dependence 
Treatments. Evidence for Action Technical Papers. Available via www.who.int/hiv/idu/
oms_ea_drug_treatment_df.pdf.
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Other forms of drug dependence treatment
Other forms of drug dependence treatment are usually less controversial than opioid 
substitution therapy in prisons, but there is little data on their effectiveness as an HIV 
prevention strategy. This is not surprising since they have not usually been introduced 
in prison with HIV prevention as one of their objectives—in contrast to OST, which 
has become increasingly available in many prison systems at least in part because of 
its potential to reduce injecting drug use and the resulting risk of spread of infection. 
Nevertheless, in addition to substitution treatment, providing abstinence-based pro-
grammes is important. Good quality, appropriate, and accessible treatment can improve 
prison security, as well as the health and social functioning of prisoners, and can reduce 
reoffending, as long as it provides ongoing treatment and support, post-release care and 
meets the individual needs of prisoners. 
But even in prison systems with large resources, drug dependence treatment only 
reaches a relatively small portion of those who need it and is not always effective. That 
is why HIV prevention measures including needle and syringe programmes need to be 
made available as well.
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Providing bleach or other disinfectants and needle and syringe programmes
Many prison systems have adopted programmes that provide disinfectants, as well as 
instruction on how to disinfect injecting equipment before re-using it, to prisoners who 
inject drugs. Evaluations of such programmes have shown that distribution of bleach 
does not compromise security. However, studies in the community have raised doubts 
about the effectiveness of bleach in decontamination of injecting equipment. In particular, 
bleach disinfection has limited benefit in preventing hepatitis C virus transmission among 
injecting drug users. In prisons, the effectiveness of bleach as a decontaminant may be 
reduced even further. Therefore, bleach programmes should be available in prisons, but 
only as a second-line strategy to needle and syringe programmes. Where bleach pro-
grammes are implemented, full-strength household bleach should be made easily and 
discreetly accessible to prisoners in various locations in the prison, together with infor-
mation and education about how to clean injecting equipment and information about the 
limited efficacy of bleach as a disinfectant for inactivating HIV and particularly HCV.
Because of the limited effectiveness of bleach, a growing number of prisons is making 
needles and syringes available to prisoners who inject drugs. Needle and syringe pro-
grammes for people who use drugs in the community have been available in many parts 
of the world for years as part of the backbone of HIV prevention, and have been shown 
to reduce the spread of HIV. The principle of equivalence of health care in prisons dictates 
that the same level of protection available in the community should be available to those 
in prison. A person who injects drugs should not lose access to this potentially life-saving 
prevention measure upon entering prison.
Prison needle and syringe programmes have been implemented in both men’s and 
women’s prisons, in institutions of varying sizes, in both civilian and military systems, 
in institutions that house prisoners in individual cells and those that house prisoners 
in barracks, in institutions with different security ratings, and in different forms of 
custody (remand and sentenced, open and closed). 
Several models of distribution of sterile injecting equipment have been used, including 
automatic dispensing machines, hand-to-hand distribution by prison physicians, other 
prison health-care staff or drug counsellors, or by external community health workers, 
and distribution by prisoners trained as peer outreach workers.
Making needles and syringes available to prisoners is probably the most controversial 
HIV prevention measure in prison. Often prison staff have opposed it, saying that needles 
could be used as weapons against staff and/or fellow prisoners and that making them 
available would be tantamount to condoning prisoners’ drug use and giving up on efforts 
to prevent drugs from coming into the prisons.
However, the experience of the many prisons in which programmes have been 
implemented has been positive not only for prisoners, but also for prison staff:
P " rison-based needle and syringe programmes are effective in reducing needle 
sharing and resulting HIV infection.
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T " he programmes have had other benefits, such as a decrease in injection-related 
abscesses, phlebitis, endocarditis, etc. In one prison, a decrease in overdose 
incidents and deaths was observed. One of the reasons cited for this is that the 
implementation of needle exchange and the adoption of a harm-reduction phi-
losophy within the prison fundamentally changed the way that prison health and 
social work staff were able to engage in counselling with prisoners. Honest dis-
cussions about risk behaviour and overdose risk were able to take place in an 
atmosphere where prisoners did not have to fear sanctions for admitting their 
drug use. 
N " eedle and syringe programmes do not undermine abstinence-based programmes. 
Drugs have remained prohibited within prisons where such programmes are in 
place. Security staff remain responsible for locating and confiscating illegal drugs. 
However, it is recognized that if and when drugs find their way into the prison 
and are used by prisoners, the priority must be to prevent the transmission of HIV 
and HCV via unsafe injecting practices. Therefore, while drugs themselves remain 
illegal, needles that are part of the official needle and syringe programme are not. 
Evaluations have found that needle and syringe programmes in prisons actually 
facilitate referral of drug users to drug dependence treatment programmes, and 
have led to an increase in the number of prisoners accessing such programmes.
N " eedle and syringe programmes have brought people who use drugs in contact 
with health care staff and peer educators, and allowed for provision of education 
and information on other aspects of HIV, HCV, and other infections. 
S " ince the first programme started in 1992, there have been no reports of syringes 
ever having been used as weapons in any prison with an operating programme. 
In fact, there are reports of an increase in staff safety in prisons with needle 
and syringe programmes, due to the fact that accidental injuries to staff from 
hidden syringes during cell searches have been reduced. The decrease in the 
possibility of injury is due to the fact that prisoners are permitted to store inject-
ing equipment in a particular area and therefore do not hide it, thus reducing 
the risk of needle-stick injury during searches. Staff have also reported that the 
introduction of needle and syringe programmes makes injecting equipment more 
easy to control. 
A " vailability of syringes does not result in an increased number of drug injectors, 
an increase in overall drug use, or an increase in the amount of drugs in the 
institutions. In a few prisons, evaluations actually found that reported levels of 
drug use or injecting decreased.
B " efore their implementation, prison staff regularly had to be convinced to accept 
or at least tolerate the needle and syringe programmes. Nevertheless, once in place, 
acceptance increased and was generally high among prison staff, as well as among 
drug users and non-drug using prisoners. Staff attitudes towards the programmes 
were least positive in those prisons in which prisoners experienced problems 
accessing syringes and/or did not trust that they could obtain them without suf-
fering negative consequences, leading to continued illegal trade with syringes in 
the prison and generally, to reduced benefits of the programme.
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S " upport by prisoners and prison staff is important, and both prisoners and staff 
should receive information and education about the programmes and their expected 
benefits, and be involved in their design and implementation.
Often, health-care staff have been instrumental in starting and running needle and syringe 
programmes in prisons.
Box 37.  Switzerland: health care staff start first needle  
and syringe programme
The first prison needle and syringe programme started as an act of “medical disobedience.” In Swit-
zerland, sterile injecting equipment first became available to prisoners in 1992, at Oberschöngrün prison 
for men. Dr Probst, a part-time medical officer working at Oberschöngrün, was faced with the ethical 
dilemma of as many as 15 of 70 prisoners regularly injecting drugs, with no adequate preventive 
measures. Probst began distributing sterile injecting equipment without informing the warden. When 
the warden discovered this, instead of firing Probst he listened to Probst’s arguments and sought 
approval to sanction the distribution of needles and syringes.
Box 38.  Moldova: health care staff supervise peer-led needle and 
syringe programme
In Moldova, the prison needle and syringe programme evolved through two stages. During Stage 1 
needles and syringes were distributed hand-to-hand to prisoners through the prison medical unit. Dur-
ing the four or five months that this distribution system was in place, between 40 and 50 needles and 
syringes were exchanged. However, the project team decided that this method of distribution was not 
satisfactory. Their most significant concern was that the programme was being accessed by only 25 
to 30 per cent of the prisoners known to inject drugs. A number of barriers were identified. These 
included difficulty in establishing a rapport between the medical staff and the prisoners who were 
injecting, a lack of anonymity and of confidentiality in the service, and the fact that needle exchange 
was only available during office hours. Therefore, under Stage 2 of the programme, eight peer volun-
teers were trained to provide harm-reduction services in four different sites in the prison. Two peer 
volunteers were assigned to work at each site and were available on a 24-hour basis because the sites 
were based within the prison living units. The activities and programmes were carried out in coopera-
tion with the prison physician. In the first nine months of 2002, 65 per cent to 70 per cent of people 
known to inject drugs in the prison were accessing the programme through the peer volunteers. 
Health-care staff remain involved in the programme, but only as supervisors.
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Collaborative HIV-TB activities
TB is one of the major causes of morbidity and mortality in HIV patients. The detection 
and treatment of tuberculosis is one important measure for addressing the HIV epidemic. 
Since HIV prevalence rates are often several fold higher in prison than in the general 
community, the risk of TB in prisons is also multiplied. Increased case detection of TB 
among prisoners will serve to bring treatment to one of the most common infection in 
people living with HIV, and if necessary, to provide preventive treatment to HIV positive 
patients. In people living with HIV in whom active tuberculosis has been ruled out, con-
sideration should be given to providing Isoniazid Preventive Therapy (IPT), which can 
reduce the progression to active TB. 
The increased likelihood of co-morbidity of HIV and TB in prisons means that a collabo-
rative model of care for the two diseases is essential, but must be combined with a com-
prehensive approach to the provision of health services. Particular attention should be 
given to providing these collaborative services to drug users who are at increased risk of 
both diseases. The WHO recommends national and local coordinating bodies to plan, 
implement and monitor collaborative activities, and it is essential that the prison admin-
istration and prison health service are represented in these bodies so as to ensure proper 
integration of the national TB control programme (NTP), as well as the national HIV-AIDS 
programme in prison settings. A collaborative approach will help to reduce the spread of 
TB and HIV, both in prisons and in the general community. 
While the segregation of HIV positive prisoners has no public health rationale, and should 
not be considered, it is important to isolate active cases of tuberculosis who may transmit 
the infection to anyone within the prison, including prison staff, until they become non-
infectious after the initial treatment phase.
For details of implementing collaborative HIV-TB activities you should refer to WHO 
policies and guidelines, and consult with the relevant sections of the Ministry of Health.
For a detailed plan and guidelines used for the implementation of needle and syringe pro-
grammes, see: Ministerio Del Interior/Ministerio De Sanidad y Consumo (2003). Needle 
Exchange in Prison. Framework Programme. Madrid: Ministerio Del Interior/Ministerio De Sanidad 
y Consumo. Essential for anyone wishing to see how a successful programme can be estab-
lished in a prison. Available in Spanish, English, and French. Another, less comprehensive, 
document on the same issues, entitled “Elements key for the installation of programs of 
exchange ok (sic) syringes in prison” (Elementos clave para la implantacion de Programas de 
Intercambio de Jeringuillas en Prision) is available at www.msc.es/ciudadanos/enfLesiones/
enfTransmisibles/sida/prevencion/progInterJeringuillas/PIJPrisiones/elemClavePIJIng.htm
WHO, UNODC, UNAIDS (2007). Interventions to Address HIV in Prisons: Needle and Syringe 
Programmes and Decontamination Strategies. Evidence for Action Technical Papers. Available 
at www.who.int/hiv/idu/prison/en/index.html or www.unodc.org/unodc/en/hiv-aids/
publications.html. 
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Hepatitis B vaccination
Hepatitis B is easily spread in prisons. In contrast to HIV, the risk of infection can be 
reduced through the administration of a vaccine. Some prison systems already make 
hepatitis B vaccination available to all prisoners and prison staff. If it is available in 
your prison, you should encourage all prisoners and your fellow staff to be vaccinated. 
If it is not, you should inform the prison management of the benefits of making the 
vaccination available. In addition, consideration should be given to offer hepatitis A 
vaccination to prisoners at risk.
Hepatitis C prevention
In addition to contributing to reduced risk of HIV transmission in prisons, most of 
the measures described above also contribute to reducing the risk of hepatitis C 
virus (HCV) transmission. However, as explained above, in box 5, HCV is much more 
easily spread than HIV, including through sharing of shavers and toothbrushes, as 
well as through tattooing and body piercing. It is therefore important that all prison-
ers and staff receive information about the risks of HCV transmission in prison and 
are educated about the ways to reduce that risk. In addition, shavers and tooth-
brushes should be made available to prisoners so that they do not have to share 
them with fellow prisoners; and prisons should consider implementing measures to 
reduce the spread of HCV through tattooing and body piercing, such as making 
sterile tattooing equipment available to prisoners.
For comprehensive information about tuberculosis control in prisons, see:
World Health Organization & International Committee of the Red Cross (2001). Tuberculosis 
Control in Prisons: A Manual for Programme Managers. Available in English, Spanish, and Russian 
via www.who.int/docstore/gtb/publications/prisonsNTP/.
J. Veen. Tuberculosis control in prisons. In: World Health Organization, Regional Office for 
Europe (2007). Health in Prisons—A WHO Guide to the Essentials in Prison Health.
WHO (2007) Status Paper on Prisons and Tuberculosis. www.euro.who.int/Document/
E89906.pdf
For information about a programme to treat multiple drug resistant TB in prisons in Siberia, 
see: www.phri.org/programs/programme_russiantb.asp 
WHO (to be published in 2008) Providing Comprehensive TB and HIV Prevention, Treatment and 
Care Services for Injecting Drug Users—A collaborative Approach.
WHO. Interim policy on collaborative TB/HIV activities (2004). Available in English, French, 
Russian, and Spanish at www.who.int/tb/publications/tbhiv_interim_policy/en/.
!
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Detection and treatment of sexually transmitted infections
Early detection and treatment of sexually transmitted infections (STIs) is important 
because these infections increase the chances of an individual transmitting and acquir-
ing HIV. STIs that disrupt the integrity of the skin or mucous membranes increase the 
infectiousness and susceptibility to HIV. For this reason, health care staff should screen 
individuals for STIs and offer treatment, and educate prisoners about the importance of 
prevention and treatment of STIs.
Practical questions for health service staff in prisons
General health management 
As described in the earlier sections, the prevention of HIV infection, and the treatment 
and support of people living with HIV in prisons, while requiring specific actions such as 
HIV prevention measures, must be integrated into a comprehensive health strategy for 
prisons. A health strategy in prisons is not only about the diagnosis and management of 
disease, but encompasses both health prevention and health promotion.
Initial medical screening
Health prevention and promotion should begin at the point of entry into a prison where 
an initial medical screening should take place as soon as possible, but usually within 24 
to 48 hours. The screening may be done by a doctor, but also by a suitably trained nurse 
who reports to the prison doctor. As well as identifying common diseases and ensuring 
continuation of any treatments, the screening should provide health prevention and pro-
motion messages on the risks of HIV, hepatitis, sexually transmitted infections and other 
diseases such as TB, to all new prisoners. It is particularly important to identify prisoners 
who may undergo drug or alcohol withdrawal upon entering prison. It is also important 
to identify prisoners with mental disorders since they may require diversion to mental 
health services for treatment, rather than imprisonment. Also, you should pay attention 
to those groups of prisoners who may be at risk of self-harm or suicide, such as first time 
offenders and young men and women.
Accessing health services
Prisoners should be provided with information about how to access the prison health 
services, and the confidential nature of any appointments and records must be stressed 
so as to increase the trust of the prisoner. If peer education programmes are in place in 
your prison, the prisoner should be provided with basic information on how to access 
such programmes.
In general, prisoners are entitled to free health care services in prison since, while impris-
oned, they have no income and are dependent upon the prison service for their daily 
existence. The health services should be of an equivalent level to those available in the 
community and should include medical, psychiatric/psychological and dental care. This 
is not to say that the prison must have all of these services permanently on site, but 
through establishing formal links and collaborations prisoners must have access to 
the relevant medical staff, including specialists, and in-patient care, in the community 
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hospitals or clinics. Links with the community health services will also ensure that there 
is support for prison health staff and the availability of continuing medical education to 
ensure the maintenance of professional standards and new treatments. It is crucial that 
the legitimate security concerns of the prison administration do not impede the access of 
prisoners to outside health facilities, and prior arrangements for secure transport and 
treatment must be made between the prison and the health facilities. 
Health care versus security
The ethical medical treatment of prisoners dictates that the care of the prisoner should be 
the health care providers’ primary concern. Health-care providers in prisons have the 
same duties and responsibilities as health-care providers in the community. However, by 
nature of working in, and in many cases being employed by, the prison service, there can 
be contradictions between the health needs of a prisoner and the security concerns of the 
administration. These are sometimes referred to as “dual loyalties”, where health-care 
providers owe simultaneous obligations to the patient and to a third party, such as the 
state or to a prison, police or military service. The health-care providers must not subor-
dinate their medical judgement to security concerns, but must retain independent clinical 
judgement. For example, the handcuffing of patients during consultations can clearly 
interfere with treatment and with the trust of the prisoner. Attention should be paid to 
securing the facility or room, rather than handcuffing the patient. 
Providing antiretroviral therapy and other treatment for prisoners with HIV or AIDS 
The advent of widely available and increasingly affordable antiretroviral (ARV) therapy 
for people with HIV has meant that, for those who receive the medication, HIV has become 
a manageable disease. The World Health Organization and other organizations having 
been driving an initiative to make ARVs available to as many patients as possible, espe-
cially in those countries where HIV prevalence is high and resources low. At the 2005 
World Summit and at the 2006 High Level Meeting on AIDS, world leaders committed to 
pursue all necessary efforts towards the goal of universal access to comprehensive HIV 
prevention programmes, treatment, care and support by 2010. In support of this, addi-
tional resources to fund an expanded response have become available, including through 
the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Thanks to these initiatives, ART is increasingly becoming available in developing coun-
tries and countries in transition, and countries are moving towards the goal of universal 
access to treatment by 2010. Therefore, it will be critical to ensure that treatment also 
becomes available to all prisoners who need it.
As prisons need to provide standard of treatment equivalent to outside, prisons have to 
be ready to provide ARVs to prisoners with HIV wherever treatment becomes available in 
the community, including enabling treatment without interruption upon arrest and ensur-
ing treatment can continue without interruption upon release. As has been detailed in the 
preceding sections, since the risk of spread of HIV is much greater in prisons, the control 
of the infection in prisons, which can include ARV therapy, is an integral part of control 
in the community. This is especially true for those prisoners who have already com-
menced ARVs in the community, and for whom the treatment would be interrupted by 
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entry into prison, or may be interrupted upon release. Continuation of treatment with 
ARVs is a crucial point, as even a short interruption of the treatment may lead to HIV 
resistance to the drugs.
Administering ARVs in prison settings is a challenge, but experience in a growing number 
of countries shows that it can be done, with good results, provided it is well planned, 
undertaken as part of a country’s general treatment scale-up effort, integrated with the 
provision of treatment outside prisons, and adequately supported by resources and staff. 
The following issues need to be considered:
Y " ou will have to receive training in the comprehensive management of HIV and 
AIDS, including the provision of antiretroviral therapy.
F " orming partnerships or entering into agreements with local or regional outside 
health clinics, hospitals and universities and civil society organizations (including 
organizations of people living with HIV) to provide antiretroviral therapy and other 
services for prisoners, and developing integrated rather than parallel care and 
treatment programmes can be useful. Ideally, prisoners should be able to access 
antiretroviral medication through public health facilities during their imprison-
ment. Links with community health services are also important for obtaining 
specialist advice on the treatment regimes and on managing side-effects, and also 
for continuing care and support upon release of the individual.
I " nformation and education on access to treatment should be provided to all offend-
ers who are eligible to be on antiretroviral therapy and treatment of opportunistic 
infections.
O " n admission, you should determine whether offenders (including detainees await-
ing trial) require treatment for any HIV- or AIDS-related illness or opportunistic 
infection, such as tuberculosis. If necessary, you should refer them appropriately.
T " reatment literacy campaigns and sessions should be undertaken in prisons to 
increase people’s understanding of the benefits (and limits) of treatment.
M " easures need to be established to facilitate adherence to treatment. 
T " he treatment programme needs to contain a comprehensive discharge planning 
system for prisoners nearing release, including a system for referral to treatment 
in the general community.
T " he guidelines for administration of ARVs in prison should be the same as the 
national guidelines outside prison.
F " or cases of HIV and TB co-morbidity, attention must be paid to the potential drug 
interactions between some anti-TB drugs and some ARVs.
T " he confidentiality of prisoners’ HIV status and treatment regime must be ensured. 
This means, for example, that no special marks or signs should be placed on 
medical records, meals or cells of HIV-positive prisoners.
T " he prison health staff must give careful consideration to the practicalities of the 
daily administering of drugs and the monitoring for side-effects, since this can 
easily identify prisoners as being HIV positive. 
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Until ARV therapy is available in your prison, the recommended treatment for HIV posi-
tive individuals is “symptomatic management” of the disease. This usually requires treat-
ing and preventing the more common opportunistic infections associated with HIV. The 
WHO and UNAIDS recommendation of providing Cotrimoxazole Preventive Therapy (CPT) 
to prevent opportunistic bacterial and parasitic infections should be followed.
In the case of HIV positive patients with latent infection with Mycobacterium tuberculosis 
the WHO recommends that Isoniazid Preventive Therapy (IPT) be used to prevent progres-
sion to active tuberculosis. However, before IPT can be started, active TB must be ruled out 
since IPT in such cases would be inadequate therapy and lead to drug resistance. In the 
case of active tuberculosis, the initiating of the WHO DOTS strategy (Directly Observed 
Treatment—short course) for treating TB is as effective in HIV positive patients. 
For more information on HIV and TB treatments, including post-exposure prophylaxis, see:
WHO (2006) Antiretroviral therapy for HIV infection in adults and adolescents: recom-
mendations for a public health approach. 2006 rev. www.who.int/hiv/pub/guidelines/ 
artadultguidelines.pdf
WHO (2007) Tuberculosis care with TB-HIV co-management: Integrated Management of Adolescent 
and Adult Illness (IMAI) www.who.int/entity/hiv/TB_HIVModuleCover23.05.07.pdf
WHO (2006) HIV/AIDS Treatment and Care for Injecting Drug Users Clinical Protocol for the WHO 
European Region www.euro.who.int/document/SHA/WHO_Chapter_5_web.pdf
WHO (2006) Post exposure prophylaxis for HIV infection www.euro.who.int/document/
SHA/chap_13_prophylaxis.pdf
!
Confidentiality
Prisoners are entitled to the same respect of medical confidentiality as any other patient. 
Thus, the privacy of the medical consultation should be ensured so as to respect confiden-
tiality. It is clear that in relation to issues of HIV status, drug use, sexually transmitted infec-
tions, and in particular allegations of physical or sexual violence, prisoners must be afforded 
absolute confidentiality to allow them to discuss freely with the health staff. If, exception-
ally, guards must be present, they should remain in eyesight, but out of range of hearing. 
HIV-related stigma and discrimination is common in most countries, both inside and out-
side of prison. People living with HIV routinely face social isolation, discrimination, and 
even violence as a result of their HIV status, and in prison the risk of facing negative con-
sequences can be much greater. The stigma attached to HIV, as well as to drug use and 
same-sex activity, results not only in stress and fear for people living with HIV or AIDS, 
but can discourage people from seeking testing and/or accessing advice/information or 
treatment.
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The case sheets/medical records of individual prisoners should remain under the direct 
control and supervision of the health-care provider and should not be disclosed without 
the prior written authorization of the prisoner. They are not part of the general prison 
records. There should be no system of marking medical records, prison records or cells 
to indicate HIV status, since this can become easily known to guards and even to prison-
ers. Attention must also be given to institutional practices for delivering health care, 
health-care appointments, HIV voluntary counselling and testing, and medications. If 
they are noticeably different for those seeking information on HIV and for HIV-positive 
prisoners, this will quickly become obvious to staff and prisoners, and will discourage 
participation in prevention, testing and treatment programmes, as well as potentially 
increasing discrimination, victimization or violence.
Prison officers may believe they have the right to know who is HIV-positive and that such 
information will protect them from workplace exposure to HIV infection. It is the role of 
the prison health staff to challenge such false beliefs, and to address them through infor-
mation and education aimed specifically at prison staff. The prison administration itself, 
together with the health staff, should ensure that policies and practices are put in place 
that protect confidentiality and form part of a comprehensive HIV strategy in prisons.
Confidentiality may also be deliberately put at risk by other prisoners who, like prison 
officers, mistakenly believe that identifying people living with HIV will protect them from 
HIV infection. Misinformation about HIV can create false fears about the risk of HIV 
transmission via shared living spaces, shared bathing areas, or shared food utensils. If 
such attitudes are not challenged, they can undermine the effectiveness of HIV prevention 
initiatives among prisoners by creating an atmosphere where identifying HIV-positive 
prisoners—rather than reducing high risk behaviours—is seen as the most effective man-
ner to protect oneself against HIV infection. Such attitudes can also sustain an atmos-
phere of discrimination and potential violence against people living with HIV or AIDS. 
This not only has an impact on the lives of HIV-positive prisoners, it can also deter others 
from seeking voluntary HIV counselling and testing.
Early or compassionate release
In the case of terminally ill prisoners, prison policy should allow for release on compas-
sionate grounds, so that they able to die with dignity at home in the company of family or 
friends. Similarly, it may be that some prisoners are unable to receive the appropriate 
long-term or intensive level of medical care while in prison. In these cases, consideration 
should be given to the release of the prisoner so that they can obtain the adequate care in 
the community, or while at home.
In both these scenarios, the prison health staff should be in a position to provide inde-
pendent clinical judgements that are given the appropriate consideration by the prison 
administration.
Continuity of care
Prison health staff should ensure that there is a continuity of medical care for released 
prisoners. In the case of drug dependence treatments, such as methadone maintenance 
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therapy, or in the case of antiretroviral or tuberculosis therapy, the individuals, together 
with their confidential medical records, should be referred to the appropriate community 
health services. To ensure that contact with the health services is made, and maintained 
by the patient, the prison staff should enlist the help of community support groups or 
social services since simply advising a prisoner to go to a particular clinic may meet with 
little success.
Continuity of care also applies to those arriving in prison. Linkages and collaborations 
with the community health services, community organizations and social services will 
facilitate a smooth continuation for those who are already receiving some form of 
treatment and care in the community. 
Checklist 16. The role of prison health care staff
As health care workers you should provide equivalent services inside prison as you would outside. In 
the particular case of HIV, in addition to providing medical care and treatment for infected patients 
you should:
Advocate for prison policies, regulations and procedures that respect the rights of prisoners,  "
particularly to an equivalent level of healthcare, freedom from discrimination and stigmatization, 
and protection of patient confidentiality;
Ensure the promotion of both good physical and mental health, through the provision of a healthy  "
prison environment;
Ensure that the prevention of the spread of HIV and other blood borne viruses forms part of a  "
comprehensive health strategy in prisons;
Ensure proper diagnosis and treatment of sexually transmitted infections; "
Ensure early diagnosis and treatment of TB, often linked to HIV infection; "
Advocate for comprehensive HIV prevention programmes; "
Provide information and educational material to prisoners and prison staff; "
Promote and support peer education projects/programmes; "
Promote voluntary counselling and testing for HIV; "
Promote and initiate drug dependence treatment programmes; "
Promote and initiate or supervise needle and syringe programmes; "
Promote and initiate the distribution and correct use of bleach for disinfecting injecting and  "
tattooing equipment, while pointing out its limitations;
Make condoms, dental dams and lubricant available; "
Assess patients eligibility for early release; "
Ensure continuity of care, including ARV treatment, for prisoners arriving in, and leaving prison. "
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